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Abstract
The ability of short peptide fragments to self-assemble in isolation as amyloid and
amyloid-like structures has prompted their use as model systems for the study of
amyloid formation and recently also for their utilisation as novel nanofibrillar
material. The atomic force microscope (AFM) is used here to investigate the self-
assembly of two peptide systems and the development of strategies to directly
manipulate and control the structures they form.
The studies presented in Chapter 2 address the self-assembly of a peptide
fragment of the human amylin polypeptide; amylin (20-29). In the opening study we
use ex situ AFM imaging to characterise the early stages of amylin (20-29) fibril
formation. High-resolution images reveal that following an initial lag phase, fibrils
displaying a globular appearance are formed, which over time are replaced by flat
ribbon-like fibrils with no periodicity displaying a range of polymorphic structures
and assemblies. Following on from these findings, we investigate the influence of
solution conditions on amylin (20-29) fibril formation utilising in situ AFM
imaging. Altering the pH and electrolyte composition affords a range of
morphologies including, truncated and long branched or unbranched flexible fibrils
and globular aggregates.
Following on from this characterisation chapter, in Chapter 3 a strategy to
assemble specifically functionalised fibrillar material from chemically modified
amylin (20-29) peptides was investigated. Azide and alkyne moieties were
successfully coupled to the amylin (20-29) peptides. Ex situ AFM imaging and
Congo red binding confirmed that the additional steric bulk had no detrimental
effects on the fibril forming capacity of the peptides.
Finally, in Chapter 4 the focus turns to the self-assembly of a dipeptide of
phenylalanine which corresponds to the core recognition motif of the ȕ-amyloid
polypeptide. Here, the AFM is used to study the physical properties of the well-
ordered, discrete, hollow nanotubes which are formed. Their chemical stability in
organic solvents and considerable thermal stability under both dry and wet heating
conditions is revealed. Finally, the use of strong magnetic fields to directly control
and orientate the diphenylalanine nanotubes was examined by AFM.
The results presented throughout this thesis demonstrate the versatility of self-
assembling peptides for the generation of fibrillar nanostructures that can be directly
modified and controlled to generate novel architectures and functionalised well-
ordered nanomaterials.
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3D Three dimensional
AFM Atomic force microscopy
Amylin (20-29) The peptide fragment of the amylin polypeptide
corresponding to residues 20 to 29 in the human sequence.
ANS 1-anilinonaphthalene-8-sulphonate
ȕ-Amyloid ȕ-amyloid polypeptide, generic phrase for the two (ȕ(1-40)
and ȕ(1-42)) commonly found peptides in Alzheimer’s in
vivo amyloid deposits
BrCH2CO2H Bromoacetic acid
CD Circular dichroism
Cu (I) Copper in the 1st oxidation state
DCM dichloromethane
DIPEA N,N-diisopropylethylamine
DMF dimethylformamide
EM Electron microscopy
Fmoc 9-fluorenylmethyloxycarbony
FTIR Fourier transform infra red spectroscopy
HATU N-[(dimethylamino)-1H-1,2,3-triazolo[4,5-b]pyridin-1-
ylmethylene]-N-methylmethanaminium
hexafluorophosphate N-oxide
HFIP 1,1,1,3,3,3-hexafluoro-2-propanol
HOPG Highly-ordered pyrolytic graphite
HPLC High performance liquid chromatography
KCl Potassium chloride
LC-MS Liquid chromatography mass spectrometry
MgCl2 Magnesium chloride
MgSO4 Magnesium sulphate
MS Mass spectrometry
N3CH2CO2H 2-Azidoacetic acid
Na3C6H5O7 Sodium citrate
- ii -
NaCH3COO Sodium acetate
NaCl Sodium chloride
NaN3 Sodium azide
NMP N-methylpyrrolidone
NMR Nuclear magnetic resonance
pI Isoelectric point
RP-HPLC Reverse-phase high performance liquid chromatography
SEM scanning electron microscopy
SPPS Solid phase peptide synthesis
tBu tert-Butyl group
TEM transmission electron microscopy
TFA Trifluoroacetic acid
TGA thermo-gravimetric analysis
TIPS triisopropylsilane
TNBS tri-nitro benzene sulfonate
TOF SIMS Time-of-flight secondary ion mass spectrometry
Tris HCl Tris(hydroxymethyl)aminomethane buffer
Trt Trityl-group
Minds are like parachutes - they only function when open.
Thomas Dewar
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Chapter
1
Introduction
Proteins have a wide range of functions within a living cell and are crucial to the
maintenance of life. The function of proteins depends on the highly ordered three-
dimensional structure of their native folded form. The progression from gene to a
correctly folded functional protein can be a precarious journey and the cell has
developed a variety of safety nets to prevent or limit any detrimental
consequences. However, when these safety features fail, the resultant misfolded
protein can have disastrous consequences to the cell. A common feature of a
group of mammalian disorders collectively called amyloid or conformational
diseases is the aggregation of the incorrectly folded proteins into deposits of
fibrillar structures called amyloid.
1.1 Native Protein Structural Hierarchy
Proteins have complex structural hierarchy; the functional protein has a structure
folded into several levels of organisation. The physical and chemical properties of
each amino acid are conferred by the nature of its side chain, and are therefore of
considerable importance in the structure and resultant function of the protein.
Folding of the polypeptide chain is driven by non-covalent interactions which
form between the different amino acids of the polypeptide chain and is influenced
by restrictions imposed from the allowable conformations that the peptide bond
can adopt, as well as the flexibility of the amino acids and their side chains.
Secondary structure conformations are stabilised via hydrogen bonds between the
side chains of one amino acid to that of another in close spatial proximity but not
necessarily neighbouring in the primary sequence of the polypeptide chain. The
tertiary structure of the protein is the further folding of the secondary structures
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into functional domains which are stabilised by the formation of ionic, disulfide
and salt bridges between different residues and by further non-covalent
interactions, such as van der Waals forces, hydrogen bonds, etc. The various
secondary structure orientations and combinations that can be adopted by the
polypeptide chain results in a heterogeneous array of possible structures and this
explains how folded proteins can have such functional diversity. The highest
level of organisation in a protein is the quaternary structure; referring to the
assembly of individual folded polypeptide chains into functional proteins that
comprise multimeric assemblies.
1.2 Folding pathways
In the cell, the majority of protein folding occurs within the endoplasmic
reticulum, which is the primary location of protein synthesis. Several factors are
key to the folding process including:
x Packing and internalisation of hydrophobic amino acid side chains and
exclusion of the aqueous environment
x Formation of non-covalent interactions (hydrophobic, electrostatic, hydrogen
bonds)
The kinetics and thermodynamic properties of some polypeptide chains results in
the formation of a folded structure in the C-terminal portion even before the N-
terminal has been synthesised. In such circumstances protein folding is a
spontaneous event constrained merely by the speed of the ribosomes. However,
not all proteins self-assemble due to either the complexity of the folding event or
other factors such as environmental conditions. Under such circumstances the
newly synthesised polypeptide chain rapidly collapses to form a folding
Unfolded Molten Globule Folded
Figure 1.1: Progression of the unfolded nascent polypeptide chain through the
molten globule intermediate to the folded functional protein.
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intermediate; a partially organised structure called the molten globule. These
intermediates enable folding to overcome the various energy and thermodynamic
barriers experienced. The molten globule is a group of these intermediates with
similar evolving structures rather than a single distinct structure.
The molten globule has several common structural characteristics. It is
characterised by a pronounced secondary structure displaying the majority of the
structural features of the native protein (figure 1.1). Intramolecular interactions
are not properly formed and so the molten globule is lacking in higher order
structure and has a loosely packed hydrophobic core. This results in a less
compact globular structure than the native folded protein with a radius of gyration
10-30% greater [1]. The less compact structure and exposed hydrophobic core
increases the accessibility of the surrounding solvent to the hydrophobic residues.
This is a dangerous state for the protein to be in as the hydrophobic surface
increases the tendency of the intermediate to form aggregates.
Figure 1.2: Quality control mechanisms employed by the cell to combat unfolded
and misfolded proteins. The unfolded or misfolded protein has 3 possible fates in the
cell: (1) Refolding by the ATP-dependent molecular chaperones to the correct native
protein. (2) Proteolytic degradation or (3) if the misfolded protein escapes detection by
the cells quality control system it may aggregate within the cell. Adapted from [2].
(1)
(2)
(3)
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To aid the folding process, a group of ATP-dependent catalytic proteins known as
molecular chaperones, whose primary role is to prevent protein misassembly and
aggregation [3], catalyse protein folding and assist the self-assembly of the molten
globules. These catalytic proteins recognise their substrates via the hydrophobic
patches exposed in the folding intermediate [4]. By binding the hydrophobic
residues they are effectively acting as cloaking devices, masking and preventing
the intermediate from forming any unwanted interactions. If the cell deems the
misfolded protein to be irretrievable then the proteolytic machinery quickly
degrades it. In most instances misfolded proteins are mopped up by the cellular
quality control systems. However, certain proteins may escape detection,
subsequently forming aggregates of non-functional protein. The exact reason as
to why the molecular chaperones and proteases do not recognise these misfolded
proteins still remains an area of contention [5].
1.3 Protein misfolding
The key difference between a native protein and its misfolded form is a change in
conformation, whether at the secondary, tertiary or quaternary level. Misfolded
proteins are unstable within the cell and form an intermediate reminiscent of the
molten globule [6]. In vivo, the misfolding of a protein may be triggered by any
of a number of events such as the result of an intrinsic error in its primary
sequence caused during translation, or as a result of mutation in the gene, or
misreading of the genetic sequence during transcription. Alternatively it is
possible that once the folded protein has been synthesised, a conformational
change may be induced by a template misfolded form of the protein (for example
the prion protein [7]), or the protein may experience destabilising conditions that
lead to either partial or complete unfolding, such as adverse pH, variations in
ionic strength and increased temperatures. Specific solvent conditions result in
the stabilisation of the molten globule, and consequently the partially folded
intermediate retains an exposed hydrophobic core and under these conditions,
accumulates, forming insoluble aggregates [8].
During the formation of the correctly folded globular protein, the polypeptide
chain collapses to internalise amino acids with hydrophobic side chains (valine,
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leucine and isoleucine) within the core of the protein. The resultant structure is
soluble in the aqueous environment of the cell or associates with cell membranes.
However, if the protein is only partially or misfolded any exposed hydrophobic
residues will form interactions with similar surfaces [9]. The hydrophobic
interactions can cause any incorrectly folded intermediates to aggregate into
fibrillar deposits of varying sizes known as amyloid [10]. A possible role for
molecular chaperones in the prevention of amyloid deposition is their ability to
induce a conformational change in the precursors of amyloid fibrils [5],
preventing their accumulation into toxic insoluble aggregates and instead
catalysing the formation of detergent-soluble amorphous and non-toxic aggregates
that have been observed under the electron microscope [11].
1.4 Amyloid and Disease
The aggregation and subsequent deposition as amyloid of over 20 different
proteins is associated with several mammalian diseases collectively called
amyloid or conformational disorders. This group of disorders manifest both as
systemic and tissue specific conditions, and include a partial list of human fatal
neurodegenerative disorders including Alzheimer’s disease, Parkinson’s disease
and Huntington’s chorea, the transmissible spongiform encephalopathies (Kuru,
CJD and BSE), Type II diabetes mellitus and other systemic amyloidosis. A
common histopathological feature of all these disorders is the deposition of
amyloid fibrils as plaques in tissues. These plaques are observed both
intracellularly and within extracellular pockets in a range of organs including the
liver, spleen, kidneys and brain [12]. Deposition of amyloid is due to several
factors and therefore the aetiology of this group of diseases is varied manifesting
as genetically inherited, sporadic and infectious disorders (For an excellent
overview see Dobson 1999 [13]).
Although the amyloid fibrils are a common factor, it still remains an area of
contention whether these aggregates of misfolded protein are the causative agent
of the disease state [14]. Current hypothesis suggest that prefibrillar assemblies of
the amyloidogenic proteins may actually be the cytotoxic component and directly
responsible for cell death [15-17]. Furthermore, the accumulation and aggregation
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of these prefibrillar assemblies culminates in the formation of the mature amyloid
fibril [17]. There is an increasing amount of evidence supporting this proposal for
such neurodegenerative or tissue specific amyloid diseases as Alzheimer’s and
type-II diabetes mellitus. However, for other systemic amyloidosis it still remains
clear that the accumulation of large quantities of insoluble protein aggregates have
a direct pathological effect too, causing disruption to organ and tissue functions
[18].
Although most amyloid comprises aggregated misfolded or partially folded
versions of native protein, not all misfolded proteins become amyloid. In
addition, not all amyloid fibrils are associated with disease; in fact several
proteins have been shown to form amyloid fibrils in vivo with no detrimental
effects to the cell and in certain exceptions proves beneficial [19]. Two examples
of which are the Escherichae coli protein curli [14] and the yeast prion protein
Sup35 [20]. Furthermore, amyloid formation is proposed to be a generic feature of
the polypeptide chain and that the intermolecular bonds which stabilize amyloid
are also intrinsically involved in the folding of the peptide backbone common to
all proteins [8, 13, 21].
1.5 General characteristics of amyloid
The formation of the amyloid fibrils is not restricted to a subset of proteins but is
in fact a generic feature of the peptide chain and is greatly affected by
environmental conditions encountered. Fibril formation is dependent on the
accumulation of mis- or partially folded polypeptides exceeding a critical
concentration [22] and thus crowding within the cell caused by low clearance or
increased production facilitates interactions between misfolded or partially-folded
proteins. Variations in the localised environment can affect fibrillisation, such as
slight changes in temperature or pH [23].
Although the amyloidogenic proteins are the predominant component of in vivo
amyloid other molecules are commonly found associated or incorporated within
the fibrils. These molecular species are often common to many unrelated amyloid
deposits. Among these factors is the serum amyloid-P component (SAP), which is
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common to all amyloid found in vivo [24] and is proposed to aid amyloid fibrils to
escape proteolytic degradation in the cell [25].
Despite the origins of amyloid from a diverse array of proteins, all amyloid fibrils
can be characterised by three generic structural criteria. Firstly, amyloid display
similar morphologies and are typically long unbranched fibrillar structures. Fibril
dimensions are typically less than 10 nm in diameter with lengths in microns scale
[26]. Secondly, all amyloid when stained with the azo dye Congo red display a
green-gold birefringence under cross-polarised light [27, 28]. This birefringence is
directly related to the ordered structural anisotropy of the dye molecule and the
core structure of the amyloid fibril. Thirdly, all amyloid have a common structural
core; the cross-beta (ȕ) structural conformation.
1.5.1 Amyloid structure
Early X-ray diffraction analysis of amyloid revealed a common diffraction pattern
displaying an intense and relatively sharp 4.75 Å meridonal reflection and a
weaker and more diffuse equatorial reflection at 9.8 Å [29]. A characteristic
diffraction pattern of the cross-beta (ȕ) structural conformation, a common
secondary structure conformation found in many proteins [30]. The cross-ȕ
structure is a particular folding conformation of ȕ-sheets, in which the constituent
ȕ-strands are arranged perpendicular to the fibre axis and the ȕ-sheets arranged
parallel. The individual ȕ-strands may be arranged in parallel or antiparallel
configurations relative to each other. The 4.75 Å meridonal reflection is generated
by the hydrogen bonding spacing between adjacent ȕ-strands, and the face-to-face
stacking of the ȕ-sheets gives rise to the equatorial reflection at 9.8 Å. To date all
amyloid fibrils including ex vivo, in vitro and fibrils synthesised from
oligopeptides display this common core structure [31].
Further details of the core structure and refinement of a generic amyloid model
were gained from synchrotron X-ray diffraction experiments on transthyretin
amyloid fibres carried out by Blake and Serpell [32]. The higher-resolution data
obtained from the synchrotron X-ray experiments revealed additional very weak
meridonal reflections at 3.2, 2.8-9, 2.39-41, 2.22-7 and 2.00-2 Å, which fit a
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repeat distance index of 115.5 Å parallel to the fibril axis. Leading to the proposal
that the ȕ-strands comprising the cross-ȕ structure of the transthyretin fibril are
grouped within this 115.5 Å distance into a novel repeating unit of 24-strands
along the axis of the fibril, in which the 24th strand is twisted by 360 degrees
relative to the 0th. Corresponding to a well-ordered core structure extending over
the entire fibril axis, which is stabilised by hydrogen bonding along the ȕ-sheet
helix in which 24 ȕ-strands are arranged with a helical pitch of 115.5 Å, lying
parallel to the fibril axis. A molecular model [32] of a single ȕ-sheet helix is
presented in figure 1.3 with the helical pitch indicated. The loop regions which
join together the individual strands are not shown.
The spacing and intensities of the 10 Å equatorial reflections in the synchrotron
X-ray diffraction patterns indicate that a single fibril comprises several of the ȕ-
sheet helices stacked face-to-face and perpendicular to the fibril axis. The diffuse
reflection is likely to represent the varying distances between individual ȕ-sheets
24 ȕ-strands with
a helical pitch of
115.5 Å
A
B
Figure 1.3: An isolated ȕ-sheet helix from the core structure of the amyloid
fibril. A: View of the ȕ-sheet helix along the axis of the fibril demonstrating the
parallel arrangement of the 24 ȕ-strands within each 115.5 Å helical pitch. B:
cross sectional view of the ȕ-sheet helix. (Adapted from Blake et al ‘96 [32])
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within the fibril, with the distance dependent on the side chain packing of the
peptide chains.
Analysis of the X-ray diffraction patterns from other amyloid show similar
meridonal and equatorial reflections [33, 34]. Consequently it is proposed that this
core structure determined for the transthyretin amyloid in which the ȕ-sheets are
arranged as a continuous helix configuration within the common cross-ȕ core
structure is a generic structural arrangement within amyloid.
Electron microscopy analysis of amyloid combined with the detailed X-ray
diffraction data revealed that fibrils display a distinct structural hierarchy with
several levels of sub-fibrillar assembly and structural organisation [35-37]. The
fibrillar structure comprising several ȕ-sheet helices stacked face-to-face is
designated the protofilament and is the lowest structural level of amyloid
observable by EM and AFM [35]. Several protofilaments are found coiled
together, in the majority, arranged around a hollow, core or channel [35, 38] to
form a protofilament. The protofilament is found aggregated together by further
coiling or by lateral association into fibrillar deposits. A schematic representation
of the various structural levels within amyloid is presented in figure 1.4.
Amyloidogenic
protein
Conformational
change or ȕ-
strand stacking
assembly assembly aggregation
subprotofilament protofilament protofilam
ent
fibrillar
deposits
Figure 1.4: Schematic of the structural hierarchy of the amyloid fibril. The cross-ȕ
structure of the amyloid fibril includes a hollow channel through the centre of the fibril. The
structure of the fibril comprises several well-ordered sub-fibrillar levels.
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The core ȕ-sheet structure and hierarchical organisation are proposed to be generic
characteristics of amyloid, however the exact number and orientation of
protofilaments within the fibril is protein specific and dependent on the sequence
of the polypeptide chain. Moreover, not all of the polypeptide chain is
incorporated within the folds of the ordered ȕ-sheets, consequently the superfluous
and connecting regions influence the interactions and packing arrangements
between protofilaments [39, 40]. Furthermore, the orientation of the ȕ-strands
within the individual ȕ-sheets is protein specific and may be either antiparallel or
parallel.
Summarised in table 1.1 is a list of the suggested structural hierarchy of five
different amyloid fibrils as determined from a selection of X-ray diffraction,
NMR, EM and AFM studies. In illustration, the proposed structural arrangement
Protein Associated disease
Mature
proto-
filament
diameter
Structural hierarchy
within the mature
protofilament
Example
references
Aȕ-peptide (1-
40) & (1-42)
Alzheimer’s disease 6-10 nm 5-6 protofilaments
3-5 nm in diameter
[41, 42]
Amylin Type II diabetes
mellitus
8-13 nm 2 to 4 protofilaments
3-5 nm in diameter
[43, 44]
Ig light chain Light chain
amyloidosis
7-8 nm 5 protofilaments 2-3
nm in diameter
[45]
Lysozyme
(Asp67His
variant)
Autosomal dominant
hereditary
amyloidosis
8-10 nm 5 protofilaments
3 nm in diameter
[46]
Transthyretin
(full length &
fragment)
Senile systemic
amyloidosis
13 nm 4 protofilaments of
4-6 nm in diameter
arranged in pairs
[36, 47]
Table 1.1: Summary of the structural information obtained for five amyloidogenic
proteins. Proteins are listed with the associated disease state. The range of dimensions of
the mature protofilaments typically observed and the structural hierarchy of species
comprising the protofilaments are presented in columns 3 and 4. Examples of the references
citing experimental data in support of the structural information are presented in the final
column.
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models for the polypeptide chains of two dissimilar amyloid proteins within the
common cross-ȕ structure of their fibrils are discussed below.
The proposed structural model for protofilaments of the human amylin
polypeptide suggests that the polypeptide chain folds in an S-shape with 3 ȕ-
strands formed by residues 12-17, 22-27 and 31-37. ȕ-turns allow the polypeptide
to fold into the S-conformation with long-range interactions between residues
F15, F23 and Y37 [48]. Stacking of the ȕ-strands perpendicular to the fibril axis
gives 3 in-register superpleated ȕ-sheets which run parallel to the fibril axis in a
cross-ȕ conformation. The S-shaped fold gives rise to a small left-handed
rotational twist in the ȕ-sheet [44, 49, 50]. Protofilaments comprising 3
protofilaments arranged with a left handed helical twist are the predominant
species [43]. While other structural models have been suggested for the
configuration of the ȕ-strands, currently this model is in strongest agreement with
experimental observations.
By comparison the model of the fibrils formed by Aȕ (1-40) and (1-42) proteins
suggests that protofilaments (>2 nm in diameter) are assembled from pairs of ȕ-
sheets. The ȕ-sheet is composed of two ȕ-strands formed from residues 25-30 and
30-40 in an anti-parallel arrangement [41, 51-53]. A ȕ-turn at residues 12-24
enables the two ȕ-strands to form two, in-register, parallel ȕ-sheets in contact via
side chain interactions giving rise to the characteristic cross-ȕ X-ray diffraction
patterns [54]. The folding of the polypeptide chain is such that the protofilament
has a hydrophobic core with one hydrophobic face. EM and X-ray analysis
suggest that five or six protofilaments aggregate, most likely driven by
hydrophobic forces, into a helical arrangement around a central core channel, 5.5
nm in diameter [38, 41].
1.5.2 Amyloid fibril morphology
As noted earlier, a generic structural feature of amyloid is a long, unbranched
fibrillar structure. There is however, a degree of heterogeneity displayed by the
morphologies of fibrils formed not only by different proteins but also within the
fibril population formed from the same protein species. EM and AFM studies of
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amyloid have revealed the polymorphic nature of the amyloid fibril; insulin
amyloid forms helically twisted fibrils with four different morphologies
dependent on the number of protofilaments present [55], the fibrils formed by
lysozyme Asp67His are wavy [26], whereas both human amylin and human Aȕ
amyloid exhibit similar heterogeneous polymorphic mature fibrils that may be
helical, with left-handed coiling and axial cross-over periodicity of 25-50 nm,
twisted ribbons or as ribbon-like arrays [43, 56, 57]. This apparent polymorphic
nature is thought to arise not only due to the varying numbers of protofilaments
incorporated within the amyloid fibril but may also be directly influenced by
environmental conditions [23].
1.6 Fibrillisation pathway
The rate of protein aggregation is greatly dependent on several factors
intrinsically linked to the amino acid sequence of the polypeptide chain. With
importance on amino acid size, propensity to form ȕ-sheets as well as the
hydrophobic nature of the polypeptide sequence [58-60] and growing evidence in
favour of aromatic stacking interactions [61-63].
Kinetic studies of amyloid formation indicate a two phase nucleation-dependent
mechanism, in which an initial lag phase occurs followed by a period of rapid
growth and elongation of fibrils [64-66]. The initial step requires the formation of
a nucleus and therefore is dependent on protein concentration and suitable
environmental conditions. Following the lag phase, assembly and growth of fibrils
occurs rapidly at an exponential rate, limited merely by the availability of the
protein.
In the initial lag stage of fibril formation, dimeric or low-oligomeric building
blocks further oligomerise to form prefibrillar structures [57, 66-68]. Aggregation
and ordered assembly of these structures result in the formation of the
protofilament and consequently assembly into protofilaments and fibrillar species.
Seeding of preformed fibrillar aggregates into protein/peptide solutions eliminates
the lag phase [69, 70]. Interestingly, ‘cross-seeding’ of different proteins can
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occur, though the level of diversity in the amino acid sequence constrains the
efficiency of seeding [70-71]. This sequence specificity may be explained by the
long-range interactions that stabilise the amyloid structure. This apparent cross-
seeding is likely to explain the species barrier phenomenon associated with the
transmissible spongiform encephalopathies; the level of transmission is lowered
between different species [73].
1.6.1 Driving forces and stabilising interactions
A fundamental question in amyloid formation which remains in part unanswered
focuses on the identification of the driving forces behind self-assembly and
aggregation. Not only will answers to this question complete our understanding of
amyloid formation but most importantly will aid the development of therapeutic
strategies to combat the degenerative amyloid diseases.
Given that the formation of amyloid is a generic feature of the polypeptide chain,
it seems highly probable that the interactions and forces involved are intrinsic to
the polypeptide backbone. Consequently, the interactions which govern correct
protein folding may also be involved in the self-assembly and aggregation of the
well-ordered amyloid, considering the same building block is involved in both
[13].
Amyloid formation is dominated by a specific pathway of non-specific
interactions involving non-covalent molecular recognition and self-assembly. The
aggregation pathway commences with the attraction of misfolded or partially
folded polypeptide chains by electrostatic and hydrophobic interactions. Regions
of the polypeptide chain that would normally be internalised may, in the non-
natively folded polypeptide chain, be exposed to the surrounding solvent and thus
prone to aggregation driven by such forces [74].
There is also growing evidence in support of the role of aromatic residues in the
ordered self-assembly process. Aromatic interaction between the planar ring side
chains of the aromatic amino acids are often observed in protein-protein
recognition events [75]. The attractive forces between aromatic rings form
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interactions that are predominantly entropy driven and thereby provide some of
the energetic contribution during the fibril assembly process [60, 62, 75, 76,]. In
addition, ʌ-ʌ stacking requires that the planar aromatic side-chains have restricted
geometries relative to one another [75]. Consequently, aromatic interactions may
also contribute to directionality and ordered arrangement of the polypeptide chain
within the ȕ-sheet core.
The aggregated polypeptide chains form oligomeric species which, once reaching
a specific size, act as nuclei for the elongation of the fibril. The size of oligomer is
entirely protein and condition dependent; oligomers of full-length amylin form
oligomers 2 to 6 nm in height before elongating into protofilaments [64], by
comparison pre-fibrillar oligomers of Aȕ (1-40) are 4-6 nm in height [56, 77].
Several mechanistic models have been proposed to describe the exact process by
which the individual polypeptide/peptide chains form the oligomeric nuclei [66,
78-81], with further suggestion that the mechanism may be amyloid species
specific [82]. However all are in agreement that protofilament assembly involves
either the longitudinal association of these pre-fibrillar structurally-ordered
oligomeric species [64, 83] or by the addition of monomers to the ends of the
growing fibril [66].
Once formed the elongating fibril exhibits considerable stability, the major
contributor of which is the hydrogen bonding network which exists between
individual ȕ-strands within the ȕ-sheet which thus extends along the core structure
of the fibril.
1.6.2 Core amyloidogenic fragments
The quest to identify a common factor in the amyloid protein responsible for fibril
formation has in part focussed on the identification of sequence motifs within the
native proteins. The synthesis of large aggregation prone polypeptide chains is
both difficult and expensive. Therefore, shorter fragments of these amyloidogenic
polypeptides are often studied as model systems to understand the interactions and
mechanisms which govern amyloid assembly [84].
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Although no common sequence homology has been demonstrated, key
amyloidogenic regions within the individual polypeptide chains have been
identified. These sequences are crucial for amyloid formation and intrinsically
form part of the ȕ-sheet core of the fibril [85]. In the native, correctly folded
polypeptide chain these aggregation ‘hot spots’ are likely to be hidden away
within the hydrophobic core of the protein with their side chains involved in
stabilising interactions [85].
These amyloidogenic sequences have been identified in the majority of
amyloidogenic proteins largely utilising mutagenic (proline and alanine) scanning
and through biophysical examination of structures formed by short peptide
sequences [86-88]. The short peptide fragments which include the amyloidogenic
motifs readily self-assemble into fibrillar structures under a range of conditions.
Generally these fibrillar structures still retain the 3 generic amyloid criteria but
may often vary, dependent on the size of the fragment, in fibril dimensions and
morphology (in example [88-91]). Therefore it may be surmised that the
information required for amyloid formation is retained within these key
amyloidogenic regions that are incorporated within the cross-ȕ core of the fibril.
For many of the amyloidogenic proteins, there may be several short peptide
sequences which are capable of forming amyloid-like fibrils in isolation.
However, within most of the proteins there is a key sequence of amino acids
without which the whole protein will not form amyloid; referred to as the ‘core
amyloidogenic’ motif. For example, rat amylin has considerable sequence
homology to the human protein differing by only 6 amino acids, though rat amylin
does not form amyloid. Five of the six variations in amino acid sequence between
the two homologues have been pinpointed to a 10 amino acid stretch
corresponding to residues 20 to 29. Analysis of this region revealed that the
central ȕ-strand (residues 22 to 27) within the core cross-ȕ structure of the fibril
was formed by this section. Consequently the sequence NFGAIL (residues 22 to
27) has been designated the minimum core amyloidogenic region for amylin.
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The information derived on the properties and characteristics of the short
fragments provides detail of the interactions which govern the assembly of that
specific amino acid sequence. However, when contemplating the assembly
interactions which govern the whole polypeptide chain these individual findings
must be considered in the context of the influences imposed by the surrounding
polypeptide chain. Especially when taken into account that fibrillogenesis of
many shorter fragments often require non-physiological conditions. For example,
the Alzheimer’s polypeptide was recently identified to have a core recognition
motif of a simple phenylalanine dipeptide [86]. This dipeptide is the smallest
fragment known to self-assemble into fibrillar structures. However, the fibrillar
structures that form are large nanotubes (>50 nm in diameter) rather than the
smaller biofibrils formed by the full-length Aȕ polypeptide. In fact the smallest
fragment of the Aȕ polypeptide known to form biofibrils similar in morphology to
the full-length polypeptide fibrils corresponds to residues 16-22, which contains
the core diphenylalanine sequence (residues 19-20) [89] clearly demonstrating
that the surrounding amino acid sequence can greatly influence the self-assembly
packing behaviour.
Although no common motif or homologous amino acid sequence within the
amyloidogenic proteins has been identified, in most instances the core
amyloidogenic regions often have a greater propensity for certain amino acids;
especially residues which are recognised to preferentially form ȕ-sheet structures.
In particular the aromatic amino acids such as phenylalanine and tyrosine have a
high prevalence in the ȕ-sheet folds. This high incidence of aromatic residues is
not thought to be coincidental but may be intrinsic to the driving forces behind the
self-assembly pathway of amyloid [62, 92]. In fact some success has been
reported with controlling the formation of amyloid by the Aȕ polypeptide using ʌ-
stacking inhibitors [93, 94].
However, in a study by Tracz et al [95] the effect of replacing Phe23 from the
core amyloidogenic region of the amylin polypeptide with leucine or alanine
revealed that the charge, size and propensity to form ȕ-sheet were much more
influential than retaining the aromatic residue in determining whether fibrils
formed from the peptide. This suggests that the driving force is not purely that of
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ʌ-ʌ stacking, certainly in amylin, but that aromatic interactions may still play a
key role in both the kinetics of self-assembly and structural arrangement within
the ordered cross-ȕ core [48].
1.7 The study of amyloid
Many of the advancements made in the study of amyloid have come to fruition
due to the development of techniques to isolate in vivo amyloid, and from studies
of the fibrils formed in vitro from polypeptide chains and shorter peptide
fragments. The fibrils formed in vitro have been demonstrated to be
ultrastructurally similar to fibrils found in vivo [96].
Presented in table 1.2 is a summary of the most commonly represented techniques
utilised in the study of amyloid. Although this list is not exhaustive, the
techniques outlined demonstrate the vast wealth of information that has been and
can be determined on the structure, properties and kinetics of amyloid fibrils.
Evidence obtained from individual techniques may stand alone, however it is
rarely taken so and conclusions are generally drawn in context and corroborated
by the findings from investigations using a variety of experimental techniques.
This refined list of techniques may be split into those evolved to study amyloid by
the histologist and those by the biophysicist. The histology approach to amyloid
determination and investigations relies primarily on the use of specific staining
and fluorescent labelling. In the majority these have been established as
techniques for the study of in vivo or ex vivo amyloid and subsequently for the
detailed study of in vitro amyloid too. Congo red dye and the fluorophore
Thioflavin T both require the ordered beta-sheet conformation of the amyloid
backbone to bind [27, 28, 97, 98]. The green gold birefringence observed under
polarised light of Congo red stained samples is seen as a bench mark indicator for
the presence of amyloid. Thioflavin T fluorescence is commonly used for kinetic
studies of the growth of amyloid in solutions as well as the effects of solution
conditions or inhibitors/promoters on the kinetics of fibrillisation.
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Table 1.2: Summary of the most commonly used techniques for the study of
amyloid. Summarised with each technique is a list of the information that can be
determined experimentally and examples of work citing such techniques.
Technique Experimental evidence obtained References
Congo red - Histopathology stain for amyloid
- Stained amyloid characteristically
displays a green gold birefringence under
polarised light
[27, 28]
Thioflavin T
fluorescence
- Specific binding to ȕ-sheet structure of
amyloid results in fluorescence of the dye
- Measurement of fibril growth in solution
- Kinetic measurement assays
[97-99]
X-ray diffraction - Fibril ultrastructure [32-34, 54,
100]
Nuclear magnetic
resonance
- Fibril ultrastructure [101-103]
Circular dichroism
or Fourier transform
infrared
spectroscopy
- The secondary structures of protein/fibril
- Observation of conformational change
- Measuring the rate of fibrillogenesis as a
function of changing structural
conformation
[8, 104]
Electron
microscopy
- Study of fibril morphology
- Ex situ kinetic study of fibrillogenesis
- Ex situ study of environmental conditions
effects on fibril formation/morphology
- Ex situ study of thermal and chemical
stability
[33, 37,
105]
Atomic force
microscopy
- Study of fibril morphology
- Direct kinetic measurements of
fibrillogenesis
- In situ study of environmental conditions
effects on fibril formation/morphology
- Direct observation of thermal and
chemical stability
- Mechanical properties (image and force
measurements)
[39, 40, 44,
56]
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The biophysical approach to investigating amyloid seeks to resolve three
fundamental issues: fibril structure determination, the mechanism of fibril
formation and understanding the kinetics of fibril formation.
X-ray diffraction and nuclear magnetic resonance (NMR) imaging have played an
important role in elucidating the ultrastructural organisation of the amyloid fibril,
providing detailed evidence on the structural hierarchy exhibited by amyloid and
revealing the core cross-ȕ spine common to all amyloid. However, difficulties in
forming crystals of pure fibrils for x-ray diffraction analysis has proven a
limitation to the extent of information obtained and strategies for improved crystal
growth are ongoing. The use of computer modelling and molecular dynamic
simulations utilises the information derived from X-ray diffraction patterns and
NMR data to generate amyloid structural models and simulations of events during
fibrillisation [92, 106, 107].
Circular dichroism (CD) and fourier transform infra red spectroscopy (FTIR) can
provide information on the secondary structure conformations of proteins in
solution. These techniques have been used to map the changing conformations
often observed in solutions of proteins as they aggregate to form amyloid fibrils;
from random coil conformations and Į-helix content to the characteristic rich ȕ-
sheet of amyloid formations. The influence of solution conditions and the
presence of potential inhibitory factors on amyloid formation can also be
investigated.
The electron microscope (EM) and the atomic force microscope (AFM) are the
most widely used instruments for in-depth study of amyloid fibril morphology.
Historically, amyloid from a variety of diseased tissue was first observed by
electron microscopy in 1959 [10]. With the development of in vitro fibrillisation
protocols, both the EM and AFM provided detailed studies of the polymorphic
nature of fibrils self-assembled from both full-length polypeptides and shorter
amyloidogenic peptide sequences. This has enabled the fibril pathway and
morphological changes to be studied over a time course allowing events during
the fibrillisation pathway to be visualised. Furthermore, morphological studies of
the influence of environmental conditions on fibrillisation have provided
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information on the interactions which govern self-assembly of the polypeptide and
peptide chain into amyloid.
The EM (including scanning electron microscopy (SEM) and transmission
electron microscopy (TEM)) is capable of generating very high-resolution images
of biological samples. However there are limitations to studying amyloid using
the EM: firstly, the requirement for extensive sample preparation in which
samples must be dried and stained before imaging, and secondly the inability to
image dynamic processes in situ; the images generated are of dehydrated samples
in their non-native state. By comparison sample preparation for the AFM is
extremely easy, requiring physisorption of a sample to a surface. Furthermore, and
most importantly, dynamic events such as fibrillogenesis can be directly
visualised by liquid imaging; samples are physisorbed to a support substrate and
imaged in a liquid environment thus maintaining the sample in a near-native
hydrated state. A drawback to imaging in solution using the AFM is that the
sample must be sufficiently immobilised to the surface. Therefore conditions
which promote physisorption of the sample to the substrate surface must first be
identified.
The study of amyloidogenic peptide self-assembly presented in this thesis has
primarily utilised the AFM to study the morphology and dynamic behaviour of
amyloid biofibrils and nanotubes. Outlined in the sections below is a brief
description of the principles of AFM and a discussion of the advances made in
understanding of amyloid using the AFM.
1.8 Atomic force microscopy (AFM)
The atomic force microscope (AFM) [108] is a surface biophysical probe capable
of generating high-resolution topographical images of surfaces and exploring the
interactions between molecules within a sample. In addition force spectroscopy
experiments can be performed using the AFM whereby the forces between the tip
and sample or interactions between individual molecules can be investigated.
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The principle of AFM imaging is analogous to a record player where sound is
generated when the stylus moves across the surface of the record. In the AFM, a
stylus is attached to a flexible cantilever; at the end of the stylus is a sharp tip,
which interacts with the surface of the sample. As the cantilever raster scans
backwards and forwards across the surface of the sample, a map of the surface
features is generated in the x and y direction. In the simplest imaging method, to
build up a topographical map of the sample surface details of variations in the
height of the surface are recorded by the movement of the cantilever in the z
direction, thus producing a two-dimensional image of the surface topography. The
deflections of the cantilever are monitored with atomic-scale sensitivity by an
optical lever system; a laser beam directed onto the cantilever is reflected via a
mirror to a position sensitive photodiode. A piezoelectric ceramic scanner controls
the motion of the cantilever by an electronic feedback mechanism. Presented in
figure 1.5 is a schematic of the typical AFM set up.
As the probe raster scans across the surface, the flexible cantilever undergoes
deflections due to the attractive and repulsive forces experienced by the tip as a
result of the overlapping electron orbitals between the atoms of the sample and the
Laser
source
Cantilever
Position sensitive
photodetector
Sample surface
AFM stage
Mirror
z
x
y Piezo
direction
Figure 1.5: Schematic representation of the AFM set up. Image inset is a
scanning electron micrograph of the tip at the end of an AFM cantilever (Image from
Olympus Corp., scale bar represents 2.4 µm).
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tip. Consequently the deflection of the cantilever is a measure of the forces
experienced by the tip. AFM cantilevers for biological imaging are very flexible
structures with spring constants of less than 1 N/m for contact mode and 2 to 42
N/m for tapping mode imaging. Typically cantilevers are silicon or silicon nitride
with lengths ranging from 100-250 µm and tip apexes with radii of curvature of 5
to 40 nm. The optimum resolution of an image is greatly affected by the shape
and apex of the tip. Currently the most commonly used commercially available
tips are oxide-sharpened pyramid shaped (see inset in figure 1.5). However, the
low aspect ratio and shape of these tips may result in the contact occurring
between the sides of the tip and the sample feature before the apex of the tip. This
causes a tip broadening artefact whereby features appear larger than their true
size, in addition two structures lying adjacent might be perceived as one. A
solution to this limitation is under development, in which long and narrow carbon
nanotubes with high aspect ratios, replace the pyramidal tip [109].
1.8.1 AFM imaging modes
In the conventional AFM, there are three operating modes for image acquisition;
contact mode, tapping-mode and non-contact mode. Each mode functions within
the different force regimes (attractive and repulsive) of the tip-sample interaction.
A brief description of these operating modes is discussed below.
1.8.1.1 Contact mode
In contact mode, the AFM probe is in constant contact with the sample surface.
As the tip or sample is raster scanned relative to one another, the repulsive contact
forces between the probe and sample cause the cantilever to bend. The z-feedback
loop monitors the cantilever deflection and constantly adjusts the height
correcting for the deflection and maintaining a constant force on the sample.
Images mapping the topography of the surface are generated either by monitoring
the changes in z-piezo height or by the movement of the laser caused by changes
in the deflection of the cantilever as it is raster scanned across the surface.
The high resolution and fast image acquisition processes used in contact mode are
typically associated with the application of high forces and therefore it is
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preferentially suited for imaging hard, non-deformable samples. When imaging
soft samples in contact mode, such as biomolecules, the lateral forces exerted by
the tip can sweep material from the sample surface. Furthermore during air
imaging, the adhesive capillary force between the adsorbed liquid layer of the
surface and the tip can cause an overall increase in force on the sample [110]
which is more likely to deform a soft biomolecular material.
1.8.1.2 Tapping mode
In tapping mode the cantilever is oscillated at or near its resonance frequency
(200-400 kHz in air and approximately 10 kHz in liquid) at amplitudes of tens of
nanometres when not in contact with the surface. As the tip is moved towards the
sample it gently taps the surface as it is raster scanned in an xy direction, only
briefly coming into contact with the fragile surface [111-113]. In tapping mode
the AFM is operating in both the repulsive and attractive regions of the tip-sample
interaction. Variations in the topography of the sample surface result in changes in
the oscillation amplitude of the cantilever; lower features will cause increased
amplitudes, conversely raised areas result in dampening of the oscillation
amplitude. Any resultant variations in the oscillation amplitudes are monitored by
a feedback circuit which maintains the amplitude of the freely oscillating
cantilever at a constant pre-set value by adjusting the z piezo. The problematic
lateral forces of contact mode imaging are no longer experienced as the applied
force is periodic and vertical as the tip intermittently comes into contact with the
surface. Consequently, tapping mode is the preferred imaging mode for
biomolecules and as such all AFM images presented in this thesis have been
generated in this operating mode.
Further information about the sample can be achieved by interpretation of the
phase shift experienced by the oscillating cantilever as it raster scans across the
sample surface. In free air the oscillation amplitude of the cantilever is pre-set at a
constant piezo drive voltage, however as the probe raster scans the surface there is
a phase lag in the oscillation relative to the driving signal due to tip-sample
interactions. The phase lag is recorded and mapped as an image and is referred to
as phase imaging [114]. The phase data can provide additional topographical
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detail and under certain tapping regimes information can be elucidated on the
visco-elastic and adhesive properties of the surface [115-117].
1.8.1.3 Non-contact
In non-contact mode the oscillating tip (at its resonant frequency) never actually
touches the sample but is instead kept at a small distance above the sample surface
within the long-range van der Waals attractive forces of the tip-sample interaction
[118]. As the tip is raster scanned across the surface, gradients in the force are
detected by changes in the tip resonant frequency or oscillation amplitude of the
cantilever. The major advantage of non-contact AFM is that the technique is non-
destructive as the tip does not make contact with the sample, a necessary factor
when studying easily deformable biomolecules. However, the attractive forces
involved are very small (as little as 10-12 N) and less sensitive to probe-sample
separation. Consequently, the images generated generally have lower spatial
resolution. This is particularly problematic in non-contact imaging in liquid where
at small tip-sample distances the van der Waals forces are greatly reduced by
more than two orders of magnitude [119, 120].
1.8.2 Force distance measurements
In addition to the imaging capabilities of the AFM, quantitative force
measurements of tip and sample interactions can be generated [121]. In an AFM
force experiment, the probe is moved vertically at a constant z-piezo velocity
towards a sample surface until contact is made and then retracted away. By
measuring the deflection experienced by the cantilever a force-distance plot can
be generated provided the spring constant of the cantilever is known. Shown in
figure 1.6 is a typical force-distance curve in which the y axis is the cantilever
deflection force (measured in nN) verses the distance travelled by the z-piezo
(measured in nm) on the x axis.
The AFM is one of few techniques (others include optical tweezers,
biomembrane-force probe) in which force-distance curves can be generated for
single molecule rupture events. This allows the mechanical properties such as
individual molecule flexibility and stiffness to be quantified. Furthermore detailed
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investigations of protein or peptide folding and unfolding events may be mapped
as well as protein-protein interactions and protein-ligand binding. For excellent
reviews detailing the scope of biomolecular AFM force measurement experiments
see [122-124].
1.9 The characterisation of amyloid by AFM
The AFM has extensively been utilised in the study of amyloid and has made
possible many advances in our understanding of amyloid. Possibly the greatest
achievement facilitated by the AFM is the study of amyloid in a hydrated
environment; enabling the direct visualisation of dynamic events during
fibrillisation.
The AFM can generate images of samples in solution at static time points as well
as dynamically generating a time-lapse sequence of images of fibrils nucleating
0
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Figure 1.6: Schematic of a typical force-distance curve. A The tip approaches
the sample surface. At B there is “jump to contact” due to attractive van der Waals
forces. The cantilever bends as the tip continues forward until point C, the predefined
maximum load. The tip is retracted and point D is the “pull off” force as the tip
disengages. At E the tip returns back to the start position away from sample contact.
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and elongating; enabling the study of rates of fibrillogenesis, as well as mapping
the progression of variations in morphologies and the development of structural
hierarchy. Furthermore, events can be studied under conditions closely
exemplifying the native physiological state.
1.9.1 Ex situ and in situ imaging
Tapping-mode AFM has been successfully utilised for high-resolution imaging in
both air (ex situ) and in solution (in situ) of fibrils formed by a range of
amyloidogenic polypeptides and their shorter peptide fragments, including Aȕ
[56, 77], amylin [44, 87, 125], Ig light chain [45, 126], and lysozyme [39] as well
as the non-disease related Sup35 [81]. Detailed morphological studies can be
made and information derived on the helical periodicity, height, and persistence
length of the fibril under various environmental conditions [57, 127]. AFM
images of ȕ2-microglobulin have demonstrated that variations in pH promote
different fibril morphologies from highly flexible worm like chains to long
straight unbranched fibrils and rod-like structures [128, 129]. In situ imaging
allows the morphology of a fibril in its hydrated state to be studied, thereby
enabling the direct visualisation of a fibril in a state near to that expected in vivo.
For the acquisition of stable high-resolution images in situ the specimen must be
sufficiently immobilized to the sample surface. This is often a limiting factor in
the imaging of biological samples using tapping mode AFM as suitable conditions
must be identified. Various strategies are employed to promote sample
immobilisation, including a choice of positively or negatively charged substrate,
or by altering the buffer conditions; adsorption is promoted by altering the sample
or surface charge through the addition of monovalent or divalent ions [111, 130,
131]. Alternatively samples may be covalently attached to a functionalised surface
[132].
The substrate of choice for the study of amyloid is predominantly mica due to its
atomically flat surface [40, 56, 133-135]. Other substrates which have been
utilised include gold [136] and highly-ordered pyrolytic graphite (HOPG). The
atomically flat HOPG is preferentially utilised for orientated and template-
directed growth of fibrils due to its crystalline nature [137, 138]. However, it has
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been noted that fibrils grown on a substrate support during in situ AFM imaging
can display different morphologies to counterparts grown in solutions, suggesting
that for some systems fibril formation is surface-dependent [135].
Particularly pertinent to the study of amyloid is the ability to mimic the in vivo
environment. Not only by imaging fibrils at physiological conditions but also by
mimicking biomimetic surfaces. Amyloid is believed to preferentially form at the
cell membrane where their prefibrillar assemblies act as pores within the
membranes leading to disruption of the membrane and loss of cell activity [139-
141]. Dynamic AFM imaging of lipid covered substrates in the presence of human
amylin and Aȕ(1-42) polypeptide solutions revealed, over a time course, the
formation of holes in the lipid rafts which resulted in membrane disruption.
Following a lag time fibrillar structures were also observed within the images
[140, 142].
An antibody, known as anti-amyloid antibody W01, has been shown by AFM
investigations to bind not only to oligomeric species (in this example to ȕ2-
microglobulin prefibrillar oligomers) but also some morphologies of the mature
fibril. Indicative therefore that the binding epitope for the antibody is freely
available on the oligomeric species but may be masked in some mature fibril
morphologies, suggesting fibril self-assembly may follow several distinct
pathways [128, 143].
1.9.2 Kinetic studies
The ability to image dynamic events by AFM has facilitated one of the most
important advances in the study of amyloid kinetics. The direct observation by
tapping mode AFM using time-lapse liquid imaging of amyloid fibril formation
[44, 56]. The rates of fibril growth can be measured and correlated with changing
morphologies, in addition the direction of growth can be studied [44, 57]. Snap
shot events during fibrillisation can be observed using ex situ AFM which detail
the changing morphology of the fibril and prefibrillar species [135]. Seeding
experiments have been performed on solutions of Aȕ polypeptide whereby the
effects of pre-formed aggregates on fibril growth can be directly visualised;
providing insights into the fibrillisation pathway [57, 144].
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The recent development of high-speed AFM capable of generating whole
topography and phase images in millisecond rather than minutes at high
resolutions [145, 146] has enabled the AFM for the first time to image biological
processes in real-time. Currently, studies of the fibrillisation pathways have been
limited to time-lapse studies; images of the sample are effectively snap shots of a
particular time point taking minutes to generate a full image. Given that the time
span of fibrillisation for many amyloid proteins involve hours rather than seconds,
time-lapse imaging appears to be more than adequate in the study of amyloid.
However, with the development of real-time imaging it may be possible to derive
more detailed information on the subtle morphological changes which occur
during some of the initial events of fibrillogenesis.
1.9.3 Investigating the physical properties of amyloid.
The thermal and chemical stability of amyloid has often been determined using
the traditional methods employed for protein studies namely the use of CD and
FTIR in which the loss of secondary structure can be dynamically measured. The
EM has also been used to study the effects of heat and chemicals on samples,
however these samples must be removed from the conditions, undergo preparative
regimes and then imaged, during which valuable information may be lost or
masked. However, the AFM is able to combine both strategies, enabling a
dynamic study of the changes in morphology with variations in temperature or by
the introduction of denaturing chemical agents into the chemically and pH robust
liquid cell to allow time-lapse imaging of any resultant artefacts.
The thermal and pressure stability of amyloid fibrils has been investigated by
AFM. Samples of transthyretin fibrils after exposure to high hydrostatic pressures
and prolonged high temperatures were imaged by ex situ AFM, revealing that
prefibrillar structures are dissociated by the conditions, however mature fibrils
were observed to remain stable [147]. In these experiments, the amyloid samples
are treated and then imaged, however modification of the AFM stage with the
incorporation of an electronic feedback-controlled heating element would enable
samples to be heated from the bottom-up during imaging in air up to ~250 °C or
in closed liquid cells up to 100 °C. This would therefore enable, through in situ
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heat imaging, the effects of temperature to be studied throughout the fibrillisation
pathway.
Other physical properties of amyloid fibrils have been quantified using the AFM
such as persistence length measurements from topography images [128]. Through
AFM imaging experiments the ability of Apo CII fibrils to circularise was shown
to be intrinsically linked to their flexibility and persistence length [148]. Other
amyloid have been noted to circularise: under high pressure conditions insulin
fibrils circularise [149], whereas equine lysozyme forms circular amyloid under
low pH conditions [150]. The circularised amyloid still retain the ability to bind
Congo red and are thought to be another morphological state adopted by amyloid
[57].
The small diameter of the AFM tip (~10 nm) and the ability to measure forces
with picoNewton sensitivity ideally suites the AFM to measuring the small
interaction forces which govern biological polymer assembly and stability and has
widely been used to investigate the mechanical properties of many polymer
systems from polysaccharides [151] to oligomeric proteins [152, 153]. Similarly
the mechanical properties of the amyloid fibril have been investigated to gain a
greater understanding of the interactions that govern fibril formation and confer
the observed stability within the amyloid plaques. In a study of insulin amyloid
the AFM was used to measure the mechanical properties of the fibrils using a
nanoindentation method: a fibril is placed over a pore or gap in a substrate (ie
between islands on a gold substrate) and the force required to push an AFM tip
down onto the fibril is measured, akin to a three-point bending test. This enables
information on the Young’s, elastic and shear moduli (measure of the stiffness,
elasticity and rigidity) of the amyloid fibril to be derived [154].
By utilising the indentation method the elastic properties of ȕ2-microglobulin
fibrils have been identified Furthermore, individual ȕ-sheets have been ‘unzipped’
or mechanically peeled away from the fibril and the forces measured using the
AFM [155]. In this experiment it was noted that the ȕ-sheets could be reversibly
and repeatedly unzipped from the main fibrils of both Aȕ (1-40) and Aȕ (25-35),
although the forces required where different for the two polypeptide chains.
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Protein secondary structure is an important factor in mechanical strength; ȕ-rich
conformations display greater mechanical resistance than Į-helical rich, which is
attributable to the H-bonding stabilising forces between ȕ-strands [156].
Furthermore, AFM force-extension measurements and molecular dynamic
simulations have shown that protein mutants differing by only a few amino acid in
their primary sequence, which still display almost identical topology, can exhibit
different mechanical resistance due to side chain interactions [157]. Consequently,
amyloid fibrils may have considerable mechanical stability due to their ȕ-sheet
conformation and therefore it has been hypothesised that fibrils may display
characteristic mechanical fingerprints which are dependent on their constituent
protein [155].
By studying the mechanical and physical properties of the amyloid fibril a greater
understanding of the interactions which govern fibril formation and stability can
be achieved. This knowledge will invariably play a key role in the development of
therapeutics, which seeks to prevent formation or destabilise the fibril or
prefibrillar material.
1.10 Amyloid and the nanoscientist
Advancements in the biotechnology industries have led to the search for more
exploitative and readily functionalised building blocks from which novel
materials can be built. The vast potential of amyloid structures has not evaded the
keen eye of the inquisitive and inventive nanoscientist. As the knowledge and
understanding of the many ideal and stable properties of the amyloid fibril have
been realised, so too have their apparent ability to be utilised in a wide range of
potential applications; a bottom-up approach to novel material fabrication [47,
158, 159].
The recent discussion into the pathogenicity of amyloid has led to the suggestion
that the cytotoxic element is the prefibrillar species and not the mature fibrils [15-
17]. If this is true then the potential range of possible applications for amyloid
may be greater than previously thought possible due to safety concerns, for
example in vivo as drug delivery vessels or implants.
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Predominantly the use of amyloid fibrils for novel biomaterials has focussed on
the exploitation of amyloidogenic fragments rather than whole proteins, due to
their ease of synthesis and handling. Gold and silver nanowires have been
assembled using nanotube scaffolds formed from the dipeptide recognition motif
of Aȕ, the Alzheimer’s protein [86] and the NM domain of the yeast prion Sup35
[160] for use in microelectronics circuitry.
The synthesis of nanofibrillar materials which can perform or support a specific
function is of particular interest to the pharmaceutical and biomedical industries.
For example, a Sup35 protein modified with a C-terminally linked green
fluorescence protein (GFP) still retained the ability to form fibrillar structures
which had green fluorescence [161]. This example demonstrates that proteins and
peptides modified with specific functionalities may still retain the ability to form
amyloid. Therefore it may be possible to engineer self-assembling fibrils with
specific catalytic activity by coupling enzymes to the main protein or alternatively
specific functional moieties could be attached to the constituent protein or peptide
and thus generate chemically functionalised fibrils.
Furthermore with the proposal that the formation of fibrillar structure with core ȕ-
sheet ultrastructure is not limited to a subset of disease related proteins but is in
fact a generic feature of the polypeptide chain, new avenues of research are being
explored for the development of self-assembling nanofibrillar material from a
range of designed amino acid sequences [2, 158, 162-165].
In this introduction a brief overview of the vast world of the amyloid fibril has
been discussed from the origins, in vivo as misaggregated proteinaceous deposits
to manipulation and exploitation as novel nanomaterials. The knowledge derived
on the structural, kinetic and physical properties of amyloid using the AFM has
been intrinsic to the developing understanding of amyloid fibrillisation. The work
presented in this thesis focuses on the study of amyloid and amyloid-like
structures using the AFM and a detailed description of the basic principles and
functioning parameters of the AFM are also discussed here.
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The aims of this PhD project are to investigate the self-assembly of peptides
utilizing the AFM, particularly with the view to characterising the morphology,
fibrillisation and properties of the fibrillar assemblies which they form.
Furthermore, to develop strategies to directly control and exploit these fibrillar
structures to explore their potential use as novel nanostructures.
The work presented in this thesis focuses on the fibrillar material self-assembled
from peptide fragments of two amyloidogenic proteins: the amylin polypeptide
associated with type-II diabetes mellitus and ȕ-amyloid (Aȕ) polypeptide
associated with Alzheimer’s disease. Specifically the experiments investigate
short fragments of these polypeptides comprising the minimal amyloidogenic
peptides containing the core recognition motif of the proteins; amylin fragment
corresponding to residues 20-29 in the human sequence and residues 19-20 of the
human Aȕ polypeptide.
1.11 Thesis outline
The first section of this work focuses on the study and exploitative potential of the
amyloid fibrils that self-assemble from amylin (20-29) peptides.
The studies presented in Chapter 2 are concerned with the self-assembly and fibril
formation of the amylin (20-29) peptide fragment. Although amylin (20-29) is a
commonly studied model peptide fragment, there are no detailed studies that
directly visualise fibrillisation and changing morphology in a hydrated sate. The
opening section of the chapter documents the synthesis of the peptide fragment
corresponding to amino acids 20-29 of the human amylin polypeptide by solid
phase peptide synthesis. Congo red assay and AFM imaging reveal that the
peptide fragments readily self-assemble, forming polymorphic amyloid fibrils.
The chapter concludes with an investigation of the influence of solution pH, ionic
strength and electrolyte composition on the morphology and fibril forming
capabilities of the peptide, which are directly visualised using both ex situ and in
situ AFM imaging.
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The experiments presented in Chapter 3 investigate the exploitative potential of
the self-assembling amylin (20-29) peptide to produce fibrils decorated with
specific functional groups. The amylin (20-29) peptide fragment is synthesised by
SPPS with either an azide or alkyne functional group coupled to the N-terminus.
High-resolution ex situ AFM imaging and Congo red staining probe whether the
peptides retain the capacity to form amyloid fibrils.
In the presence of copper (I) catalyst, alkyne and azide functional groups undergo
a chemical ligation reaction. Consequently, it may therefore be possible to form
stable covalent links between fibrils decorated with these moieties. Ex situ AFM
imaging is used to investigate the effectiveness of this chemical ligation reaction
to produce arrays of covalently linked amylin (20-29) fibrils.
The last section of this thesis focuses on the self-assembly of the second peptide
fragment, the dipeptide of phenylalanine; the core recognition motif of the ȕ-
amyloid protein. This simple dipeptide of phenylalanine readily forms nanotubes
in organic solvent, however these structures are unlike the biofibrils formed from
larger fragments of the polypeptide. The nanotubes are large hollow structures
with diameters in excess of 200 nm. The successful application of these nanotubes
for use as scaffolds for the generation of nanowires has previously been
demonstrated. The aim of this study is to further develop our knowledge of the
properties of these nanotubes and to develop a means of controlling their
assembly. In Chapter 4, in situ and ex situ tapping-mode AFM is used to
investigate the thermal and chemical stability of these nanotubes. Furthermore, the
AFM is used to directly visualise the manipulation and ordered orientation of the
nanotubes using strong magnetic fields.
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Chapter
2
Characterisation of Amylin (20-29) Fibrils
by Ex situ and In situ AFM Imaging
2.1 Introduction
Amylin is a 37 amino acid polypeptide co-secreted with insulin from the
pancreatic ȕ-cells of the islets of Langerhans [166]. Amyloid deposits of amylin
fibrils are found in over 90% of cases of type II late-onset diabetes mellitus or
non-insulin dependent diabetes mellitus (NIDDM) [19, 167, 168]. Whether or not
these amyloid deposits are a cause or effect of NIDDM is still largely unclear
[169, 170], but increasing evidence supports the hypothesis that pre-fibrillar
species of amylin amyloid are cytotoxic in vitro [171, 172].
In this chapter, the atomic force microscope is utilised for the characterisation of a
self-assembling peptide fragment of the human amylin polypeptide,
corresponding to amino acid residues 20 to 29 of the human sequence. Many
studies utilising a combination of SEM, TEM and AFM have been undertaken to
investigate the morphology and fibrillisation of the full-length amylin polypeptide
and several of its peptide fragments [43, 44, 49, 61, 87, 105, 125, 173-177]. These
studies have provided evidence that one of the key amyloidogenic regions of the
human amylin polypeptide, a 6 amino acid peptide fragment (NH2- NFGAIL –
COOH), is the smallest amylin fragment capable of self-assembly [87]. Further
studies using a combination of EM and turbidity tests have shown that the larger
10 amino acid peptide fragment (NH2- SNNFGAILSS –COOH), and the focus of this
chapter, self-assembles into fibrils which are similar in morphology to those
formed by the full-length polypeptide in vitro [48, 100, 102, 176, 178].
Substitution experiments of specific amino acids within the full-length
polypeptide revealed that residues within the core amylin (20-29) sequence are
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crucial for fibril formation. Substitution of Ser-28 for ȕ-sheet disrupting proline
completely inhibited fibril formation [88] and substitution of the aromatic residue
Phe-23 for alanine influenced the formation of higher order amyloid aggregates
[61]. Together these findings highlight the importance of the amylin (20-29)
fragment in fibril formation, however studies of longer amylin fragments reveal
that other regions of the polypeptide directly influence the morphology and
higher-order fibril assembly of the full-length polypeptide [ 48, 90, 179, 175].
The major advantage that AFM poses over SEM and TEM is that the sample can
be imaged in solution by in situ imaging. This enables a dynamic investigation of
amyloid in it’s hydrated state, and thus a study into the kinetics and real-time
fibrillisation is possible [44, 56, 57, 177]. Kinetic studies of the fibrillisation of
full-length and fragments of amylin have predominantly relied upon the use of
turbidity and spectroscopic techniques measuring Congo red, ANS (1-
Anilinanaphthalene-8-sulphonate) and Thioflavin-T binding [49, 180-182]. To
date time-lapse AFM has only been utilised for the kinetic study of full-length
amylin [44, 64] where growth of individual protofilaments, 2.4 nm in height, were
observed in Tris buffer elongating at a rate of 1.1 (±0.5) nm min-1. The fibrils had
varying morphologies and growth was bi-directional with no significant
preference for either end of the growing fibril. Kinetic studies have revealed that
fibril formation proceeded through two distinct phases and is nucleation
dependent [64]. Fibril elongation followed an initial lag period, the length of
which could be influenced by pH and temperature [181].
Although the AFM makes an ideal tool for the study of fibrillisation its use is
dependent on sufficient immobilisation of the fibrils to a solid substrate support,
particularly during in situ imaging. For the study of soft biomolecules such as
peptide fibrils the use of tapping-mode AFM, where the tip only briefly comes
into contact with the surface, is the most ideal mode of imaging [132, 177, 183].
The minimal forces applied by the tip as it oscillates across the sample surface
require only weak immobilisation of the biomolecule to the substrate, enabling
biomolecular interactions to freely occur at the surface and thus to be studied.
Immobilisation strategies in the simplest form rely on electrostatic attractions
between substrate and biomolecule. Two commonly used substrates in AFM
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imaging of amyloid [184] are muscovite mica which carries a net negative charge
and gold which has a neutral surface charge. The former substrate is more
favoured for AFM imaging due to ease of cleaning during preparation and atom
scale flatness, and for this reason is the substrate of choice for the experiments
presented in this thesis. For physisorption of a biomolecule to the substrate it may
be necessary to manipulate the electrostatic charges on either surface by means of
altering the pH or ionic environment. Introduction of co-ions or counterions either
in a buffer solution or simply by pre-adsorbing monovalent or divalent salt ions
(eg Nickel, Zinc, Cobalt, Magnesium) to the substrate enables the charge on either
the substrate or the biomolecule to be masked in favour of physisorption [131].
Time-lapse AFM imaging of full-length amylin to mica was performed in a Tris-
HCl buffer at a pH of 7.3 [44]. The isoelectric point of full-length amylin is 8.9
and therefore at this pH the peptide would carry a net positive charge due to
protonation of free amine groups of the protein.
Despite the key role of the amylin (20-29) sequence in fibril assembly by the full-
length polypeptide no detailed AFM study has been performed on the fragment,
and in particular there is no information on the early stages of amylin (20-29)
fibril formation or the morphology of the younger fibrils. The work presented in
this chapter details the characterisation of fibrils formed by the peptide fragment
amylin (20-29) by in situ and ex situ AFM imaging. The peptide fragment was
synthesised using solid phase peptide synthesis (SPPS) and a study was made into
purification using reverse-phase high performance liquid chromatography (RP-
HPLC). Preliminary high-resolution ex situ imaging was used to investigate the
polymorphic nature of young amylin (20-29) fibrils. For successful in situ AFM
imaging of amylin (20-29) fibrils the development of an immobilisation strategy
was investigated and initial studies were made into the effects of ionic solution
conditions on the morphology, kinetics and fibrillisation of amylin (20-29).
The ex situ AFM experiments presented within this chapter are the subject of an article
published in the journal Protein and Peptide Letters [134]
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2.2 Experimental
2.2.1 Materials
All amylin (20-29) was synthesised by SPPS, reagents used in the process were:
NovaSyn® TGR resin and standard Fmoc protected amino acids were purchased
from NovaBiochem; dimethylformamide (DMF) purchased from Rathburn;
piperidine, N-methylpyrrolidone (NMP), N,N-diisopropylethylamine (DIPEA),
trifluoroacetic acid (for SPPS), triisopropylsilane (TIPS) and dichloromethane
(DCM) were purchased from Sigma-Aldrich; N-[(dimethylamino)-1H-1,2,3-
triazolo[4,5-b]pyridin-1-ylmethylene]-N-methylmethanaminium
hexafluorophosphate N-oxide (HATU) obtained from Perseptive Biosystems,
Germany; ethanol, hexane, diethyl ether, acetonitrile (Far UV grade) and
trifluoroacetic acid (for HPLC) purchased from Fischer Scientific Chemicals;
Sodium chloride were purchased from Sigma-Aldrich.
Reagents used in the AFM studies: sodium citrate (dibasic and monobasic),
sodium acetate, potassium chloride (KCl), magnesium chloride (MgCl2), Tris and
Tris HCl all purchased from Sigma Aldrich. Congo red and sodium chloride were
purchased from Sigma Aldrich. Ethanol was purchased from Fischer Scientific.
2.2.2 Method
2.2.2.1 Solid phase peptide synthesis
Peptide fragment of human amylin corresponding to residues 20 to 29 (sequence
shown below) was synthesised using SPPS.
NH2 –S N N F G A I L S S- COOH
Adaptations based on the work of Nilsson et al [185] for synthesis of
amyloidogenic peptides were incorporated into the standard [186] SPPS Fmoc
procedure.
The column was packed with 0.1 mmol of an amide Rink resin, NovaSyn® TGR
resin was solvated initially with N-methylpyrolidinone, and the activation cocktail
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containing the coupling reagents, 0.8 mmol DIPEA and 0.4 mmol HATU,
solubilised in NMP, mixed with 0.4 mmol of the C-terminal amino acid (serine)
and added immediately to the column. Amino acids were loaded with a four-fold
excess to ensure maximum yield. Sufficient solvent was added to the column for
the resin to be fluid and was left at room temperature on a magnetic stirrer. The
first amino acid coupling was left overnight to ensure complete attachment to the
resin.
All the amino acids have an Fmoc group protecting the NH2 group to prevent
unwanted formation of peptide bonds. Fmoc deprotection was performed by
washing the column with 100% DMF, to remove excess activated amino acids
and then with 20% piperidine-DMF solution. Solvent washing of the column was
controlled using a LKB Biolynx 4175 Peptide Synthesiser, set to a flow rate of 3
ml/min. Fmoc deprotection and coupling efficiency was monitored
spectrophotometrically by absorbancH PHDVXUHPHQWV Ȝ280nm) of the column
eluent.
Following Fmoc deprotection, the resin was washed with NMP to remove any
trace of DMF and the succeeding amino acid with activation cocktail was added.
The process was then repeated for each amino acid until the complete sequence
was generated. The resin was washed using DMF and DCM over a Buchner
funnel and then shrunk using hexane. Cleavage of the peptide chain from the resin
and deprotection of side chain groups was performed by the addition of a mixture
of 90% v/v trifluoroacetic acid (TFA), 2% v/v triisopropylsilane (TIPS) and 8%
v/v water, for 2 hours. The suspension was then filtered and the filtrate
evaporated under vacuum. The residual material was titrated with diethyl ether,
and the resulting powder (100 mg), consisting of the crude peptide was stored
below 4ºC.
2.2.2.2 Liquid chromatography mass spectometry (LC-MS)
Presence and purity of the peptide was determined using LC-MS. Crude peptide
was injected onto the column at a concentration of 1 mg/ml in ultrapure water (pH
6, resistivity 18.2 Mȍcm). A C18 analytical column (Bore size 5 ȝm) was run at a
linear gradient of 25 to 100% solution B (90% v/v acetonitrile and 0.06% v/v
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trifluoroacetic acid) over 30 minutes with flow rate of 0.25 ml/min, with detector
monitoring eOXHQWDWȜ214 nm.
2.2.2.3 High performance liquid chromatography (HPLC)
Peptide was purified by reverse-phase HPLC using a C8 semi-preparative column
(bore size 5 ȝm) on a Beckman Gold System. Solvent A was water and 0.06%
v/v trifluoroacetic acid and solvent B, 90% v/v acetonitrile and 0.06% v/v
trifluoroacetic acid. Presence of peptide in the eluent was monitored
spectrophotometrically by monitoring absorbance at wavelength of 214 nm. The
conditions and parameters used for the HPLC purification are a scaled up and
developed method based on those used for LC-MS. To achieve more efficient
purification, the peptide was loaded at a higher concentration, by dissolving 2
mg/ml of crude peptide in 40% acetonitrile. Criteria for method development
were based on improving the resolution of target peak, increasing separation of
contaminants and minimising run time. The finalised method was a gradient of 25
to 100 % B over 20 minutes with flow rate of 5 ml/min and injection volume of
200 ȝl.
HPLC solvents were removed from the purified peptide sample under vacuum
using a Rotavac system and the purified peptide sample lyophilised over 36
hours and stored below 4ÛC.
2.2.2.4 Congo red assay
The histopathology stain Congo red is commonly used in the detection of amyloid
[27] and was used to determine the formation of amyloid fibrils by our amylin
(20-29) peptides. A saturated solution of Congo red was prepared using 0.2g of
Congo red powder per 100 ml of 80% v/v ethanol solution saturated with sodium
chloride. Purified and crude lyophilised peptide samples were suspended in
ultrapure water (pH 6, resistivity 18.2 Mȍcm) at concentration of 1 mg/ml. The
suspension was aged for 18 and 48 hours at room temperature to ensure maximum
allowance for fibrils to form. At each time interval a 10 Pl aliquot was dropped
onto a clean glass slide and air-dried. Samples were stained for 1 minute by
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addition of the saturated Congo red solution. Excess stain was removed by
washing with ethanol and the slide air-dried.
2.2.2.4.1 Optical microscopy and birefringence
Birefringence was examined using a Leitz Diaplan light microscope with
polarisers and 10 and 25 times magnification objective lens. The polariser lens
are set at a 45 degrees to each other, one in the incident beam and the other set
above the slide stage between the objective lens and camera. Images of the
sample under normal and polarised light were captured using a Nikon 100 digital
camera.
2.2.2.5 Ex situ AFM imaging
The lyophilized amylin (20 to 29) peptide was solubilised in ultrapure water (pH
6, resistivity 18.2 Mȍcm) at a concentration of 1 mg/ml. Samples were left to
form fibrils at room temperature up to 48 hours. In some instances, to prevent
molecular overcrowding of the AFM scan area, stock solutions were diluted to
concentrations of 100 ȝg/ml in ultrapure water immediately prior to imaging.
Aliquots of 10 ȝl were dropped onto freshly cleaved mica (1 cm2), dried in a N2
gas stream and imaged immediately. Ultrapure water stored under identical
conditions and for the same time period was used as a control preparation; here
imaging showed no fibrillar structures. Images presented were generated using a
Nanoscope IIIa AFM (Digital Instruments, Veeco Metrology Group, Santa
Barbara CA). All imaging was performed in air in tapping mode with scan rates
of 1.5-2.5 Hz using silicon TESP tapping probes (supplied by Veeco Metrology
Group) mounted on cantilevers with nominal spring constants of 42 N/m (range of
34.4-37.2 N/m) and nominal resonant frequency of 320 kHz (range of 280-360
kHz).
2.2.2.6 In situ AFM imaging of amylin (20-29) fibrils
2.2.2.6.1 Sample Preparation
The lyophilised peptide was initially solubilised in ultrapure water (pH 5.6,
resistivity 18.2 Mȍcm) at a concentration of 1 mg/ml. After 1 hour at room
temperature, the sample was diluted to give a final peptide concentration of 100-
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200 ȝg/ml in varying salt solutions and left to incubate at room temperature. All
solutions were prepared on day of the experiment from ultrapure water. The salt
solutions investigated are summarised in table 2.1, which lists the salt
concentrations used and solution pH. Both the potassium chloride and magnesium
chloride were acidified by stepwise addition of hydrochloric acid to achieve the
desired pH of 4.0. A 30 ȝl drop of solution was placed onto freshly cleaved mica
and an aliquot transferred to an AFM liquid cell immediately prior to imaging.
Ionic content pH
10-50 mM Tris HCl 7.2
10-100 mM KCl 4.0
100 mM MgCl2 4.0
50-150 mM Sodium acetate 5.5
125 mM Sodium acetate with KCl salts 5.5
125 mM Sodium acetate with MgCl2 salts 5.0
50-150 mM Sodium citrate 4.0
130 mM Sodium acetate with KCl salts 4.0
125 mM Sodium acetate with KCl salts 4.0
125 mM Sodium acetate with MgCl2 salts 4.0
Table 2.1: An overview of the buffer and ion solutions investigated for
the immobilisation of amylin (20-29) fibrils to mica.
2.2.2.6.2 AFM Imaging
All images were collected using a Nanoscope IIIa atomic force microscope in
tapping mode at scan rates of 2-3 Hz using silicon nitride cantilevers with
resonant frequencies of 31-34 kHz and spring constant of 0.08 N/m.
2.2.2.7 AFM image analysis
Data was processed using two computer packages, the analytical processing
options from the Nanoscope software version 5.21b48 (Digital Instruments,
Veeco Metrology Group, Santa Barbara CA) and SPIP program (Image
Metrology ApS USA). Images show topography and phase data (where indicated)
with scale bars. Z range contrast scale bars are presented alongside images where
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appropriate. The upper z range value is stated above each scale bar with lighter
colours indicating higher topographical features and greater phase contrast
respectively.
2.3 Results
2.3.1 Solid phase peptide synthesis
The ten amino acid peptide fragment corresponding to residues 20-29 of the
human amylin polypeptide was successfully synthesised using solid phase peptide
synthesis. After each amino acid coupling, an absorption reading of the column
eluent was measured using a spectrophotometer to ensure that coupling was
successful. However, it was found that after the addition of the third amino acid
(leucine) clumping of the resin occurred suggesting the possibility of aggregation
of the resin/peptide chain. In order to eliminate this and improve chances of
complete coupling, 5 of the ten (bold-type in the sequence below) subsequent
amino acids were double coupled.
H2N– S N N F G A I L S S –COOH
Double coupling involves the addition of the same amino acid twice: after the first
addition and coupling of the amino acid there is no Fmoc deprotection, instead the
same amino acid is reapplied to the reaction with coupling activation cocktail, left
for a further 2 to 3 hours before the column is washed with DMF, and then the
cycle continues with the next amino acid addition following deprotection. This
maximises the efficiency of coupling by increasing the tendency of all growing
peptide chains to couple with the new amino acid and thus maintaining a high
yield of the correct full-length peptide.
Purity of the end product, a white powder (100 mg) was characterised by LC-MS.
The real time chromatography UV trace is shown in Figure 2.1a. A positive ion
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mass spectrum of the largest peak (at 12.43 minutes) is presented in figure 2.1b
and confirms the presence of the target peptide.
Yield : 100 mg (85.7%)
ES-MS : m/z 1008.6 (100 %, [M]+).
2.3.2 HPLC
Purification of the peptide was carried out on a C18 preparative column using high
performance liquid chromatography. The starting method, based on the conditions
used in the LC-MS, was developed by scaling up the conditions utilised in the
smaller analytical column to the HPLC preparative column.
In the optimised method, solvents remained the same but with an increased flow
rate of 5 ml/min. The sample injection volume was increased to 200 ȝl of 2 mg/ml
peptide in 40% v/v acetonitrile. The column was washed with a gradient of 25 to
100 % B over 8 minutes, remaining at 100 % B for 5 minutes to ensure release of
all bound material, then reduction to 25 % B and run at this ratio for 10 minutes to
re-equilibrate the column.
LC-MS analysis of the eluent collected at approximately 5.5 minutes confirmed
the presence of the molecular ion corresponding to the peptide. Subsequent
analysis of a blank run confirmed all peptide was washed off the column at this
time.
Using this method, purified peptide yields were low and combined with the high
solvent consumption during the purification process, despite maximum
refinement, proved highly inefficient; 3 mg of crude peptide yielded only 0.61 mg
of purified peptide.
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Figure 2.1 Liquid chromatography mass spectrometry spectra for the crude
peptide sample. The real-time chromatography UV trace is shown in figure 2.1a.
The molecular ion spectrum for the peak at 12.43 minutes is shown in figure 2.1b,
identifying the presence of the target peptide ion [M]+.
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2.3.3 Congo red assay
The histology stain Congo red is used as a common bench indicator for the
presence of amyloid. Positive results are indicated by a green-gold birefringence
when viewed under the polarised light microscope. Aged samples of the crude and
purified amylin (20-29) in solution were assayed for the presence of amyloid by
staining with Congo red and the presence of any birefringence under polarised
light noted.
Following incubation of both the crude peptide and the purified peptide in
solution for 18 hours, aliquoted samples were dried and stained with Congo red
dye. Figure 2.2 presents images of the stained peptide samples: the crude peptide
viewed under normal (figure 2.2a) and polarised light (figure 2.2b), and the
stained purified peptide sample viewed under normal (figure 2.2c) and polarised
light (figure 2.2d). Additionally the samples were left for a further 30 hours to
ensure maximum opportunity for amyloid formation. Figure 2.2e shows the crude
peptide viewed under normal light and figure 2.2f under polarised light. The
stained purified peptide sample viewed under normal light is shown in figure 2.2g
and polarised light in figure 2.2h. Both samples under normal light have the red
colour of the dye. When the samples were viewed under polarised light the
characteristic green gold birefringence is observed for both the crude and purified
samples at both time intervals. The birefringence can predominantly be noted
around the outer edges of dense aggregates of samples, which form as an artefact
of drying.
2.3.4 AFM ex situ imaging
The aim of the experiments in the following section was to achieve a detailed
study of the morphology of amylin (20-29) fibrils by ex situ tapping mode AFM
imaging; specifically studying the variation in fibrillar morphology over time with
emphasis on younger fibril characterisation.
2.3.4.1 Preliminary ex situ AFM images
Preliminary investigations were made into the fibril forming capacity of the crude
and purified peptide samples, primarily to evaluate the level of necessity for
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Figure 2.2: Congo red staining of amylin (20-29) samples. Aged for 18 hours
crude (a and b) and purified (c and d) peptide samples under normal (left) and
polarised (right) light. Aged for 48 hours crude (e and f) and purified (g and h)
peptide samples under normal (left) and polarised (right) light. Peptide
concentration 1 mg/ml.
c d
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purification. Samples of the crude peptide and the purified peptide were stored
under identical conditions at room temperature for 18 hours and 48 hours to
ensure the maximum time for any fibrillar structures to form. Figure 2.3a is a
typical example of the topography (left) and phase (right) image of the crude
peptide sample at 18 hours. Individual fibrillar structures can clearly be seen in
the high resolution image. Similarly, fibrillar structures are observed in the
purified peptide sample at 18 hours (figure 2.3b). In both the purified and crude
sample images study of the background mica surface shows a similar extent of
deposition of non-aggregated material. This deposited material appears to have
had no detrimental influence on fibril formation and subsequent immobilisation to
the mica surface.
Figures 2.4a and 2.4b are representative AFM images of the crude and purified
samples (respectively) aged and imaged after 48 hours. The samples appear
similar in topography with a dense layering of fibrous material on the mica
surface. Additionally large dense aggregates are observed irregularly arranged on
top of the fibrous layer in both samples.
2.3.4.2 Fibril morphology
Ex situ tapping-mode AFM was used to obtain low and high-resolution images of
the morphology of amylin (20-29) fibrils. Figures 2.6 to 2.12 are a representative
selection of the topography and phase images generated of peptide fibrils formed
in solutions of ultrapure water (concentration 1 mg/ml) aged between 2 and 48
hours and imaged ex situ on freshly cleaved mica substrate. To prevent molecular
over-crowding of the scan area, it was often necessary to dilute the sample using
ultrapure water prior to imaging. Dimensions given are the mean r the standard
deviation of a sample of randomly selected fibrils within the scan areas.
In control experiments, ultrapure water without peptide was incubated under
identical conditions. At the same time as an aliquot of peptide solution was
removed and imaged, an aliquot of the control was dropped onto freshly cleaved
mica and then imaged, only clear mica surfaces were observed (images not
shown).
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Figure 2.3: Ex situ AFM images of the amylin (20-29) peptide sample a) after
purification and b) the crude peptide sample at 18 hours. Peptides were solubilised
in ultrapure water for 18 hours before aliquot samples were removed and dried onto
freshly cleaved mica. The final peptide concentrations were 100 µg/ml. Topography
images are shown to the left and phase images on the right with z range contrast bar.
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Figure 2.4: Ex situ AFM images of the amylin (20-29) peptide sample a) after
purification and b) the crude peptide sample at 48 hours. Peptides were
solubilised in ultrapure water for 48 hours before aliquot samples were removed and
dried onto freshly cleaved mica. The final peptide concentrations were 100 µg/ml.
Topography images are shown to the left and phase images on the right with z range
contrast bars.
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2.3.4.2.1 Amylin (20-29) at t=18 hours
The images in figures 2.6-8 are a typical selection of the amylin (20-29) fibrils
formed in ultrapure water for 18 hours at a concentration of 1 mg/ml. Immediately
prior to imaging in air using tapping-mode AFM, aliquots of solution were diluted
to 100 µg/ml before drying onto freshly cleaved mica.
The images shown in figure 2.6a are of a selection of individual fibrils observed
in the peptide solutions aged for 18 hours, several different fibril dimensions can
be observed. Fibrils were straight (green arrow) and curved (blue arrow),
branched (red arrow) or unbranched (black arrow). Figure 2.6b shows a high-
resolution image of the boxed area in figure 2.6a, highlighting the end of a fibril.
This fibril is 1.195 ȝm in length with an average width of 26.15(±2.8) nm. At the
end of the fibril there is a reduction in height and slight decrease in width (white
arrow) compared to the rest of the fibril. The fibril then branches into two arms of
similar height but smaller widths (pink arrow). Figure 2.5 is a histogram of the
half-height width of a sample selection (n = 150) of fibrils found in the 18 hour
samples. The mean half-height width is 27.31(±8.36) nm.
Several distinctive morphological features that were encountered during imaging
are presented in the topography and phase images presented in figure 2.7. Figure
2.7a shows a high-resolution image of fibrils extending outwards in a fan-like
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Figure 2.5: Histogram of the half-height width distribution of amylin
(20-29) fibrils aged 18 hours. Mean fibril half-height width is
27.31(±8.36) nm (n = 150)
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manner from a dense central point. Fibrils are of similar width, with average
dimensions of 34.4(±8.1) nm. A regularly observed feature is the splitting or
branching of a single fibril. Branches are generally of equal width and are in most
cases as wide as the originating fibril (figures 2.7b and 2.7c). The point at which
a fibril splits in two appears to be random, and occasionally the branches rejoin to
form a single fibril again (figure 2.7c). A high-resolution image of such a feature
can be seen in figure 2.7d, in which the originating fibril is 33.03(±6.83) nm, the
branches are 24.89(±3.89) nm and 28.84(±4.59) nm and the remerged fibril is
34.5(±5.30) nm.
The phase images presented in to the right in figures 2.7a, 2.8b and c, provide
additional complementary information to the topography data on the morphology
of the amylin (20-29) fibrils; distinct boundaries between individual fibrils can be
elucidated.
Individual protofilaments were also observed organised into higher-order
structures. The image shown in figure 2.8a is typical of protofilaments assembled
into twisted bundles. The twisting of the bundles appears to have no regular
periodicity and displayed variation in the number of protofilaments incorporated
within each bundle. Also of note, protofilaments within the twisted bundles could
extend out from one bundle to form that of another, generating a network.
Furthermore, protofilaments were also observed laterally aligned, forming sheet-
like assemblies as demonstrated in the topography and phase image shown in
figure 2.8b and at a higher-resolution shown in figure 2.8c. In such cases a more
uniform array is produced, and the protofilaments are more linear than in the
twisted bundles with no discernable branching.
2.3.4.2.2 Fibril Variation with Time
A preliminary study to investigate the time-scale of amylin (20-29) fibrillogenesis
was performed. Aliquot samples were removed from a 1 mg/ml stock solution of
amylin (20-29) after successive 2 hour time periods (0, 2, 4, 6 hours), dried onto
freshly cleaved mica and imaged in air using tapping mode AFM. The high-
resolution topography images are shown in figure 2.9.
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Figure 2.6: Ex situ AFM images of individual fibrils of amylin (20-29) stored for
18 hours. Peptides were solubilised in ultrapure water for 18 hours before aliquot
samples were removed and dried onto freshly cleaved mica. The final peptide
concentration was 100 µg/ml. Figure 6a is a topography image, the arrows highlight
the range of different fibril morphologies. A higher resolution topography image of the
boxed area is shown in figure 6b. Arrows indicate two different widths (16.7 (r3.1)
nm and 23.9 (r2.6) nm) of the protofilament. Z range contrast bars are shown.
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Figure 2.7: High-resolution ex situ AFM images of amylin (20-29) fibril
morphologies at 18 hours. The final peptide concentration was 100 µg/ml in ultrapure
water. Figure 7a shows a topography (left) and phase (right) image of fibrils fanning out
from a central point. The topography image shown in figure 7b is of a fibril splitting or
branching. The topography image shown in figure 7c is another example of fibril
branching, the higher-resolution image of the boxed area shown in figure 7d is of a fibril
splitting and remerging. Z range contrast bars are shown.
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Figure 2.8: Ex situ AFM images of higher-order assemblies of amylin (20-29)
fibrils aged 18 hours. Final peptide concentration 100 µg/ml in ultrapure water.
Figure 8a shows a typical topography image of fibrils associated into twisted
assemblies. The arrows indicate two bundles with different sizes and morphologies.
Figure 8b shows a topographic (left) and phase (right) image of laterally associated
fibrillar assemblies. Figure 8c is a higher-resolution topographic image of the boxed
area in figure 8a. Z range contrast bars are shown.
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Fibrillar structures were first observed after incubation of the solution for 4 hours
(figure 2.9c). Prior to this, no fibrous material was noted. However the mica
surface had a granular appearance presumably due to pre-aggregation material,
which is still apparent in the higher resolution image in figure 2.9c of the sample
at 4 hours but which is dramatically reduced at 6 hours (figure 2.9d). Many of the
early protofilaments display a twisting along their axis, giving the structures a
globular appearance (figures 2.10 and 2.11). This was more prevalent in the fibrils
in the samples aged 6 hours. The twisting periodicity varied between different
protofilaments and in some instances had no regular turn. Figure 2.10a and b are
typical high-resolution topography images of the protofilaments at 4 hours, with
further topographical information detailed in the phase images. At 4 hours the
majority of fibrillar structures displayed twisting along their axis; however the
periodicity varied amongst the protofilaments in the sample. Figure 2.10c is a
cross-sectional profile along the axis of the fibril in the boxed area in figure 2.10b;
the measured periodicity is approximately 40 nm with some variation between
twists and a fibril half-height width of 20.3 nm. By comparison the fibril in figure
2.10a has a periodicity of approximately 48 nm despite a half-height width of only
10.1 nm. Examples of protofilaments from samples 6 hours old can be seen in the
topography image shown in figure 2.11a. This is typical of the sample at this time
point and highlights the variation in protofilaments; many display periodicity
along their axis whilst the remaining have a featureless morphology. The higher-
resolution topography image in figure 2.11b is of the boxed area in figure 2.11a
and highlights several protofilaments with periodicity along their axis. Figure
2.11c shows a height cross-sectional profile along the axis of the boxed
protofilament in figure 2.11b which has a regular periodicity of approximately 75
nm and maximum half-height width of 26.4 nm and height of 4.1 nm. The
twisting periodicity was not observed in solutions of protofilaments incubated for
longer periods (18+ hours) (figures 2.7 and 2.8).
2.3.4.2.3 Fibril Morphology at 48 hours
Peptide solutions were stored at room temperature for a further 30 hours in
ultrapure water at a concentration of 1 mg/ml, and then aliquots removed, dropped
onto freshly cleaved mica and dried immediately prior to imaging in air using
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Figure 2.9: Ex situ AFM images of amylin (20-29) after 0, 2, 4 and 6 hours
incubation. Final peptide concentration was 1 mg/ml in ultrapure water. Topography
images are of the peptide sample at a) 0 hours, b) 2 hours, c) 4 hours and d) 6 hours.
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Figure 2.10: Ex situ AFM images of amylin (20-29) fibrils aged 4 hours. Final
peptide concentration was 1 mg/ml in ultrapure water. The periodicity observed in
younger fibrils is demonstrated in the topography (right) and phase (left) images
shown in figure 10a and figure 10b. Figure 10c is a line plot along the axis of the
fibril in the box of figure 10b, showing an example of the regular periodicity observed
in younger fibrils.
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Figure 2.11: Ex situ AFM images of amylin (20-29) fibrils aged 6 hours. The final
peptide concentration was 1 mg/ml in ultrapure water. Figure 11a shows a
topography image, a higher-resolution topography image of the boxed area is shown
in figure 11b. Z range contrast bars are shown. Figure 11c is a line profile of the
height variations along the axis of the fibril in the box of figure 11b, showing an
example of the periodicity observed in younger fibrils.
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tapping mode AFM. Typical topography and phase images are shown in figure
2.12.
In most samples, a fibrous layer was observed (Figure 2.12) covering the entire
sample area and appeared much denser than previously seen in the samples aged
18 hours. In the upper portion of figure 2.12a, higher raised aggregates can be
seen on the denser portion of the fibril surface layer. The aggregates are of varied
dimensions with no discernable morphology. There is no regularity to the location
of the aggregates on the surface layer and it is not apparent whether these are
aggregates which have adsorbed to the preformed fibrils or a mis-aggregated
clump bulging outwards from a fibril. Figure 2.12b is a higher-resolution
topography and phase image of the fibrous layer, several of the protofilaments are
broken, a likely effect of the drying process. The mean half-height width of
protofilaments at 48 hours was 33.7 (±6.9) nm and height of 2.19 (± 0.54) nm. In
Figure 2.12, several general features are worth noting, firstly that the fibrils
appear to be layered in sections in which they are laterally assembled with no
twisting and coiling, and second that the majority of fibrils appear straight and
unbranched. Although these layering features could be a characteristic of aged
fibrils, it is also possible that this may be an artefact of drying, especially the
tendency for the fibrils to layer in a unidirectional manner.
The images displayed in Figures 2.12c and d are of an area on the perimeter of the
fibrous layer. The topographical image of a fibrillar structure extending away
from the layer is shown in figure 2.12c. The topography image suggests that the
structure is a single fibril; however a zoom in of the structure indicates a bundle of
at least 3 fibrils (figure 2.12d). The bundle is 1.78 ȝm in length and 52 nm wide,
with the widths of the individual fibrils being 25.4, 26.6 and 30.7 nm. The fibrils
within the bundle are straight with a regular uniform surface along their entire
axis and no noticeable surface features.
2.3.5 AFM in situ imaging
The aim of the following experiments was to study amylin (20-29) fibrils in a
hydrated form by AFM liquid imaging. A variety of salt solutions were
investigated to determine the necessary conditions for physisorption of the amylin
Chapter 2 Characterisation of amylin (20-29) fibrils
- 60 -
Figure 2.12: Ex situ AFM images of amylin (20-29) fibrils aged 48 hours. The final
peptide concentration was 1 mg/ml in ultrapure water. Figure 12a shows a
topography (left) and phase (right) image, a higher-resolution topography (left) and
phase (right) image of the boxed area is shown in figure. Figure 12c shows
topography image at the perimeter of the fibrous area, a higher-resolution topography
image of the boxed area is shown in figure 12d. Z range contrast bars are shown.
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(20-29) fibrils to muscovite mica. An overview of the buffers and ionic species
investigated are listed in table 2.2. Only a few of the conditions investigated
provided a suitable environment for the immobilisation of the peptide material to
the substrate, which was necessary for stable and reproducible AFM imaging.
Ionic content pH
10 & 50 mM Tris HCl 7.2
10, 50, & 100 mM KCl (acidified) 4.0
100 mM MgCl2 (acidified) 4.0
50, 100, 150 mM Sodium acetate 5.5
125 mM Sodium acetate and 30 mM KCl 5.5
125 mM Sodium acetate and 30 mM MgCl2 5.0
50, 100, 150 mM Sodium citrate 4.0
130 mM Sodium acetate and 30 mM KCl 4.0
125 mM Sodium acetate and 30 mM KCl 4.0
125 mM Sodium acetate and 30 mM MgCl2 4.0
Table 2.2: Concentrations and pHs of the buffer and ion solutions
investigated for the immobilisation of amylin (20-29) fibrils to mica.
2.3.5.1 Ultrapure Water
The images displayed in figure 2.13 are typical topography images observed when
amylin (20-29) at a concentration of 125 µg/ml was imaged in ultrapure water
after 18 hours (figure 2.13a and b). No fibrillar structures were observed
physisorbed to the mica surface at either 18 or after the sample was left for a
further 6 hours (images not shown). Control images of ultrapure water stored
under identical conditions revealed clear mica (figure 2.13c).
Taking into account the air imaging experiments in the previous section in which
fibrillar structures readily form in ultrapure water, it is likely that the
immobilisation of the fibrils rather than impaired formation is the reason for these
findings. Therefore it may be surmised that ultrapure water is not sufficient to
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enable immobilisation of the amylin (20-29) fibrils to mica and thus further
investigations were required.
2.3.5.2 Tris HCl
The study by Goldsbury et al 1999 [44] followed the fibrillisation of full-length
amylin on mica substrate using 10 mM Tris HCl (pH 7.3) system and so was
deemed a good starting strategy for imaging the amylin (20-29) fragment fibril in
solution. Figure 2.14a shows a typical topography image of the amylin (20-29)
sample (peptide concentration 100 µg/ml) after 8 hours in 10 mM Tris HCl at pH
7.2. No fibrillar structures are observed, instead the mica surface has a mottled
appearance, which may be aggregated material that has not undergone
fibrillisation. To increase the ionic strength of the Tris ions, the imaging
concentration was increased to 50 mM. At 50 mM Tris HCl pH 7.2 small clumped
aggregates are observed, however no fibrillar structures are observed (Figure
2.14b).
The isoelectric point for amylin (20-29) has been calculated to be 5.2. Therefore
at pHs below this value, the peptides would have an overall positive charge. The
surface of muscovite mica has an overall net negative charge, therefore using an
ionic environment with a pH below 5.2, physisorption of the peptides and fibrils
to the mica surface should be promoted. The topography image presented in
figure 2.14c is of amylin (20-29) in 10 mM Tris HCl at pH 5.0. In similarity to the
higher pH images, no fibrils are observed in the sample and the mica surface has a
deposition of aggregated material. Figure 2.14d is a low-resolution topography
image of a control solution of 10 mM Tris HCl at pH 5.0 with no amylin (20-29)
present. As expected the mica surface appears clear with no material deposition.
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Figure 2.13: In situ AFM images of amylin (20-29) fibrils in ultrapure water at 18
hours. The final peptide concentration was 125 µg/ml. Figure 13a shows a
topography image, a higher resolution topography image is shown in Figure 13b.
Figure 13c is a topography image of the control solution. Z range contrast bars are
shown.
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Figure 2.14: In situ AFM images of amylin (20-29) fibrils 10 mM and 50 mM Tris
HCl. Peptide solutions were aged for 8 hours before imaging. The final peptide
concentration for all was 100 µg/ml. Figure 14a shows a topography image of peptide
in 10 mM TrisHCl at pH 7.2 and figure 14b shows a topography image of peptide in
50 mM TrisHCl pH 7.2. Figure 14c shows a topography image of peptide in 10 mM
TrisHCl pH 5.0. Figure 14d is a topography image of the control sample. Z range
contrast bars are shown.
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2.3.5.3 Potassium chloride
The rationale behind the following set of experiments was to investigate the
ability of ionic solutions with pH’s lower than the isoelectric point of amylin (20-
29) to facilitate the physisorption of the peptide fibrils to a mica surface.
The topography image shown in figure 2.15a is typical of the low-resolution
liquid images of amylin (20-29) in solutions of 10 mM potassium chloride pH 4.
The amylin sample was prepared in ultrapure water and then diluted to 100 µg/ml
in the potassium chloride (KCl) solution after 4 hours and imaged in solution after
8 hours. The mica surface has a granular appearance which is most likely peptide
material and not potassium salts agglomerates as the solution was filtered through
a 0.2 µm filter prior to use and were not observed in control samples.
To determine whether the KCl had interfered with the self-assembly of the amylin
(20-29) fibrils, aliquot samples were removed after 6 ½ hours and dried onto
freshly cleaved mica. Figure 2.15b and c are typical low and high-resolution
(respectively) images of the dried sample. A dense mat of clearly defined fibrillar
structures is observed covering the entire sample surface. The high-resolution
image shows the protofilaments to have no discernable surface topographies, and
are flat ribbon-like structures with many having extending branches and
dimensions in the same range as previously observed. Worthy of note is the
apparent lack of globular material seen in the liquid images.
To determine whether a higher concentration of the monovalent salts would
facilitate physisorption, the experiment was repeated at the same pH but the ionic
strength of the KCl solution was increased 5 fold. Figure 2.16a, b and c are typical
high-resolution topography images of the fibrillar structures observed in the
solution at 8 hours, with peptide concentration of 100 µg/ml. Fibrils were
observed only as individual structures with no lateral or coiling aggregation of
several fibrils together. Fibrils were generally observed as flexible rods, either
branched (figure 2.16b) or unbranched fibril of width 10.67 nm and height of 1.66
nm can be seen in figure 2.16c, with half-height widths of 10.5 and 13.7 nm and
heights 1.66 and 1.75 nm (respectively).
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Figure 2.15: In situ and ex situ AFM images of amylin (20-29) fibrils in 10 mM
KCl pH 4. Peptide solutions were aged for 8 hours before imaging. The final peptide
concentration was 100 µg/ml. Figure 15a shows an in situ topography image. Figure
15b shows a topography image of the same sample after drying in N2 gas stream and
imaging in air (sample aged 6½ hours). A higher-resolution topography image of the
dried sample is shown in figure 15c. Z range contrast bars are shown.
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Figure 2.16: In situ AFM images of amylin (20-29) fibrils in 50 mM KCl pH 4.
Peptide solutions were aged for 8 hours before imaging. The final peptide
concentration was 50 µg/ml. Figure 16a shows a topography image. Higher-
resolution topography images of individual fibrils are shown in figure 16b and figure
16c. Z range contrast bars are shown.
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Although the solution conditions have enabled imaging of the fibrils, a double-
tipping effect was observed in all the images generated. Furthermore, the images
are unstable due to insufficient adsorption of the fibrils to the surface which has
caused the structures to appear broken. To overcome these issues the
concentration of the solution was increased further to 100 mM KCl, however no
fibrillar structures were observed at this higher KCl concentration. Furthermore,
on increasing the peptide concentration to 200 µg/ml no fibrillar material was
observed.
2.3.5.4 Magnesium chloride
Typical low and high-resolution topography images are presented in figure 2.17 of
amylin (20-29) at 8 hours in a solution of magnesium chloride (MgCl2). The
peptide concentration was 100µg/ml in a 30 mM MgCl2 solution at pH of 4. No
fibrillar structures were observed in the MgCl2 solution during imaging however
the mica surface did have aggregates of material across the surface. This
aggregated material is likely to be peptide-based as the MgCl2 solution was
filtered to 0.2 µm prior to use and were not observed in control samples in the
absence of peptide. In the higher-resolution image (figure 2.17b), one can see that
the globular materials are very low structures with no distinct surface regularity
and of varying dimensions, and most likely to be aggregated peptide deposits.
2.3.5.5 Sodium acetate
Following the limited success with simple monovalent and divalent ionic
solutions, more complex buffer solutions were investigated. Sodium acetate buffer
(pH 5.5) at three different concentrations of 50, 100 and 150 mM were studied.
No fibrillar structures were observed at 8 hours in the 50 mM sodium acetate,
instead a dense layer of material was present covering the entire mica surface.
Figure 2.18a is a typical topography image of amylin (20-29) at a concentration of
150 µg/ml in 50 mM sodium acetate. The mat of material contains some holes,
but no individual fibrillar structures could be elucidated at either low or high
resolution. With the intention of reducing the dense coverage of material the
peptide concentration was lowered to 100 µg/ml. Figure 2.18b is typical of the
topography images observed; a dense layer of material has still formed on the
surface and no distinguishable fibril features were apparent. From these images it
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Figure 2.17: In situ AFM images of amylin (20-29) fibrils 30 mM MgCl2 pH 4.
Peptide solutions were aged for 8 hours before imaging. The final peptide
concentration was 100 µg/ml. Figure 17a shows a topography image, a higher-
resolution topography image is shown in figure 17b. Z range contrast bars are shown.
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Figure 2.18: In situ AFM images of amylin (20-29) fibrils 50 mM sodium acetate
pH 5.5. Peptide solutions were aged for 8 hours before imaging. Figure 18a shows a
topography image of the sample at a final peptide concentration of 150 µg/ml. To
reduce molecular overcrowding of the scan area the peptide concentration was
reduced to 100 µg/ml, figure 18b shows a topography image of the sample. Z range
contrast bars are shown.
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is not clear whether the sodium acetate has interfered with fibril formation and
thus no fibrils are formed or that there are fibrils present but that the individual
fibrils are not resolvable by the AFM tip aperture due to dense aggregation and
packing together on the surface.
On increasing the sodium acetate concentration to 100 mM success was achieved
in imaging individual fibrillar structures. A selected sample of the successive
topography images captured during the course of the study are shown in figure
2.19a to f. An animation of these images can be found in Appendix A. The images
were collected over approximately 2 ½ hours when the peptide solution was aged
between 5 to 7 ½ hours, the exact length of minutes is noted against the individual
image. The peptide concentration was 100 µg/ml. Fibrils appear to originate from
a dense clump and elongate outwards retaining the same width and height along
the entire axis. Fibrils were flat ribbon-like structures with widths in the range of
10-15 nm and heights of 2-4 nm. Individual fibrils often appeared granular along
their surface but did not generate branches from a central axis, instead several
fibrils elongated from the same nucleating clump. An unfortunate artefact of AFM
imaging in solution is drift, despite efforts to maintain the same position on the
mica during the course of imaging there was some drift experienced. A red cross
marks the same spot on the mica surface in each of the images shown in figure
2.19a-f. Figure 2.19g is a control topography image of the 100 mM sodium
acetate solution in the absence of peptide, no fibrillar structures are present.
A study of the kinetics of fibril formation was performed on a random sample of
protofilaments from these images. The change in length of the fibrils was
measured over time and plotted as a graph shown in figure 2.19h. The average
increase in length was calculated per minute and varied between fibril from
approximately 2 to 10 nm min-1. The growth of fibrils could be bidirectional and it
was often noted that the growth was suppressed if another fibril blocked the path
of the elongating fibril. This may be a reason for the variation in fibril rates as a
growing fibril once blocked by another would not undergo any further increase in
length over the time period.
360 mins 384 mins366 mins
a b c
Figure 2.19: In situ AFM images of amylin (20-29) fibrils in 100 mM sodium acetate pH 5.5. The final peptide concentration was 100 µg/ml. Figures
19a-f are successive topography images with the age of the solution shown in minutes below. The red cross highlights the same point on the mica
surface in each image. Z range contrast bars are shown. The line graph shown in figure 19g is the change in length with time of 7 randomly chosen
fibrils within the scan area. The rate of fibril elongation is shown as nm per min. Figure 19h shows a topography image of the control sample. Z range
contrast bar is shown.
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(Figure 2.19 continued: In situ AFM images of amylin (20-29) fibrils in 100 mM sodium acetate pH 5.5 )
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The concentration of sodium acetate was increased further to 150 mM (pH 5.5). A
typical low-resolution topography image of 150 µg/ml amylin (20-29) in 150 mM
sodium acetate at 8 hours is shown in figure 2.20a and a higher-resolution image
of the boxed area is shown in figure 2.20b. No fibrillar structures were present at
this higher buffer concentration; however the mica surface has a grainy
appearance. To determine whether the higher sodium acetate concentration had
interfered with fibrillisation a sample was removed and dried onto freshly cleaved
mica, the topography images are shown in figure 2.20c and a higher-resolution
image is shown in figure 2.20d. The dried sample revealed that fibrils are still
forming in 150 mM sodium acetate concentration, however large aggregates of
varying size and morphology were frequently observed too. These aggregates are
most likely amorphous aggregates of peptide rather than buffer salts as the
solution was filtered to 0.2 µm prior to use.
2.3.5.6 Sodium acetate and potassium chloride system
Given the differing dimensions and morphologies of the fibrillar structures
observed in the sodium acetate buffer solutions to those observed in the KCl ion
solution, a further experiment was devised to investigate the electrostatic effects
of a buffer with a monovalent ion on the fibril formation of amylin (20-29).
Clear high-resolution images of the amylin (20-29) fibrils were produced using a
125 mM sodium acetate and 30 mM potassium chloride system. Figure 2.21a is a
typical low-resolution topography image of the fibrillar structures observed in the
sample at 18 hours with a peptide concentration of 150 µg/ml. A high-resolution
topography image of the boxed area in figure 2.21a is presented in figure 2.21b
and a zoomed in 3D representation of the surface is shown in figure 2.21c. The
fibrils were unbranched and ribbon-like structures with no apparent surface
morphology. Fibrils appear to preferentially aggregate together forming isolated
clumps directly onto the mica surface. Unlike the aggregation patterns observed in
fibrils self-assembled in water and imaged in air, no twisting or coiling of the
fibrils into bundles was observed. However, here the fibrils have a propensity to
laterally align (highlighted by arrow in figure 2.21c). Individual fibrils have
considerable flexibility with the ability to freely form curves and loops and to
overlap one another on the surface.
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Figure 2.20: In situ and ex situ AFM images of amylin (20-29) fibrils 150 mM
sodium acetate pH 5.5. Peptide solutions were aged for 8 hours before imaging. The
final peptide concentration was 150 µg/ml. Figure 20a shows a topography images
with a higher-resolution topography image of the boxed area is shown in figure 20b.
Figure 20c shows a topography image of the sample after drying. Figure 20d shows
a digital zoom image of the boxed area in fig 20c.
a b
c d
1 µm
1 µm
250 nm
250 nm
Chapter 2 Characterisation of amylin (20-29) fibrils
- 77 -
Figure 2.21: In situ AFM images of amylin (20-29) fibrils 125 mM sodium acetate
and 30 mM KCl at pH 5.5. Peptide solutions were aged for 8 hours before imaging.
The final peptide concentration was 150 µg/ml. Figure 21a shows a topography
image of the sample, a higher-resolution topography image of the boxed area is
shown in figure 21b. A 3D representation of the topography image in figure 21b is
shown in figure 21c. Figure 21d is a histogram of the frequency distribution of fibril
half-height widths in the sample. Z range contrast bars are shown.
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The histogram in figure 2.21d shows the half-height width distribution for the
fibrils in 125 mM sodium acetate and 30 mM potassium chloride, the mean width
was calculated as 8.27 (±2.17) nm and mean height of 1.5 (±0.21) nm.
2.3.5.7 Sodium acetate and magnesium chloride system
The topography image shown in figure 2.22a is typical of the low-resolution
information obtained from samples of 200 µg/ml amylin (20-29) in 125 mM
sodium acetate with 30 mM magnesium chloride at 8 hours. A dense covering of
globular structures can be observed. A high-resolution topography image shown
in figure 2.22b and the 3D topography representation (figure 2.22c) reveal that the
structures are densely aggregated together and are several layers thick.
Furthermore, it can be observed that the globular structures are sufficiently stable
in their multilayer packing to remain fully bound to one another even during the
raster scanning of the tip during imaging. The globular structures vary in
dimension with widths ranging from 30 to 100 nm. In control samples of sodium
acetate and magnesium chloride no such structures are observed, and therefore it
is surmised that these globular features comprise aggregated peptide material.
Previous results have not revealed any similar structures in solutions of amylin
(20-29) peptide with either sodium acetate (figure 2.19-21) or magnesium
chloride (figure 2.18). In these samples amylin (20-29) was placed directly at time
= 0 into a solution of sodium acetate and MgCl2. Therefore to determine whether
the MgCl2 in combination with sodium acetate was interfering with the
fibrillisation of amylin (20-29), the addition of MgCl2 to the fibrillisation mixture
was delayed until 4.5 hours and 6 hours. The rationale behind these timings was
based on the preliminary ex situ imaging study in which the first observation of
small fibrils was recorded at approx 4 hours with a significant increase in the
number of fibrils at 6 hours (figure 2.9). Therefore by addition of MgCl2 at these
time points, fibrils should already be formed. If no fibrils are observed then it may
be assumed that the MgCl2/sodium acetate combination has a unique aggregating
effect on the pre-formed fibrils.
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Figure 2.22: In situ AFM images of amylin (20-29) fibrils in 125 mM sodium
acetate and 30 mM MgCl2 . The final peptide concentration was 200 µg/ml. Figure
22a shows a topography image of the peptide sample when MgCl2 was added at t= 0
hours. A higher resolution topography image of the sample is shown in figure 22b
and a 3D representation of the surface is shown in figure 22c. Figure 22d shows a
topography image of the peptide sample when MgCl2 was added at t= 4.5 hours. A
higher resolution topography image of the sample is shown in figure 22e, and figure
22f is a 3D representation of the surface. Z range contrast bars are shown. Continued
on next page.
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Figure 2.22 (continued): In situ AFM images of amylin (20-29) fibrils in 125 mM
sodium acetate and 30 mM MgCl2. The final peptide concentration was 200 µg/ml.
Figure 22g shows a topography (left) and phase (right) image of the peptide sample
when MgCl2 was added at t= 6 hours. Z range contrast bars are shown. A 3D
representation of the surface is shown in figure 22h and a cross-sectional profile
shown in figure 22i. Figure 22j shows a topography image of the control sample. Z
range contrast bars are shown.
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The high-resolution topography images shown in Figure 2.22 d and e are of the
globular structures observed when 30 mM MgCl2 was added to a solution of
amylin (20-29) in 125 mM sodium acetate after 4.5 hours and then imaged up to 8
hours. These globular structures are slightly smaller, have a more spherical
appearance but are not as densely packed (figure 2.22f) as previously seen in the
samples with MgCl2 present from 0 hours (figures 2.22 a-c); however no fibrillar
structures were observed.
Conversely when the experiment was repeated using identical conditions but the
MgCl2 was added at 6 hours fibrillar structures were observed. Figure 2.22g is a
high-resolution topography image (left) of the sample at 8 hours, further
topographical information can be obtained from the phase image to the right. A
3D representation of the sample surface is shown in figure 2.22h. The fibrils
appear to be adsorbed to monolayer of material covering the mica surface.
Dimensions are greater than previously observed for amylin (20-29) fibrils and
are in the range of 25 to 40 nm in width. The cross-sectional profile (figure 2.22i)
shows that the monolayer is approximately 2.8 to 3.2 nm thick and is in the same
height range as the fibrils adsorbed to its surface. A control topography image in
the absence of peptide is shown in figure 2.22j.
2.3.5.8 Sodium citrate
Sodium citrate was selected for its lower pH buffering capacity and was
investigated at 3 concentrations of 50, 100 and 150 mM at pH 4. Typical high-
resolution topography images of amylin (20-29) at a concentration of 150 µg/ml
imaged in each of the solutions are shown in figure 2.23.
As can be seen in the topography image presented in figure 2.23a, at 50 mM
sodium citrate fibrillar structures were observed adsorbed to the mica surface in
samples aged 8 hours. During imaging in 50 mM sodium citrate, despite using
low scan rates and scan area of 1 µm, it was found that topographical features
generally appeared blurred and undefined. Due to this imaging artefact, features
may appear larger than their true dimension.
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On repeating the experiment using a higher concentration of 100 mM sodium
citrate a combination of fibrillar structures and non-descript aggregates were
observed on the mica surface. Figure 2.23b is a typical high-resolution image of
the topographical structures observed at 8 hours. The aggregates are alike in
appearance to those observed in 100 mM sodium acetate (figure 2.19) and the
fibrillar structures appear to originate from the aggregates in a similar manner.
Figure 2.23c is a higher-resolution image of the boxed area in figure 2.23b, all
fibrils appear to be projecting from an aggregate of material. Fibril dimension are
comparable to those observed in the sodium acetate and potassium chloride
images (figure 2.21) in the range of 5 to 10 nm. Given the small dimensions of the
fibrillar structures, it is possible that the aperture of the AFM tip is too large
(mean NPS tapping-mode tip radius is 15 nm (Olympus)) to resolve topographical
features within the aggregates. Therefore it is possible that these aggregates may
not be single structures but instead are an agglomeration of laterally aligned
truncated protofilaments or pre-fibrillar intermediates.
However, when the peptide sample was imaged at a higher concentration of 150
mM buffer, no fibrillar structures were observed, even after 24 hours in solution.
Figure 2.23d is typical of the high-resolution topography images of the sample at
24 hours, adsorbed to the mica surface are aggregates with a range of sizes. It can
be assumed that as the control images of sodium citrate with no peptide present
produced clear images (images not shown) that these aggregates comprise of
peptide material. Following imaging of the liquid sample, the mica was dried and
imaged. Figure 2.23e is the tapping-mode air image of the mica section. Large
quantities of fibrils can be seem which suggests that the 150 mM sodium citrate
solution does not prevent fibrillisation, but that the higher concentration is not
conducive to imaging of the amylin (20-29) fibrils.
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Figure 2.23: In situ AFM images of amylin (20-29) fibrils in 50, 100 and 150 mM
sodium citrate at pH 4.0. The final peptide concentration was 150 µg/ml. Figure 23a
shows a topography image of amylin (20-29) fibrils in 50 mM sodium citrate. Figure
23b shows a topography image of amylin (20-29) fibrils in 100 mM sodium citrate, a
higher-resolution image of the boxed area is shown in figure 23c. Figure 23d shows
a topography image of amylin (20-29) fibrils in 150 mM sodium citrate at 24 hours and
figure 23e shows an ex situ topography image of the same sample after drying. Z
range contrast bars are shown.
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2.3.5.9 Sodium citrate and potassium chloride system
The topography images presented in figure 2.24 are typical of the fibrillar
structures observed in 125 mM sodium citrate and 30 mM potassium chloride
solution. The fibrils were straight and unbranched with a smooth outer topography
at 18 hours, displaying considerable flexibility, and in some instances with the
ability to bend almost as a hairpin. Figure 2.24b is a zoom topography image
showing an area of high fibrillar aggregation. The 3D representation (figure
2.24c) of the same area shows that the height at what appears to be the epicentre
of the aggregation is not the cumulative height of the surrounding fibrils.
Therefore, indicative that this point may be a nucleation point from which the
fibrils originate rather than several fibrils overlapping on the surface. Such a
feature was observed previously during ex situ imaging (figure 2.7a).
Fibrillar dimensions had a half-height width distribution (figure 2.24d) with mean
of 18.03 (±2.13) nm. The fibrils displayed a height distribution with mean of 1.5
(±0.23) nm. These dimensions suggest that the fibrils have a flat ribbon-like
appearance.
The blurred edges of the fibrils and noise within the image suggest that the fibrils
were not fully adsorbed to the mica surface, remaining slightly flexible within the
solution whilst the AFM tip was scanning the surface. In fact, prolonged imaging
of the sample was not possible due to aggregation of material to the tip which
resulted in double-tipping and considerable noise distortion during imaging. The
background has a mottled appearance (figure 2.24b) indicating that the aggregated
fibrils are layered on top of a dense layer of material. It can be assumed that this
surface layer contains peptide material as control images in the absence of amylin
(20-29) show only clear mica surfaces (images not shown).
A time-lapse study of fibrils in 130 mM sodium citrate and 30 mM potassium
chloride was performed between 0 and 8 ½ hours; successive topography images
are shown in figure 2.25a to f. There is little change in the fibril dimensions over
the time course; however the topography images highlight the flexibility in the
fibrils.
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Figure 2.24: In situ AFM images of amylin (20-29) fibrils 130 mM sodium citrate
and 30 mM KCl at pH 4. Samples imaged at 18 hours, KCl added at t =0 hours, the
final peptide concentration was 150 µg/ml. Figure 24a shows a topography image of
the peptide sample, a higher-resolution topography image of the boxed area is shown
in figure 24b. Z range contrast bars are shown. A 3D representation of the surface is
shown in figure 24c. Figure 24d is a histogram of the frequency distribution of fibril
half-height widths in the sample.
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Figure 2.25: AFM images of amylin (20-29) fibrils 125 mM sodium citrate and
30 mM KCl at pH 5.5. KCl added from t = 0 hours, imaging started after 6 hours.
The final peptide concentration was 250 µg/ml. The topography images shown in
figures 25a-f are of the same location on the mica surface collected over the time
course, the time of image capture is shown in minutes. Figure 25g shows a
topography image of the sample at 18 hours. Figure 25h shows a topography
image of the control sample. Z range contrast bars are shown.
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2.3.5.10 Sodium citrate and magnesium chloride system
When amylin (20-29) was imaged in solution of 100 mM sodium citrate and 30
mM MgCl2 (pH 4) images show that there was widespread deposition on the
surface of globular structures, no fibrillar structures were observed. Figure 2.26a
is a typical high-resolution topography image of the sample at 8 hours; a 3D
representation of the surface has been generated and is presented in figure 2.26b.
The globular structures, although not as well defined are similar to those observed
in 150 mM sodium acetate and 30 mM MgCl2 solutions. The apparent lack of
definition in the globular features may be attributed to slight drift and double-
tipping occurring during imaging. The structures vary in width but display a
similar height measurement as is highlighted in the 3D image and cross-sectional
profile (figure 2.26c); height of structures was in the range of 1.2 to 1.6 nm. These
globular structures are not aggregates of buffer salts as the solutions were filtered
to 0.2 µm prior to imaging. Furthermore a typical control image of the 150 mM
sodium acetate and 30 mM MgCl2 solution with no peptide present is shown in
figure 2.26d; both the topography image and phase data show clear mica surfaces.
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Figure 2.26: In situ AFM images of amylin (20-29) fibrils in 100 mM sodium
citrate and 30 mM MgCl2 pH 4. MgCl2 added at t =0 hours. The final peptide
concentration was 250 µg/ml. Figure 26a shows a topography image captured at 8
hours, a 3D representation of the surface is shown in figure 26b. Figure 26c is a
cross-sectional profile of the features highlighted by the line in figure 26a. Figure 26d
shows a topography (left) and phase (right) image of the control sample. Z range
contrast bars are shown.
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2.3.6 Summary of results from in situ imaging
Listed in table 2.3 below is a summary of the findings and observations made
during in situ AFM imaging of amylin (20-29) under various environmental
conditions.
Ionic content pH Fibrils Observations
Ultrapure water 5.6 No
10 mM Tris HCl 7.2 No
50 mM TrisHCl 7.2 No
10 mM KCl 4.0 No Fibrils observed in dried
sample
50 mM KCl 4.0 Yes Loosely immobilised. Long
flexible fibrils
100 mM KCl 4.0 No
30 mM MgCl2 4.0 No
50 mM sodium acetate 5.5 No
100 mM sodium acetate 5.5 Yes Fibrils observed elongating
from aggregates of truncated
fibrils
150 mM sodium acetate 5.5 No Fibrils observed in dried
sample
125 mM sodium acetate and 30
mM KCl
5.5 Yes Long flexible unbranched
ribbons
125 mM sodium acetate and 30
mM MgCl2
5.0 No/Yes Globular aggregates. Fibrils
observed when MgCl2 added
after 6 hours
50 mM sodium citrate 4.0 Yes Short fibrils
100 mM sodium citrate 4.0 Yes Predominantly truncated
laterally assembled fibrils
with longer fibril projections
observed
150 mM sodium citrate 4.0 No Fibrils observed in dried
sample
125 mM sodium citrate and 30
mM KCl
4.0 Yes Long flexible unbranched
ribbons
130 mM sodium citrate and 30
mM KCl
4.0 Yes Long flexible unbranched
ribbons
125 mM sodium citrate and 30
mM MgCl2
4.0 No Globular aggregates
Table 2.3: Summary of the observations noted during in situ AFM imaging of
amylin (20-29) samples under a range of pH and ionic environments.
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2.4 Discussion
The first section of this chapter deals with the successful synthesis of the 10
amino acid peptide fragment corresponding to residues 20 to 29 of the human
amylin polypeptide using Fmoc solid phase peptide synthesis (figure 2.1).
Preliminary ex situ AFM images presented of amylin (20-29) fibrils formed in
ultrapure water suggest that the fibrils are freely forming and display similar
morphologies irrespective of whether the peptide proceeded through a HPLC
purification step or not. When taken into consideration that the purity of the crude
peptide sample, as estimated by LC-MS, was approximately 80 % with the
remaining 20 % attributed to residual solvents rather than incomplete peptide
chains it was decided not to proceed with this purification step. Particularly in this
regard was the fact that purification was time consuming and produced low yields
of pure peptide with no observable benefits.
Comparison of the AFM images of crude peptide after both 18 hours and 48 hours
in solution with similar images of the purified peptide sample (figure 2.3 and 2.4)
clearly shows that any impurities present in the crude sample have had no
detrimental effect on the formation of fibrillar structures by the peptides. In the
background of the 18 hour image (figure 2.3) non-fibrillar debris that is
physisorbed to the mica surface is observed, and to greater extent in the crude
peptide sample. However, this material does not prevent fibrillisation, and may
simply be amorphous aggregates of peptide which had yet to elongate into fibrillar
formations. Furthermore, the Congo red assay performed on both crude and
purified samples corroborates these AFM data as a green/gold birefringence (a
positive for the presence of amyloid) was observed after staining in both samples
(figure 2.2).
2.4.1 Preliminary ex situ AFM imaging
The representative AFM images presented in this chapter demonstrate the
polymorphic nature of the fibrils formed by the peptide fragment of amylin (20-
29). The following section discusses the preliminary experiments performed using
tapping-mode ex situ AFM imaging of amylin 20-29 fibrils aged up to 48 hours.
We refer to ex situ as samples which have been removed from a stock sample at
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specific time points and dried in an N2 air stream onto freshly cleaved mica.
Therefore these images present information on the morphology of the fibrillar
structures at snapshots in time.
Electron microscopy studies by Goldsbury’s group [49] show mature (aged more
than 48 hours) amylin (20-29) fibrils to be straight and rod like structures;
however, currently there is no published information on fibrils from solutions
stored for less than 24 hours. Here we have investigated the morphology of fibrils
from solutions stored for shorter time periods.
Our findings suggest that protofilaments form after a lag period of 4 hours in
solution (figure 2.9), and that these early fibrils have a cable-like appearance with
varied periodicity dependent on the fibril (Figures 2.10 and 11). The majority of
fibrils observed between 18 and 48 hours in solution were straight rod-like
structures (figures 2.6, 2.7-8 & 2.12) which were observed individually or further
associated within higher-order assemblies displaying a range of morphologies.
Fibrils could be seen individually as well as assembled into bundles that were
irregularly coiled or laterally aligned. Branching of fibrils into two new fibrils was
frequently observed (figure 2.7). Branching of fibrils has been reported for other
amyloid and has been suggested that branching is further proof of the structural
hierarchy of amyloid; as two sub-fibrillar species, i.e. protofilaments or
protofilaments, aggregate together to form the mature fibril, branching occurs
when the two constituent sub-fibrillar species are not associated together, with one
forming a branch and the other the main stem [40]. A common feature also noted
was thinning at the end of a fibril. Again, an explanation for this could be that the
thicker fibril is comprised of several lower order sub-fibrillar structures and the
thinner end is a single overhanging constituent protofilament.
The observation of higher-ordered association of fibrils either by lateral alignment
or twisting into coils and bundles has previously been noted in formations of full-
length amylin protofilaments [43, 187], in which it was noted that two similar
populations exist; protofilaments that coil with distinct axial periodicity and a
second group in which the protofilaments laterally align [43]. These data are
suggestive that the interactions governing the formation of higher-order structures
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in the full-length protofilaments may be retained within the shorter peptide
fragment of amylin (20-29). Although it is not known whether these higher-order
assemblies are due to an artefact of the sample preparation method, this
phenomenon has been previously observed both by EM and AFM in which
sample preparation in the two techniques is different [34, 43, 44]. Therefore
further study of the aggregation properties of amylin (20-29) would prove
beneficial to clarify this point, particularly investigation of aggregation patterns in
solutions, which is dealt with in the following section of this chapter.
Periodicity along the axis of a fibril was only observed in young samples (4 and 6
hours); some fibrils appeared to comprise globular structures with irregular
periodicity. However, this was not observed in any of the solutions of fibrils aged
for longer periods. This is suggestive of the fact that over the time course these
younger protofilaments mature into fibrils which do not display any periodicity.
These findings are not mirrored by fibrils formed from full-length and other
longer fragments of human amylin in which mature fibrils retain the twisted
cable-like appearance with a regular periodicity of the nascent protofilament [43,
44, 49]. However, the straight rod-like appearance of the older amylin (20-29)
fibrils is in agreement with published EM images of amylin (20-29) fibrils [49, 87,
88, 90] which had been aged in solution for at least 24 hours.
The observation that younger protofilaments display a periodicity, which
disappears when they mature into older fibrils, indicates the morphology of
amylin (20-29) protofilaments may vary during growth. Furthermore, it is possible
that the structures observed in the preparations aged for 4 and 6 hours are nascent
intermediates of the protofilament and a lower-order structure. This suggestion
provides further support for the proposal that all amyloid have a generic highly
ordered structural hierarchy in which the amyloid fibril is formed from the
aggregation of protofilaments that are assemblies of protofilaments comprising of
several subprotofilaments [33]. Our ex situ observations provide evidence that
amylin (20-29) forms protofilaments that display this hierarchy, and therefore the
ability to form the highly organized and structured amyloid fibril, is intrinsically
retained within the fragment of amylin (20-29).
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Analysis of the fibril sizes revealed that those incubated for 6 and 18 hours
displayed a population distribution with mean widths of 27.31 (±8.36) nm (figure
2.6). Whereas after 48 hours there was some evidence of higher-order structures,
with an additional population of individual fibrils exhibiting widths of
approximately 50 nm. In EM studies findings have suggested that the amylin (20-
29) peptide forms additional lower order 3.6 nm wide protofilaments that laterally
assemble into ribbons [49]. Similar protofilaments with dimensions of 5 nm have
also been recorded in full-length and other fragments of amylin samples [43, 49].
It is possible that such structures are present here but not visible in these AFM
images due to the limitations caused by the sharpness of the AFM tip; the apex of
the cantilever tips used for these experiments have a radii of approximately 20 nm
and therefore may not distinguish between protofilaments which are themselves
expected to be only 5 nm in width. Furthermore, when recording dimension
measurements one must take into account the effects of AFM tip convolution in
which features appear broader. As a result width dimensions may be an
overestimate of the true value, however height measurements are accurate.
Nonetheless, these measurements suggest that the protofilaments formed by
amylin (20-29) are flat ribbon-like structures. This provides further evidence that
this fragment of amylin forms fibrillar structures similar in morphology to those
formed by full-length amylin [49].
2.4.2 In situ AFM
Several interesting aggregation patterns and fibril morphologies were observed in
the ex situ images, including the aggregation of fibrils into irregular twisted
bundles or as lateral arrays and dense sheets. However, one may question whether
these observations are an intrinsic aggregation motif of amylin (20-29) fibrils or
merely an artefact of drying. The AFM is an ideal tool for the imaging of
biomolecules due its capacity to image in an aqueous environment. In the
following discussion the development of a system for the immobilization and
imaging of amylin (20-29) fibrils in solution using the AFM is examined and the
subsequent study on the influence of the aqueous ionic environment on fibril
formation and morphology. Additionally, our preliminary study into the kinetics
of fibrillisation of amylin (20-29) by time-lapse AFM imaging will be discussed.
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2.4.2.1 Immobilisation strategy
The initial starting point for designing an immobilisation strategy was based on
the system used by Goldsbury et al 1999 [44] for the study of full-length amylin
fibrils. The time-lapse study of amylin fibrils was performed in solutions of 10
mM Tris HCl at pH 7.3 using mica as the substrate. However, when these
conditions were recreated in our own experiments, no amylin (20-29) fibrils were
observed, instead a dense matt of material was immobilised to the mica surface
(figure 2.15a) and the constituent material did not resemble the expected (based
on ex situ imaging) fibrillar structures. Furthermore when the concentration of
Tris HCl was raised to 50 mM only amorphous material was observed (figure
2.15b). These findings are not wholly unexpected given the differences in amino
acid sequence between the full-length 37 amino acid long polypeptide and our 10
amino acid peptide fragment. The full length amylin polypeptide has an estimated
pI of 8.90 by comparison to a pI of 5.24 for amylin (20-29), therefore in solutions
of Tris HCl at a pH 7.3 one would expect the net charge on the peptide fragment,
and thus conferred to the fibrils, to be negative resulting in repulsion from the
negatively charged mica surface [133, 188, 189] and no immobilisation.
Consequently, further investigations were required, with the selection of the
solutions and concentration variations shown in table 2.2. These studies show that
for immobilisation and imaging, only 4 ionic environments proved fruitful. These
systems were based around sodium acetate and sodium citrate buffer alone or in
combination with KCl and MgCl2 salts. The sodium acetate solutions were pH 5.5
and the sodium citrate pH 4. Fibrillar structures were observed in solutions solely
comprising sodium acetate (100 mM, pH 5.5) and sodium citrate (50 & 100 mM,
pH 4) (figure 2.19 and 2.23 respectively). In solutions of the monovalent salt, KCl
at a concentration of 50 mM and pH 4, images of the fibrils were captured,
however double-tipping and unstable structures were observed (figure 2.16).
However, by the additional presence of either sodium acetate or sodium citrate,
the imaging quality and resolution was greatly improved (figures 2.21 and 2.24).
In general, the images captured in sodium acetate with KCl were clearer with
higher resolution, and topographical features appeared more stable during
scanning. By contrast, whilst imaging in solutions of the divalent salt MgCl2 no
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fibrillar structures and only loosely bound irregular material with no distinct
morphology was observed (figure 2.18). By comparison in EM studies of full-
length amylin, fibril morphologies varied dependent on pH and ionic solution.
Short rapidly forming fibrils were noted in low concentrations of sodium citrate
and long extended fibrils displaying periodicity in low concentrations of sodium
acetate [90].
Overall, several conclusions can be drawn from this initial study into the surface
binding of the amylin (20-29) fibrils to a mica substrate. In general, the results
demonstrate that the ionic strength of a solution plays an important role in the
immobilisation of the fibrils to the mica. For fibril surface binding the ionic
environment should be such that either the negative charge of the mica surface or
the charge of the peptide fibril (the overall charge of the fibril is conferred by the
ionisable groups of the peptide monomers, namely the terminal -NH3 and -COOH
group) is sufficiently masked by the electrolytes present in the solution so that
stable adhesive van der Waals forces of attraction will dominate the fibril-mica
surface interaction.
Our findings indicate that in solutions with low ionic concentrations of sodium
acetate and sodium citrate buffer alone amylin (20-29) fibrils are observed bound
to the substrate surface. However, when the ionic strength of the buffers was
increased no surface binding of the fibrils was observed. In a similar pattern,
fibrils in solutions of acidified KCl at pH 4.0 require ionic concentrations of 50
mM to bind to the mica surface, but on raising the ionic strength further the fibrils
no longer physisorb to the surface. At the lower ionic concentration the electrical
double layer formed by the monovalent K+ ions within the solution bulk was
sufficient to mask the repulsive forces arising from like charges on the fibril and
substrate surfaces. This screening reduces the distance between the charged
surfaces enabling the van der Waals forces of attraction to dominate and thus
surface binding. In solution the K+ ions which are exposed on the basal surface of
the mica disassociate giving rise to the negative charge on the mica surface. In
electrolyte solutions these K+ ions can be replaced by the cations from the solution
[188, 189], consequently as the ionic strength of the KCl solution was increased
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further a diffuse layer of cations formed at the mica surface resulting in the
repulsion of the positively charged peptide fibril and no surface binding.
2.4.2.2 Effects of the ionic environment
The fibrillar structures observed in solutions of both the sodium acetate and
sodium citrate with KCl salts displayed similar long, flat ribbon-like
morphologies and had considerable flexibility. Some fibrils branched into arms
with the same dimensions: however the majority were unbranched with no
noticeable surface features. Analysis of the fibril half-height widths revealed a
normal distribution in size, but with varying mean values (figures 2.21 and 2.24).
The fibrils in sodium acetate and KCl ranged in width from 4 to 13 nm with a
mean of 8.27 (±2.17) nm and height mean of 1.5 (±0.21) nm. Conversely, the
fibrils imaged in sodium citrate and KCl were almost double the width with a
mean of 18.03 (±2.13) ranging from 13 to 24 nm, however the height mean was
the same at 1.5 (±0.23) nm.
This apparent difference in fibril widths may be a consequence of tip convolution
where topographical features appear broader than their true dimensions and is a
consequence of the shape of the tip. It is possible that the tip used to image the
sodium citrate and KCl solution had a higher aspect ratio in comparison to that
used for the sodium acetate imaging. Given that the height measurements are
similar for both solution conditions this is the most likely conclusion and therefore
it is unlikely that the pronounced difference in widths is due to solution conditions
alone. However, it is possible that the difference in solution pH and the ions
present in solution may have attributed to some of the difference in dimensions.
Especially when taken into account that the dimension measurements are based on
a sample from a combination of several experiments where different tips have
been used. It is possible that the change in pH, or citrate cation compared to
acetate anion may have influenced the association of sub-hierarchical species into
the observed fibrillar structures. The role of aromatic interactions and hydrophic
bonding has been well documented in the formation of amylin fibrils [92, 107,
176, 190]. These interactions and the side chains of residues are all influenced by
the ionic environment.
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Interestingly, similar aggregation patterns were noted in the in situ (both sodium
acetate and sodium citrate with KCl aged 18 hours) images and the ex situ data,
proof that the lateral alignment and propensity to clump together is an inherent
feature of the fibrils and not an artefact of drying. However, aggregation of fibrils
occurred more prominently by lateral association with twisting and coiling of
fibrils together not as commonly observed in the solution images. This may be a
result of lower order protofilaments associating and interacting laterally to form
the visible fibril rather than by intertwining and coiling. Additionally, no
periodicity was noted in younger fibrils (figure 2.19) imaged in situ, however this
may be a limitation of tip sharpness and image resolution. The apparent
aggregation and clumping of fibrils into pockets on the mica surface gives further
indication of the hydrophobic nature of the fibrils and the electrostatic interactions
governing their behaviour in solution.
In preparations of amylin (20-29) in sodium acetate and MgCl2 a unique
observation of globular aggregates were seen densely packed on the mica surface.
The widths of the globular aggregates range from 30 to 110 nm with mean surface
area of 3.57 (±1.8) x103 nm2. By comparison, these widths are much larger than
the dimensions measured for the fibrils imaged in situ. On investigation it was
found that these globular structures formed when MgCl2 was present in the initial
solution at time 0, but weren’t observed in peptide solutions of either sodium
acetate alone or MgCl2 only. Furthermore that when amylin (20-29) was initially
placed into solutions of sodium acetate and then 30 mM MgCl2 was added after
4½ hours, globular structures were still observed, but in general had smaller
dimensions and were not as densely packaged on the surface. However, when the
experiment was repeated with MgCl2 added to solutions of pre-formed fibrils
(after 6 hours in sodium acetate solution) no globular structures were observed.
Instead fibrils were observed physisorbed on top of a single layer of material on
the mica surface (figure 2.22g). The point at which fibrils form in solutions of
amylin (20-29) had been pinpointed based on our ex situ imaging data (figure 2.9)
to be between 4 hours, where a very small population of fibrils was observed, to a
larger population at 6 hours. Therefore at 6 hours it is highly probable that a
significant number of protofilaments have already formed and are present in the
solution. This is in fact what was observed; on addition of MgCl2 to the solution
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of sodium acetate and amylin (20-29) at 6 hours fibrillar structures were seen.
Therefore, it can be surmised that sodium acetate with MgCl2 has no detrimental
effects on the preformed fibrils and is sufficient to facilitate surface binding of the
fibrils. However, by addition of MgCl2 to the sodium acetate and peptide solution
prior to fibril formation (time = 0 to ~4 hours), the combination of ionic species is
such that the aggregation of amylin (20-29) results in only globular aggregate
formation. Similarly, although less well defined, globular structures were also
observed (figure 2.26) in solutions of sodium citrate and amylin (20-29) when
MgCl2was present from time = 0, which were not observed in solutions of sodium
citrate and peptide.
These findings suggest that electrostatic interactions play an important role in
amylin (20-29) fibril formation and aggregation. Furthermore, that the phenomena
noted are a result of ionic environmental effects on the peptide induced by the
presence of the MgCl rather than impaired physisorption of fibrils to the mica
surface. It also follows that the globular structures are formed as a result of
electrostatic interactions due to the introduction of the divalent cation, Mg2+
which are unfavourable to fibril formation. An explanation for this observation
maybe in the formation of non-covalent complexes that are coordinated by the
Mg2+ cations between charged groups on the peptides. Binding of the Mg2+
cations may have a two-fold consequence, firstly the cation complexes with and
masks the charged terminal carboxylate group on the peptide. Consequently
screening any repulsion experienced by like charges on the monomeric peptides
may reduce the intermolecular interactions needed for the promotion of the beta-
sheet conformation necessary for fibril formation. Secondly, the formation of
cross-linking ionic complexes between individual peptides may prevent the
formation of pre-fibrillar species and instead results in the fast aggregation of the
peptides into amorphous aggregates as observed in figure 2.22 and 2.26. Divalent
cations have previously been reported to mediate the formation of low mass
oligomeric species by stabilising through complexation or by aiding the
conformational change associated with several of the self-assembling proteins
through the formation of similar metal ion complexes. However, unlike the
findings presented here these low oligomeric species proceeded, and in some
instances at accelerated rates, to form fibrillar structures [191, 192].
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Presented in figure 2.27 is a schematic summary of the variety of different
morphologies observed in samples of amylin (20-29) under the different
environmental conditions investigated within this chapter.
The influence of solution environment on fibril formation has been documented
for several other amyloidogenic proteins. The promotion of different fibril
morphologies has been observed on alterations in pH and electrolyte
concentration; morphologies included globular aggregates, spherulites, toroidal
structures, worm-like and rod-like chains as well as longer fibrils [126-128, 193].
The formation of these polymorphic structures has been suggested to occur due to
the promotion of different assembly pathways by the solution environment.
Suggestive that the self-assembly of the polypeptide into amyloid proceeds via
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any of several competitive kinetic pathways [128] and that the observed structures
may be directly-nucleating pre-fibrillar intermediates or off-pathway assemblies
of the various pathways.
2.4.2.3 Kinetic study
The preliminary studies investigating the kinetics of formation of amylin (20-29)
fibrils by in situ imaging in 100 mM sodium acetate pH 5.5 solution, revealed that
growth rates varied dependent on the fibril and ranged from 2 to 11 nm min-1.
These rates are much faster in comparison to the published rate of 1.1 nm min-1 as
determined by time-lapse AFM for full-length amylin [44]. A faster rate of
formation is not unexpected given the shorter chain length of the amylin (20-29)
peptide. The peptide in comparison to the full-length chain would require less
packaging and therefore there is a higher probability that the peptides free in the
surrounding solution will be in the correct steric conformation for interaction with
the growing peptide fibril on the sample surface. Similarly to full-length amylin,
we also observed longitudinal elongation of fibrils occurring from either end of a
fibril with no apparent polar preference. A two phase model has been proposed for
the growth of fibrils by full-length amylin where lateral growth from a preformed
nucleus of oligomers precedes a second phase of longitudinal growth of mature
fibrils [64]. This hypothesis appears to fit with the observations presented in
figure 2.19, where clear aggregates are observed in pre-formed clumps and from
these fibrils grow longitudinally. Furthermore, during ex situ imaging of samples
formed in water, fibrils were observed growing out from a central nucleating point
(figure 2.7).
2.5 Conclusion
Amylin (20-29) peptide fibrils self-assemble in a range of electrolyte solutions to
form fibrillar structures which display polymorphic assemblies. Using a
combination of ex situ and in situ tapping-mode AFM imaging we have
demonstrated the change in fibril morphology with time and under the influence
of various electrolyte solution environments. Additionally, as a consequence of
solution conditions, a possible off-pathway globular aggregate formation has been
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identified. Suggestive that the ionic environment may be used to influence the
morphology of fibrils by inducing different amyloid folding pathways.
Furthermore, we have been able to image for the first time amylin (20-29) fibrils
in solution and perform kinetic studies on the fibrillisation.
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Chapter
3
Modification of amylin (20-29) peptides
3.1 Introduction
In the previous chapter we have shown that the peptide fragment of amylin
corresponding to residues 20-29 of the human polypeptide readily forms fibrils
under a selection of solution environments. The fibrils that form display a range of
morphologies and display a propensity to aggregate together. The aggregation of
the fibrils was driven by non-covalent interactions and could, to some extent, be
controlled by the surrounding solution conditions. However, the ability to directly
manipulate the fibrils by controlling fibrillisation or surface immobilisation in a
predictable and orientated manner, as well as forming strongly linked assemblies
would enable these fibrils to be used in a broad range of potential applications
from peptide scaffolds to functionalised surfaces or matrices.
A wide range of strategies are available and have been successfully utilised for the
control and exploitation of peptide fibrils and peptide-based assemblies including,
template-directed growth using highly-ordered surfaces [137], nanolithography
[194, 195] and self-assembled monolayers [196-198]. One strategy for the
manipulation of peptide-based systems is the exploitation of specific functional
groups already present on the biomolecule or by the introduction of a specific
moiety [47, 199, 200].
In this chapter the potential for the directed control of amylin (20-29) fibrils by
the introduction of specific functional moieties to the peptide is explored.
Specifically by the chemical modification of the amylin (20-29) peptide during
synthesis by the coupling of two functional groups to the N-terminal of the
peptide. The functional groups are an azide and an alkyne group. The azide
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moiety is a linear molecule of three nitrogen atoms with an orthogonal double
bond in which there is a delocalised cloud of four ʌ-electrons over the three
nitrogen atoms. The electrons of the central nitrogen atom are sp hybridised
allowing some bending of the bonds within the linear structure, making the
molecule an ideal nucleophile [201]. The alkyne moiety is a hydrocarbon
containing a carbon-carbon triple bond. The carbon atoms in the triple bond are sp
hybridised and overlap of the orbitals forms a delocalised cloud of ʌ electrons
around the carbon-carbon bond [202].
A terminal alkyne (dipolarophile) and azide (1,3 dipole) group can undergo fusion
to form a 1,4-disubstituted 1,2,3-triazole, in the presence of a copper (I) catalyst,
by means of the Huisgen 1,3-dipolar cycloaddition reaction mechanism [203,
204]; more popularly known as ‘click chemistry’. The 1,2,3-triazole group is a
thermally and hydrolytically stable five-membered aromatic heterocycle [204]
comprising heteroatoms at position 1,2 and 3, in this instance nitrogen atoms. By
coupling of either an azide or alkyne group to the N-terminal of the amylin (20-
29) peptide, the aim was to generate fibrils assembled from these functionalised
peptides. Furthermore, to investigate the use of the cycloaddition reaction
chemistry to form strong covalent links between the fibrils in the form of the
1,2,3-triazole ring in an attempt to synthesise higher-ordered structures. The
proposed mechanism [204-206,] for the copper (I)-catalysed 1,3-dipolar
cycloaddition reaction of an azide and terminal alkyne is presented in scheme 3.1.
The mechanism favours an indirect ligation through a series of intermediates
rather than the direct formation of the triazole ring.
The stepwise catalytic cycle initiates with the formation of a copper (I) acetylide
species (1) via alkyne ʌ complexation which requires ligand dissociation and
deprotonation. The copper (I) acetylide species exists as a family of interchanging
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N
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R
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Scheme 3.1: Proposed catalytic cycle for the Cu (I) catalysed cycloaddition
reaction of terminal alkynes and azides. Source Bock et al (2006) [205].
species in solution (2). For catalysis to proceed, it is thought that two metal
centres, one or two alkyne ligands and other labile ligands for competitive 1,3
dipole binding are required. The pathway proceeds through the activation of the
azide functionality by the second copper atom of the copper (I) acetylide complex
(3). Simultaneously, the reactivity of the acetylide towards cyclization is increased
by the further ʌ complexation of terminally bound acetylide to a proximal copper
atom. A copper acetylide-azide species is generated by the displacement of one
ligand by an azide. Cyclization of the complex to produce a metallocycle (4)
occurs by the nucleophilic attack of carbon 4 of the acetylide at nitrogen 3 of the
azide. The bound azide is thus in an optimum position within the metallocycle for
the subsequent ring contraction, which proceeds by the transformation of the
metallocycle into a triazole-copper derivative (5). The reaction cycle ends by
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protonation of the triazole-copper derivative which affords the 1,2,3-triazole
product (6) and regeneration of the copper catalyst species.
The triazole ring, as with many products of 1,3-dipolar cycloaddition reactions
[207, 208] forms as a mixture of two possible regioisomers a 1,4-disubstituted or
1,5-disubstitued 1,2,3 triazole. However, Rostovtsev et al [204] note that in the
copper (I) catalysed reaction, formation of the triazole ring proceeds
regioselectively favouring the formation of the 1,4 isomer. The regiospecificity of
the product is determined by the energy levels of the molecular orbitals of the
dipolarophile and 1,3 dipole. In the cycloaddition reaction bonding occurs by
interaction of the highest occupied molecular orbital (HOMO) of one component,
which may be either the 1,3-dipole or the dipolarophile, and the lowest
unoccupied molecular orbital (LUMO) of the complementary group in the pairing.
The combination with the smallest energy gap will bind and results in either
formation of the 1,4 or 1,5 regioisomer. In the copper (I) catalysed reaction, the
copper initially binds to the alkyne and the energy of the LUMO of the
coordinated alkyne is reduced. This has two outcomes, firstly the reaction
proceeds regioselectively whereby the predominant isoform is the 1,4-
disubstituted 1,2,3 triazole and secondly, there is an overall increase in the energy
of the system and thus copper acts as a catalyst to speed up the reaction [203, 204,
207, 209].
Copper (I)-catalysed 1,3 cycloaddition reactions of azides and alkynes have
previously been utilised for a range of biological applications, including use in the
bioconjugation of labels and ligands on cell-surfaces [210, 211], as well as for
fluorescent labelling of proteins and peptides [212, 213]. Furthermore, this form
of click chemistry has previously been investigated for utilisation in peptide-based
systems for the generation of peptide scaffolds, in which a range of peptides with
varying sequences and lengths (up to 12-mer) were synthesised with terminal
azide groups [214]. These peptides were site-selectively ligated to a resin-bound
cyclic peptide scaffold using the cycloaddition reaction by formation of the 1,4
disubstituted 1,2,3 triazole between the terminal azide of the peptides and site-
specific alkyne groups on the cyclic peptide scaffold. Although there is no current
literature on the direct use of the 1,3-dipolar cycloaddition of azide and alkynes in
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peptide fibril nanostructures, collectively these few examples suggests that the
chemistry may be compatible with the larger peptide structures. Therefore, it is
proposed that incorporation of the azide and alkyne functionalities into the amylin
(20-29) fibrils would enable a range of possible future applications. For example,
the formation of triazole rings between fibrils could be exploited in the production
of a covalently linked fibrillar matrix, alternatively the functional groups and
chemistry could be utilised as a means of covalently linking the fibrils to an azide
or alkyne functionalised surface for covalent immobilisation of the fibrils.
The experiments presented in this chapter are preliminary investigations on the
use of the 1,3-dipolar cycloaddition reaction of azide and alkynes for the
manipulation of amylin (20-29) fibrils. The experimental design aims to answer
two fundamental questions. Firstly, what influence will the introduction of
additional steric bulk (in the form of the azide or alkyne functional group) to the
terminal of the amylin (20-29) peptide have on fibril formation? Secondly, are the
functional groups sufficiently exposed on the outer surface of the fibrils, and in
close enough proximity for the copper (I) catalysed cycloaddition reaction to
proceed for 1,2,3-triazole ring formation? The AFM will be utilised in the study to
investigate the properties and fibrillisation of these modified peptides.
3.2 Experimental
3.2.1 Materials
Amylin (20-29) was synthesised by SPPS, reagents used in the process were:
NovaSyn® TGR resin and standard Fmoc protected amino acids which were
purchased from NovaBiochem; dimethylformamide (DMF) purchased from
Rathburn; piperidine, N-methylpyrolidinone, N,N-diisopropylethylamine
(DIPEA), 2,4,6-trinitrobenzenesulphonic acid (TNBS), trifluoroacetic acid (for
SPPS), triisopropylsilane (TIPS) and dichloromethane (DCM) were purchased
from Sigma-Aldrich; N-[(dimethylamino)-1H-1,2,3-triazolo[4,5-b]pyridin-1-
ylmethylene]-N-methylmethanaminium hexafluorophosphate N-oxide (HATU)
obtained from Perseptive Biosystems, Germany; ethanol, hexane, diethyl ether,
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acetonitrile (Far UV grade), and trifluoroacetic acid (for HPLC) purchased from
Fischer Scientific Chemicals; sodium chloride and magnesium sulphate were
purchased from Sigma-Aldrich. Bromoacetic acid, Sodium azide and propiolic
acid were purchased from Sigma-Aldrich. For the Congo red assay, Congo red
and sodium chloride were from Sigma Aldrich and ethanol from Fischer Scientific
Chemicals. For the cycloaddition assay Copper (II) Sulphate pentahydrate and L-
Ascorbic Acid were from Sigma-Aldrich and ethanol was purchased from Fischer
Scientific.
3.2.2 Method
3.2.2.1 Solid phase peptide synthesis
The peptide fragment of human amylin corresponding to residues 20 to 29 (for the
sequence see Chapter 2) was synthesised using solid phase peptide synthesis
(SPPS). The same SPPS protocol to that outlined in chapter 2 was followed, with
the exception that Fmoc protecting groups were removed manually (see below).
The column was packed with 0.1 mmol of an amide Rink resin, NovaSyn® TGR.
Resin was solvated initially with N-methylpyrolidinone (NMP). The activation
cocktail containing the coupling reagents, 0.8 mmol DIPEA and 0.4 mmol HATU,
solubilised in NMP, was mixed with 0.4 mmol of the C-terminal amino acid
(serine) and added immediately to the reaction vessel. Amino acids were loaded
with a four-fold excess to ensure maximum yield. Sufficient solvent was added to
the reaction vessel for the resin to be fluid and was left at room temperature on a
magnetic stirrer. The first amino acid coupling was left overnight to ensure
complete attachment to the resin.
Following each new amino acid coupling a tri-nitro benzene sulfonate (TNBS)
test was performed to determine whether complete coupling had occurred. A
small sample of resin was removed from the reaction vessel and washed several
times with ethanol to remove any unbound amino acids. A few drops of DIPEA
and TNBS in equal quantity were added in sufficient volume, and the colour of
the resin beads and solution observed. In the event of incomplete coupling, the
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free amines present will result in the beads appearing red. Conversely, when the
coupling has proceeded fully, the beads and solution are colourless. In the event
of incomplete coupling the reaction was allowed to proceed for a further 1-2 hours
until no red beads and solution was observed.
Following complete coupling of the amino acid, any excess coupling solvent was
removed from the reaction vessel by vacuum and the resin washed 5 times with an
excess volume of NMP. Fmoc deprotection of the serine amino group in
preparation for the coupling of the next amino acid was performed by washing the
reaction vessel with 100% DMF, to remove excess activated amino acids.
Sufficient deprotection reagent of 20% piperidine-NMP solution was added to
cover the resin and left with N2 gas bubbling through to ensure complete mixing
for 15-30 minutes.
Following Fmoc deprotection, the resin was washed with NMP (5 times excess
bed volume) to remove any trace of deprotection reagent and the next amino acid
in the sequence was added with the activation cocktail. The process was then
repeated for each amino acid until the complete sequence was generated.
Following the final Fmoc deprotection, the resin was washed using DMF and
DCM over a Buchner funnel and then shrunk using hexane.
Prior to cleavage of the peptide from the resin an additional step was included to
add either the alkyne moiety or azide moiety to the N-terminal of the peptide
chain. The resin was divided in half, with a small portion set aside for mass
spectrometry analysis of the peptide sequence.
3.2.2.2 Coupling of azide group to N-terminus
The azide moiety was introduced to the N-terminus of the amylin (20-29) peptide
in the form of azidoacetic acid. The initial step in this process was the synthesis of
the azidoacetic acid.
3.2.2.2.1 2-Azidoacetic acid synthesis
2-Azidoacetic acid (N3CH2CO2H) was synthesised according to the methodology
of Dyke et al [215] from sodium azide (NaN3) and bromoacetic acid
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(BrCH2CO2H). Great care was taken during the synthesis to minimise the risk of
explosion whilst using the highly explosive azides.
A saturated aqueous solution of sodium azide (780.42 mg) was mixed in a 2:1
ratio with bromoacetic acid (833.7 mg), and stirred continuously for 24 hours in
an ice bath. The reaction mixture was then acidified to pH 5 by the addition of
aqueous hydrogen chloride. Thin layer chromatography was performed as an
indicator for the presence of product (azidoacetic acid) and reagents during and at
the end of the reaction.
The 2-azidoacetic acid product was extracted by salting out with a saturated
quantity of sodium chloride. The aqueous layer was extracted using diethyl ether
several times and the combined organic layers were dried over anhydrous
magnesium sulphate. Final traces of water and diethyl ether were removed under
vacuum. The final product obtained was 60 mg of a yellow oil. Characterisation
of the end product was performed by electron-spray liquid chromatography mass
spectrometry (LC-MS), H1-nuclear magnetic resonance (NMR) and infrared
spectroscopy (IR).
3.2.2.2.1.1 LC-MS
Mass spectra were obtained using a Micromass LCT Mass spectrometer with
autosampler. The sample was prepared by dissolving in acetonitrile/water
solution. Samples were analysed by negative ion electron spray.
3.2.2.2.1.2
1
H-NMR
H1-NMR spectra were acquired on a Bruker 400 MHz instrument (Bruker, UK).
The samples were prepared in deuterated chloroform (CDCl3). All chemical shifts
are relative to a tetramethylsilane (TMS) internal standard.
3.2.2.2.1.3 IR spectroscopy
Transmission infrared spectra were acquired on a Nicolet Avatar 360 FT-IR
instrument using NaCl discs. Mid-IR spectra were acquired over the range 400 –
4000 cm-1.
NaN3 + BrCH2CO2H N3CH2CO2H
aq HCl
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3.2.2.2.2 2-Azidoacetic acid coupling
In preparation for the coupling of the azide moiety to the N-terminus of the
amylin (20-29) peptide chain, 150 mg of peptide bound resin was resolvated and
washed with NMP.
A three-fold excess of 2-azidoacetic acid (30 mg) and the activation cocktail
containing the coupling reagents, 0.8 mmol DIPEA and 0.4 mmol HATU,
solubilised in NMP, was added immediately to the reaction vessel. The reaction
was left bubbling through with N2 gas for 3 hours. A TNBS test was performed on
a small sample of resin to ensure full coupling of the azide group to the peptide
chain had occurred. Following successful coupling of the azide moiety to the
amylin (20-29) peptide the side groups were deprotected and the peptide chain
cleaved from the resin as outlined below.
3.2.2.3 Coupling of alkyne to N-terminus
The alkyne moiety was introduced to the amylin (20-29) in the form of propiolic
acid (C3H2O2). Coupling of the peptide chain with the propiolic acid requires the
formation of a peptide bond between the NH2 group of the N-terminal serine of
the amylin (20-29) peptide chain and the carboxylic acid group of the propiolic
acid.
A portion of the peptide-bound resin (213.1 mg) was resolvated with sufficient
NMP and washed with several bed volumes. A three-fold excess of propiolic acid
(450 µl) and the activation cocktail containing the coupling reagents, 0.8 mmol
DIPEA and 0.4 mmol HATU, solubilised in NMP, was added immediately to the
reaction vessel. The reaction was left bubbling through with N2 gas for 3 hours. A
TNBS test was performed on a small sample of resin to ensure full coupling of the
OH
O O
peptide
Peptide
HATU, DIPEA in NMP
N+
N - O
OH
N Peptide
HATU, DIPEA in NMP
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propiolic acid to the peptide chain had occurred. Following successful coupling,
the side chain protecting groups were deprotected and the alkyne-peptide chain
was cleaved from the resin as outlined below.
3.2.2.4 Side chain deprotection and resin cleavage
Cleavage of the peptide chain from the resin and deprotection of side chain groups
was performed by the addition of a mixture of 90% v/v trifluoroacetic acid (TFA),
2% v/v triisopropylsilane (TIPS) and 8% v/v water, for 2 hours. The suspension
was then filtered and the filtrate evaporated under vacuum. The residual material
was titrated with diethyl ether, and the resulting powder consisting of the crude
peptides were stored below 4ºC. The successful synthesis of the two target
peptides was confirmed by electro-spray mass spectrometry (Micromass LCT
Mass spectrometer).
3.2.2.4.1 Reverse-phase high performance liquid chromatography
The crude peptides were analysed on a reverse-phase C18 (Hypersil BDS, bore
size 4.6 mm, supplied by Shandon,UK) column. The solvent system employed
comprised: A = 0.06 % trifluoroacetic acid in ultrapure water (pH 6, resistivity
18.2 Mȍcm), B = 0.06% trifluoroacetic acid in 90% acetonitrile/ 10% ultrapure
water. Presence of the peptide in the eluent was monitored spectrophotometrically
DW Ȝ214nm. The crude peptides were dissolved in 60 % v/v acetonitrile to a
concentration of 2 mg/ml. The gradient of 30 to 100 % B over 30 minutes with
flow rate of 5 ml/min and injection volume of 200 ȝl.
3.2.2.5 Preliminary fibrillisation assay
A preliminary study to determine the fibrillisation capabilities of both forms of the
functionalized amylin (20-29) peptides was performed. The lyophilized azide- and
alkyne form of the amylin (20-29) peptide were solubilised in ultrapure water (pH
6, resistivity 18.2 Mȍcm) at a concentration of 300 µg/ml. Samples were left to
form fibrils at room temperature for 18 hours before aliquots were removed and
dried under N2 onto freshly cleaved mica and imaged using the AFM.
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3.2.2.6 Copper (I) catalysed 1,3-dipolar cycloaddition reaction assay
Investigations to establish the viability of the alkyne- and azide- coupled moiety
on the peptide fibrils for the copper (I) catalysed cycloaddition reaction for the
formation of triazole groups was performed. The assay conditions employed for
the cycloaddition reaction were based on the methodologies from the work of
Link & Tirell [210], Rostovtsev et al [204] and Wang et al [211].
The cycloaddition reaction requires the presence of copper as a catalyst which
must be in the +1 oxidation state. Here we use the +2 oxidised form of copper in
the form of CuSO4.5H2O, which is reduced in situ by the reducing agent ascorbic
acid in a 2:1 water and alcohol solution according to the method of Rostovtsev et
al [204].
The lyophilised azide- and alkyne- peptides were solubilised in ultrapure water to
a concentration of 1 mg/ml and left for 18 hours to ensure formation of fibrils.
After this initial incubation, aliquot samples of the peptides were removed and
placed into eppendorfs containing either 1 mM or 5mM copper sulphate with 5
mM or 25 mM (respectively) ascorbic acid in a 2:1 mix of water and ethanol
(referred to hereafter as copper (I) solution) to give a final peptide concentration
of 300 µg/ml. The eppendorfs contained either azide-peptide or alkyne-peptide or
a 50:50 mix of both forms of peptide. Samples were continuously mixed for a
further 8 hours at room temperature, before aliquot samples were removed and
dropped onto freshly cleaved mica and dried under N2 before imaging.
To investigate whether the cycloaddition reaction would prevent fibrillisation of
the amylin (20-29) peptides, the experiment was repeated with the exception that
1 mM or 5 mM copper sulphate with ascorbic acid in a 2:1 mix of water and
ethanol was added to a 50:50 mix of both forms of the peptide (final peptide
concentration 300 µg/ml) at time 0 hours. Samples were continuously mixed for
18 hours at room temperature, aliquot samples were then removed, dropped onto
freshly cleaved mica, and dried under N2 before imaging.
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3.2.2.7 AFM imaging
All AFM imaging was performed in air using the Nanoscope IIIa (Digital
Instruments, Veeco Metrology Group, Santa Barbara CA) in tapping mode.
Silicon TESP tapping probes (supplied by Veeco Metrology Group) mounted on
cantilevers with nominal spring constants of 42 N/m (range of 34.4-37.2 N/m) and
nominal resonant frequency of 320 kHz (range of 280-360 kHz) were used. All
imaging was performed at a final peptide concentration of 300 µg/ml. Aliquots of
10 ȝl were dropped onto freshly cleaved mica (1 cm2), dried in a N2 gas stream
and imaged immediately. Control preparations of ultrapure water (pH 6,
resistivity 18.2 Mȍcm) and solutions of copper sulphate with ascorbic acid in a
2:1 mix of water and ethanol were stored under identical conditions and for the
same time period; here imaging showed no fibrillar structures. AFM image
analysis
Data was processed using two computer packages, the analytical processing
options from the Nanoscope software version 5.21b48 (Digital Instruments,
Veeco Metrology Group, Santa Barbara CA) and SPIP program (Image
Metrology ApS USA). Images show topography and phase data (where indicated),
contrast scale bars are presented alongside images where appropriate. The upper z
range value is stated above each scale bar with lighter colours indicating higher
topographical features and greater phase contrast respectively.
3.2.2.8 Congo red assay
The formation of amyloid fibrils by the functionalised amylin (20-29) peptides
was investigated using the histopathology stain, Congo red. A saturated solution
of Congo red was prepared using 0.2g of Congo red powder per 100 ml of 80%
v/v ethanol solution saturated with sodium chloride. Both forms of the lyophilised
peptides were suspended in Ultrapure water (pH 6, resistivity 18.2 Mȍcm) at a
concentration of 1 mg/ml. The suspension was aged for 18 hours at room
temperature to ensure maximum allowance for fibril formation and a 10 Pl aliquot
was removed and dropped onto a clean glass slide and air-dried. Samples were
stained for 1 minute by the addition of the saturated Congo red solution. Excess
stain was removed by washing with ethanol and the slide air-dried.
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3.2.2.8.1 Optical microscopy and Birefringence
Birefringence was examined using a Leitz Diaplan light microscope with
polarisers and 10 and 25 times magnification objective lens. The polariser lens
are set at an angle of 45 degrees to each other, one in the incident beam and the
other set above the slide stage between the objective lens and camera. Images of
the sample under normal and polarised light were captured using a Nikon 100
digital camera.
3.3 Results
3.3.1 Azide- amylin (20-29) peptide synthesis
An azide group was added to the N-terminal of the amylin (20-29) peptide by
formation of a peptide bond by reacting 2-azidoacetic acid with the resin-mounted
peptide in the presence of the coupling activation cocktail. 2-azidoacetic acid was
successfully synthesised from sodium azide and bromoacetic acid.
Characterisation of the yellow end product is listed below, 1H-NMR and IR
(liquid) spectra are presented in figures 3.1 and 3.2 respectively.
Yield: 60 mg (60 %)
MS (ES): 100.06 (M-)
Ȟmax(NaCl): 2116.26 (N3), 1731 (C=O), 1420 (C-OH in plane bending),
1284-1221 (C-O stretching), 946 (-OH bending), 877 and 3158-
3459 (-OH stretching) cm-1
įH(400MHz, CDCl3): 4.0 ppm (2H, s, CH2)
10.6 ppm (1H, s, COOH)
Collectively the mass spectroscopy, 1H-NMR and IR characterisation indicate that
the yellow oil end product is azidoacetic acid. There was no evidence observed in
the characterisation spectra for the presence of any unreacted reactants or
intermediates in the end product.
Figure 3.1: 1H-NMR spectrum of 2-azidoacetic acid. Integrated 400 MHz 1H-NMR spectrum of the yellow oil product from the 2-azidoacetic acid
synthesis. Solvent used was CDCl3 with TMS standard. The singlet signal at 4.0 ppm is consistent with that expected for the methylene proton of the
2-azidoacetic acid and broad singlet at 10.6 ppm corresponds to the hydroxyl proton. The signal at 7.0 ppm is consistent with that observed for
CHCl3, a protonated form of the solvent.
Figure 3.2: Infra Red Spectroscopy spectrum of 2-azidoacetic acid. The mid -IR spectrum of the yellow oil product from the synthesis of 2-
azidoacetic acid. Spectrum was generated using the Nicolet Avatar 360 FT-IR using NaCl discs. The characteristic resonance of the N3 group is
observed at of 2116.26 cm-1 wavelength.
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Coupling of the azidoacetic acid to the second half of the resin proceeded
successfully and the negative mass spectrum of the azide-form of the amylin (20-
29) peptide is shown in figure 3.3. ES-MS: m/z 1089.52 ((M-3H), 100%),
1090.52 ((M-2H), 58 %) and 1091.2 ((MH), 25 %). The molecular fragments (M-
3H) and (M-2H), can be accounted for by the deprotonation of amino acid side
chain groups (alcohol group of serine) and the carboxylic acid of the peptide
chain.
Presented in figure 3.4 is a RPHPLC chromatogram typical of that obtained
during RPHPLC analysis on the azide-amylin (20-29) peptide. The chromatogram
is dominated by a peak at 10.75 minutes close to the solvent front (5 minutes),
corresponding to the target peptide. Several smaller peaks with less than 15 %
intensity are also observed at later time points.
3.3.2 Alkyne-amylin (20-29) peptide synthesis
Coupling of the alkyne moiety to the amine group of N-terminal serine residue of
the amylin (20-29) peptide fragment was successfully performed by SPPS. A
positive ion mass spectrum of the alkyne-amylin (20-29) sample is presented in
figure 3.5. ES-MS : m/z 1061.19 (46 %, [MH]).
Presented in figure 3.6 is a RP-HPLC chromatogram typical of that obtained
during RP-HPLC analysis on the alkyne-amylin (20-29) peptide. The solvent front
is observed at 5 minutes, followed by a dominant peak at 14.6 minutes
corresponding to the target peptide and lower intensity (<30 %) peak at 15.5
minutes.
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(M-H)
(M-2H)
Figure 3.3: LC-MS spectrum for the azide-form of amylin (20-29) peptide. Negative
ionisation spectrum. The parent ion (M-H) is observed at m/z 1091.51 (25%). Two peaks of
higher intensity correspond to deprotonated forms of the ion, at m/z 1090.51 (58%, (M-
2H)) and 1089.52 (base peak, (M-3H))
(M-3H)
Figure 3.4: RP-HPLC chromatogram for azide-amylin (20-29) peptide. The major
peak at 10.75 minutes corresponds to the target peptide. Smaller peaks of later
eluting impurities are also observed.
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Figure 3.5: LC-MS spectrum for the alkyne-form of amylin (20-29) peptide.
Positive ionisation spectrum. The parent molecular ion, [M-H], was observed at m/z
1061.19 corresponding to the expected molecular weight of the alkyne-amylin (20-29).
ion
(M-H)
Figure 3.6: RP-HPLC chromatogram for alkyne-amylin (20-29) peptide. A major
peak is present at 14.6 minutes, with later eluting smaller (< 30%) peak at 15.5
minutes. Method: gradient of 30 to 100 % B over 30 minutes with flow rate of 5 ml/min.
Chapter 3 Modification of amylin (20-29) peptides
- 120 -
3.3.3 Preliminary AFM study of fibrillisation
A preliminary study to investigate the influence of the azide and alkyne moieties
on fibrillisation of amylin (20-29) peptide was performed. Peptide samples were
prepared in ultrapure water at a final peptide concentration of 300 µg/ml and aged
for 24 hours at room temperature before imaging by tapping-mode ex situ AFM.
Samples of either the azide or alkyne forms of the peptide and a 50:50 mix of both
forms of the peptide were investigated.
The AFM images presented in figure 3.7 are typical of the azide-amylin (20-29)
only sample. In the low resolution topography and phase image shown in Figure
3.7a it can clearly be seen that the functionalised peptide has retained the ability to
self-assemble and form fibril structures. Several distinct morphologies of fibrils
can be observed in the azide-amylin (20-29) sample. The high resolution
topography and phase image shown in figure 3.7b is a zoom in of the lower mid
section of figure 3.7a and highlights the variation in the two population
morphologies.
The majority of the fibrillar structures observed were short, flattened ribbon-like
fibrils with mean half-height widths of 10.2 (± 2.8) nm and heights of 1.58
(±0.38) nm. The fibrils were predominantly laterally aligned on the mica surface
with a propensity to associate together in single layers. Several truncated fibrils
were observed individually, enabling a clearer view of the topography of the
fibrils. The surfaces of the fibrils appear globular and less uniform than similarly
aged fibrils of non-functionalised amylin (20-29) observed previously (figures
2.6, 2.7-8).
A second less abundant population of larger fibrils was observed in the sample.
These structures displayed greater half-height widths and heights but which varied
significantly within the sample. In the majority of these larger fibrils a periodicity
along the fibril axis can be observed. The longitudinal cross-section along the
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Figure 3.7: Ex situ AFM images of azide amylin (20-29) sample. Samples were aged
for 24 hours in ultrapure water before aliquots were dried onto freshly cleaved mica. The
final peptide concentration was 200 µg/ml. Figure 7a shows typical topography (left) and
phase (right) images of the sample. Figure 7b shows a higher-resolution topography
(left) and phase (right) images, a line profile along the axis of the boxed fibril is shown in
figure 7c and demonstrates the periodicity of the fibril twist. Z range contrast bars are
shown.
a
c
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fibril axis highlighted by the box in figure 3.7b can be seen in figure 3.7c. A
regular periodicity can be observed along the fibril axis and is approximately 55
nm. However, in other fibrils this periodicity was not always as regular and varied
in twist.
The AFM images presented in figure 3.8 are representative of the images
generated of the alkyne-amylin (20-29) sample. In contrast to the azide-amylin
(20-29) sample, no periodicity was observed in the fibrillar structures found in the
alkyne-amylin (20-29) only sample. However, in similarity, two distinct
morphologies were observed which displayed similar topographies.
One morphological type is illustrated by the fibrillar structures observed in the
low resolution topography image shown in figure 3.8a. Individual fibrils have
associated into larger fibrillar structures which have a dense network of material.
Figure 3.8b shows a zoomed in section of this network; the phase data provides
further detailed information on the constituent fibrils which comprise these
fibrillar structures. These larger structures comprise differing numbers of fibrils
which are laterally aggregated. Several of which over the lengths of the structure
have a non-uniform twist along the axis.
The second class of fibril morphology is typified by the fibrils shown in the high-
resolution topography image presented in figure 3.8c. The fibrils are observed
individually or loosely laterally associated on the mica surface. Individual fibrils
are flat ribbon-like structures with mean half-height widths of 11.28 (±2.16) nm
and mean height of 1.29 (±0.30) nm. In similarity to the fibrils formed from azide-
amylin (20-29), the surface morphology of the fibrils is in most instances non-
uniform with a slight globular appearance displaying an irregular periodicity.
The images presented in figure 3.9 are representative of the low (figure 3.9a) and
high-resolution (figure 3.9b) images of the fibrillar structures formed in samples
comprising a 50:50 mix of both azide and alkyne-amylin (20-29) peptides. Two
distinct morphologies of fibrils can be observed. The first are single-layered,
laterally aligned fibrils. The second are aggregated groups of fibrils formed into
larger fibrillar structures, which have entangled forming a network. The first
morphological population comprises of fibrils with half-height widths in the range
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Figure 3.8: Ex situ AFM images of alkyne amylin (20-29) sample. Samples were
aged for 24 hours in ultrapure water before aliquot samples were dried onto freshly
cleaved mica. The final peptide concentration was 200 µg/ml. Figure 8a shows a
topography image of the sample. Figures 8b and 8c are typical higher-resolution
topography (left) and phase (right) images demonstrating the variation in fibril
morphologies observed. Z range contrast bars are shown.
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Figure 3.9: Ex situ AFM images of 50:50 mix of azide and alkyne amylin (20-29)
samples. Equal quantities of both peptides were solubilised in ultrapure water and
aged for 24 hours, before aliquot samples were dried onto freshly cleaved mica. The
final peptide concentration was 300 µg/ml. Figure 9a shows a typical topography (left)
and phase (right) image of the sample. Higher-resolution topography (left) and phase
(right) images of the sample are shown in figure 9b. Z range contrast bars are shown.
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7 to 12 nm and heights of approximately 1.4 nm. By comparison, the smallest
resolvable fibrils displaying the second morphological type are wider with
dimensions in the range of 19 to 30 nm.
3.3.4 Congo red assay
To establish whether the fibrillar structures formed by the azide and alkyne forms
of amylin (20-29) have retained the common amyloid structure, samples were
assayed using Congo red staining; the histopathology stain for the detection of
amyloid. Under polarized light amyloid stained with Congo red dye will display a
green gold birefringence [27]. Samples of the azide-form and alkyne-form of
amylin (20-29) in ultrapure water were aged for 18 hours to ensure sufficient time
for fibril formation. Aliquot samples were dried and stained with the Congo red
dye and the appearance of birefringence noted under polarized light. The optical
micrographs shown in figures 3.10a and b are of the stained azide form of the
amylin (20-29) under non-polarised and polarized light, respectively. A green
gold birefringence can be observed under the polarized light. The micrographs
presented in figures 3.10c and d are of the alkyne-form of the amylin (20-29)
peptide under non-polarised and polarized light, respectively; a green gold
birefringence is observed.
3.3.5 Copper (I) Catalysed Cycloaddition
Following the successful fibrillisation of the functionalised amylin (20-29)
peptide, an AFM study of the peptides under the copper (I) catalysed
cycloaddition reaction conditions was performed. The study comprises several
conditions in which the peptides are either initially (t =0 hours) solubilised in 1
mM and 5 mM equivalent of copper (I), or allowed to preform into fibrils prior to
addition at 18 hours (t =18 hours) of the 1 mM and 5 mM equivalent of copper (I)
cycloaddition reaction mixture.
3.3.5.1 1 mM Copper (I)
3.3.5.1.1 Fibrillisation in the presence of Cu (I) (t=0 hours)
After incubating the azide-form and alkyne-form of the amylin (20-29) peptide in
isolation in 1 mM copper sulphate with ascorbic acid solution for 18 hours,
fibrillar structures were observed in both samples. These results provide evidence
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Figure 3.10: Congo red assay of azide- and alkyne- amylin (20-29) peptide.
Peptide samples were aged for 18 hours in ultrapure water, before aliquot samples
were removed, dried and stained with Congo red solution. Figures 10 a and b show
samples of the azide-amylin (20-29) samples under normal and polarised light
respectively. Figures 10 c and d show samples of the alkyne-amylin (20-29) samples
under normal and polarised light respectively.
a b
c d
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that neither the copper salts nor any of the components (ascorbic acid, ethanol) of
the cycloaddition reaction mixture inhibit the formation of fibrils by the
functionalized amylin (20-29) peptide. The AFM topography images presented in
figure 3.11 are typical of the azide-amylin (20-29) peptide (figure 3.11a and b)
and alkyne-amylin (20-29) peptide (figure 3.11c and d) samples at 18 hours.
In similarity to the fibrils formed by the peptides in the absence of copper salts,
the fibrils have flattened ribbon-like morphologies. The azide-amylin (20-29)
fibril samples display a mean half-height width of 10.97 (±1.8) nm and height of
2.69 (±0.31) nm. By comparison, the average half-height width of the fibrils from
the alkyne-amylin (20-29) sample was 18.33 (±2.7) and mean height of 1.84
(±0.51) nm.
Figure 3.11a is a topography image typical of the fibrils formed by the azide-
amylin (20-29) peptide. The fibrils captured in the high-resolution topography
image in figure 3.11b demonstrate the uniform and smooth topography of the
fibrils. In the upper portion of the group of fibrils highlighted by the arrow in
figure 3.11b, two fibrils are observed twisted together. This form of association
was infrequently observed in the samples and the majority of fibrils were
observed individually or with some propensity to associate together laterally. The
mica surface appeared clear of physisorbed non-fibrillar material except for small
pockets of amorphous debris which can be observed in the background of the
images. All solutions were filtered through 0.2 µm gauze prior to use, therefore it
is likely that the debris is dried salt deposits or non-fibrillised peptide material.
Typical fibrillar material observed in the alkyne-amylin (20-29) peptide samples
is presented in the topography image shown in figure 3.11c. Fibrils were rarely
observed individually, but instead were predominantly associated together in
aggregates of several fibrils that interconnected to form networks of loosely coiled
or laterally grouped larger structures. Figure 3.11d is a higher-resolution
topography image and demonstrates the uniform and smooth topography of the
individual alkyne-amylin (20-29) fibrils.
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Collectively the images presented above in figure 3.11 demonstrate that the
presence of the copper (I) solution is not inhibitive to the formation of fibrils by
either forms of the amylin (20-29) peptide. Therefore the next stage in this set of
experiments, was to perform the cycloaddition reaction assay, combining both
forms of the functionalized amylin (20-29) peptide in the presence of copper (I)
salts. Equal quantities of both forms of the peptide were solubilised together in the
cycloaddition copper solution and mixed continuously for 18 hours. Aliquots of
both samples were removed, dropped onto freshly cleaved mica and imaged in air
using tapping mode AFM. Presented in figures 3.12 are a typical selection of the
images that were generated.
Two distinct fibril morphologies were observed. Figure 3.12a is a typical
topography image of the first morphology type, where lower-order fibrils are
predominantly observed assembled into larger higher-order fibrillar structures.
These structures showed considerable variation in dimension ranging in half-
height widths from 55 to 130 nm and average height of 9.7 (±3.2) nm. The lower-
order fibrils are resolvable in these structures giving them a non-uniform surface
topography. In some instances a distinct periodicity can be observed where
several lower-order fibrils are entwined together. A typical example of this is
shown in figure 3.12b which is a digital zoom of the central boxed area in figure
3.12a; the fibril has a distinct globular appearance with a slightly irregular but
distinct periodicity. Figure 3.12c is a digital zoom of the upper boxed area in
figure 3.12a, the lower-order fibrils are resolvable within the higher-order
structures but do not display any periodicity and do not appear to be coiled around
one another.
The second morphology is typified by the fibrils present in the topography image
presented in figure 3.12d. Fibrils are thinner and shorter, and laterally align into
layers one fibril thick. This population of fibrils had a mean half-height width of
16.7 (±3.02) and height of 1.75 (±1.1) nm. Figure 3.12e is a high-resolution zoom
of the boxed area in figure 3.12d highlighting the differences in dimensions and
morphologies between the two types of fibril.
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Figure 3.11: Ex situ AFM images of 1 mM Cu+ present from 0 hours azide and
alkyne amylin (20-29) samples. Peptide was solubilised in 1 mM Cu+ salt solution, at
18 hours aliquot samples were dried onto freshly cleaved mica. The final peptide
concentration was 300 µg/ml. Topography images of the azide peptide sample are
shown in figure 11a and higher-resolution in figure 11b. Topography images of the
alkyne peptide sample are shown in figure 11c and figure 11d. Z range contrast bars
are shown.
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Figure 3.12: Ex situ AFM images of 50:50 mix of both peptides in 1 mM Cu+
present from 0 hours. Peptide was solubilised in 1 mM Cu+ salt solution, at 18 hours
aliquot samples were dried onto freshly cleaved mica. The final peptide concentration
was 300 µg/ml. Figure 12a is a topography image of the peptide sample, higher-
resolution topography images of the boxed areas are shown in figure 12b highlighting
a typical fibril displaying periodicity, and figure 12c highlighting fibrils with no
periodicity. Figure 12d is a topography image, a higher-resolution topography image
of the boxed area is shown in figure 12e, demonstrating the different fibril
morphologies. Z range contrast bars are shown.
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3.3.5.1.2 Addition of Cu (I) to solutions of pre-formed fibrils (t =18 hours)
An additional assay was performed to investigate the influence of the
cycloaddition reaction on pre-formed fibrils of the azide and alkyne amylin (20-
29) either in isolation or in combination. Peptide solutions were prepared initially
in ultrapure water and aged for 18 hours at which point the samples were diluted
to a final peptide concentration of 300 µg/ml by the addition of the cycloaddition
1 mM copper sulphate with ascorbic acid in water/ethanol and mixed
continuously for a further 8 hours.
The images shown in figure 3.13 are of the samples containing azide-amylin (20-
29) only peptide. Figure 3.13a is typical of the low-resolution topography images
of the fibrillar structures formed. Fibrils were long and ribbon-like in appearance
and were observed individually or aggregated as interconnected assemblies. The
half-height widths of individual fibrils were greater than previously observed with
a mean of 30.24 (±2.6) nm, but displayed a similar mean height of 1.15 (±0.27)
nm.
In the majority, aggregation of fibrils was by lateral association into
interconnected networks of irregular bundles. A typical example of this
aggregation pattern can be seen in the high-resolution topography image presented
in figure 3.13b. Many of the fibrils associated into these bundles were shorter
than the fibrils observed individually.
As with the samples formed in the absence of copper, the twisting of several
fibrils into one structure was observed. Figure 3.13c is a high-resolution
topography and phase image showing the association of two fibrils (10.8 nm and
13.8 nm) into a single fibril (15.0 nm) by coiling. The phase image enables the
two constituent fibrils to be clearly seen. The profile inset is of the cross-section
along the axis of the coiled portion of the fibril, the regular periodicity of the
twisted fibrils is approximately 32 nm.
An interesting phenomena which was unique to this sample, was the presence of
small, dense aggregated balls of fibrils. A typical example of these formations is
presented in the high-resolution topography and phase image shown in figure
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3.13d. The cross-sectional profile of the fibril ball, shown by the line in the
topography image, is presented in the inset panel. As can be seen from the profile,
the structure is more a mound on the mica surface than a ball. There is variation in
height across the structure with a maximum height of 9.5 nm. Together with the
additional topographical details offered by the phase image, these ‘balls’ appear to
be formed from irregular bundles of overlapping fibrils analogous to a loose and
unevenly wound ball of string. Several ‘ends’ of the constituent fibrils can be seen
projecting outwards from the central mass together with longer individual fibrils.
Some fibril balls appear more densely packed together than others, however the
AFM images do not provide any detailed information on how or why these fibril
balls have formed.
Presented in figure 3.14 are images of the alkyne-amylin (20-29) only sample
following addition of the cycloaddition reaction mixture at 18 hours. Figure 3.14a
is a high- resolution topography and phase image of the lateral assembly of the
alkyne-amylin (20-29) fibrils. The phase data provides further topographical detail
of the lateral assemblies and enables individual fibrils which are tightly packed
within the assemblies to be elucidated. Several fibrils can be seen emerging from
the large aggregates, these individual fibrils display heights with a mean of 1.84
(±0.56) nm. By comparison, the heights of the fibrillar aggregates range from 2.9
to 8.4 nm in height, suggestive that the fibrils are aggregating laterally both side
by side and stacked upwards. In the previous examples of lateral assembly of
fibrils from either form or mixes of the peptide, aggregation has only been noted
side-by-side and not by stacking to form layers several fibrils thick.
Figure 3.14b is a low-resolution topography and phase image, the boxed area has
been zoomed in digitally and is shown in figure 3.14c. These images highlight a
different type of aggregation pattern of the alkyne-amylin (20-29) fibrils, in which
fibrils are observed projecting from a dense central area. Unlike the fibril balls
noted in the azide-only samples (figure 3.13d), these dense central points do not
have any resolvable ordered structure or surface topography, are more tightly
packed, and are considerably greater in height (> 20 nm). However, it is possible
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Figure 3.13: Ex situ AFM images of 1 mM Cu+ present from 18 hours azide–
amylin (20-29) sample. Peptide was solubilised initially in ultrapure water, at 18
hours Cu+ salts were introduced. Samples were aged for 8 hours in copper solution
before drying onto freshly cleaved mica. The final peptide concentration was 300
µg/ml. Figure 13a is an ex situ topography imag of the peptide sample. Z range
contrast bars are shown. Higher-resolution topography images highlighting individual
features are shown in figure 13b (topography), figure 13c (topography and phase)
and figure 13d (topography and phase). Insets are cross-sectional profiles.
d
ba
500 nm 50 nm
50 nm
50 nm
c
Chapter 3 Modification of amylin (20-29) peptides
- 134 -
25.0 nm
15.0
0.0
b
50.0 nm
25.0
0.0
50.0°
15.0
0.0
25.0°
12.5
0.0
a
Figure 3.14: Ex situ AFM images of 1 mM Cu+ present from 18 hours alkyne–
amylin (20-29) sample. Peptide was solubilised in ultrapure water, at 18 hours Cu+
salts were introduced. Samples were aged for 8 hours in copper solutions before
drying onto freshly cleaved mica. The final peptide concentration was 300 µg/ml.
Figure 14a shows a high-resolution topography (left) and phase (right) image of the
peptide sample. Figure 14b shows a topography (left) and phase (right) image of a
different fibril morphology type, a higher-resolution 1.6 µm x 1.6 µm topography image
of the boxed area is shown in figure 14c. Z range contrast bars are shown.
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that these structures are similar to the fibril balls but tighter packing results in un-
resolvable structure.
The topography images shown in figure 3.15 are representative of those generated
for samples containing equal quantities of both forms of the peptide, which were
allowed to form fibrils in ultrapure water before the addition of the cycloaddition
copper solution at 18 hours, after which time the solution was mixed continuously
for a further 8 hours. Figure 3.15a is a low-resolution topography image of the
fibrils observed. Despite consistently using the same peptide concentration (300
µg/ml), fibrils were observed infrequently in the samples. Fibrils were present
either individually or as small groups aggregated together in a manner typical of
those shown in figure 3.15a. Individual fibrils are long and flat structures with
smooth surface topographies. Dimensions of the fibrils were larger than that
measured for the same sample but in the absence of copper and had a mean half-
height width was 33.7 (±6.4) nm and mean height of 3.80 (±1.4) nm. Several
examples of fibrils grouped together by intertwining of several fibrils to form
larger fibrillar structures can be found in the image in figure 3.15a. The fibrils
highlighted by the boxed area are an example of this; a higher-resolution
topography image in of this area is shown in figure 3.15b. Three individual fibrils
can be seen emerging from a larger structure at the bottom of the image, one of
which branches higher up to produce a fibril with the same dimensions. The
original fibril is then observed coiling together with another of the starting fibrils
to form a single structure again. The digitally zoomed in area shown in figure
3.15c is another example where the coiling of several fibrils to form a larger
structure is evident due to the unraveling or loose coiling of the constituent fibrils.
The fibril marked with an arrow in this group appears to have regions of different
thickness (19.7 nm, 31.3 nm and 20.2 nm), which may be evidence of further
structural hierarchy, given that the smaller thickness dimensions are in keeping
with those seen in figure 3.12.
3.3.5.2 5 mM Copper (I)
In the current literature investigating the applications and mechanisms of this 1,3
dipolar cycloaddition reaction the concentration of copper (I) salts employed
Chapter 3 Modification of amylin (20-29) peptides
- 136 -
Figure 3.15: Ex situ AFM images of 50:50 mix of both peptides in 1 mM Cu+
present from 18 hours. Peptide was solubilised in ultrapure water, at 18 hours Cu+
salts were introduced. Samples were aged for 8 hours in copper solution before
drying onto freshly cleaved mica. The final peptide concentration was 300 µg/ml.
Figure 15a shows a topography image, a line profile along the axis of the fibril
between the arrow markers is shown in figure 15b, demonstrating the periodicity of
the twist. A higher-resolution topography image of the boxed area is shown in figure
15c. The arrow in the high-resolution topography image shown in figure 15d
highlights a lower-order fibril. Z range contrast bars are shown.
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range from 0.5 mM to 2 mM [204, 211, 213, 214, 216]. Given that no change in
fibril morphology or assembly has been observed here for copper concentrations
of 1 mM, a follow-up experiment was performed to assay the effects of a five-fold
increase in copper concentration on fibril formation and assembly.
3.3.5.2.1 Fibrillisation in the presence of Cu (I) (t=0 hours)
Presented in figure 3.16 are typical AFM images in air of samples of 50:50 mix of
both forms of amylin (20-29) peptide solubilised in solutions of 5 mM copper
sulphate with ascorbic acid in ethanol/water and aged for 18 hours. The low-
resolution topography and phase image shown in figure 3.16a are typical of the
fibrils formed under these conditions. Fibrils were flat ribbon-like structures
which aggregated together in large dense pockets on the mica surface. Similar
densely packed regions were observed in the samples containing no copper and in
the alkyne-only peptide samples. Fibril width and length dimensions are
equivalent to those measured in samples in the absence of copper and in 1 mM
copper, with mean half-height width of 17.59 (±2.7) nm. However an increase in
fibril heights with a mean of 5.54 (±1.95) nm was observed.
The high-resolution topography and phase image presented in figure 3.16b is a
zoom in to the perimeter of one of the dense aggregate pockets and reveals more
morphological detail of the individual fibrils. The surface topography of the fibrils
is not as smooth as that observed in any of the previous samples. In the phase
image, the fibril surfaces appear fragmented, which may provide further support
that the fibrils are the assembly of lower-order fibrillar structures that are
resolvable in this image. The lower-order fibrils appear in most instances to be
truncated structures.
3.3.5.2.2 Addition of Cu (I) to solutions of pre-formed fibrils (t =18 hours)
The images presented in figure 3.17 are of samples of a 50:50 mix of both forms
of amylin (20-29) peptide in which the 5 mM copper cycloaddition reaction
mixture was not added until 18 hours, at which point it was left for a further 8
hours before imaging. In the low-resolution topography and phase image
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presented in figure 3.17a, two distinct types of fibril morphology and aggregation
pattern can be seen and are similar to those observed in the samples in the absence
of copper. The first type are low lying fibrils that laterally align as a tightly
packed blanket with few gaps forming a uniform single thickness layer on the
mica surface. The fibrils display a mean half-height width of 20.8 (±3.52) nm and
height of 2.25 (±0.74) nm. In contrast, fibrils displaying the second type of
morphology aggregate together to form irregular, larger interconnected bundles.
The bundles that are deposited on the top of the laterally aligned fibril layer, in
general, cause disruption to the underlying layer and clear mica can be observed
(exemplified in the bottom right corner of the phase image in figure 3.17a). The
fibrils are larger and have a mean half-height of 38.10 (±6.60) nm and mean
height of 6.53 (±2.59). The higher-resolution topography image shown in figure
3.17b demonstrates the differences in size and aggregation pattern of the two
types of morphologies and highlights the dense packing of the laterally aligned
fibrils. The smooth and uniform surface topography of the fibrils from both
morphologies can be seen clearly in the high-resolution image shown in figure
3.17c.
To allow for comparisons to be drawn, frequency distributions of the half-height
widths and height measurements of the fibrillar structures formed in samples
containing both forms of the peptide in 0, 1, and 5 mM copper have been plotted
and are presented in figure 3.18. The histograms shown in figures 3.18a and b are
the frequency distributions of the half-height widths of fibrils observed in samples
where the copper catalyst was present from 0 hours and 18 hours respectively.
The histogram presented in figures 3.18c and d are fibril height frequency
distributions of samples where the copper catalyst was present from 0 hours and
18 hours respectively.
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Figure 3.16: Ex situ AFM images of 50:50 mix of both peptides in 5 mM Cu+
present from 0 hours. Peptide was solubilised in 5 mM Cu+ salt solution, at 18 hours
aliquot samples were dried onto freshly cleaved mica. The final peptide concentration
was 300 µg/ml. Figure 16a shows a topography (left) and phase (right) image of the
peptide sample. A higher-resolution topography (left) and phase (right) image of an
area in the top centre is shown in figure 16b. Z range contrast bars are shown.
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Figure 3.17: Ex situ AFM images of 50:50 mix of both peptides in 5 mM Cu+
present from 18 hours. Peptide was solubilised in ultrapure water, at 18 hours Cu+
salts were introduced. Samples were aged for 8 hours in copper solution before drying
onto freshly cleaved mica. The final peptide concentration was 300 µg/ml. Figure 17a
shows a topography (left) and phase (right) image of the peptide sample. A higher-
resolution topography image is shown in figure 17b demonstrating the different fibril
morphologies, a high-resolution topography image of the boxed area is shown in
figure 17c. Z range contrast bars are shown.
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Figure 3.17: Histograms showing the frequency distribution of amylin (20-29) fibril
widths and heights in copper catalyst concentrations of 0, 1 and 5 mM. Histograms of the
frequency distribution of fibril half-height widths formed in copper solutions present from a) 0
hours and b) 18 hours. Histograms of the frequency distribution of fibril heights formed in
copper solutions present from c) 0 hours and d) 18 hours. Fibril widths and heights were
measured from AFM ex situ images of samples containing mixtures of both azide and alkyne
forms of amylin (20-29) with either 0 or 1 or 5 mM copper catalyst solution added either prior to
fibril formation at 0 hours or to pre-formed fibril samples at 18 hours.
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3.4 Discussion
In this chapter the effects on fibrillisation of the introduction of an azide and
terminal alkyne functional group to the amylin (20-29) peptide has been
investigated by AFM and Congo red staining. In addition, the use of the 1,3
dipolar cycloaddition reaction of azide and alkynes to form 1,2,3 triazole rings has
been studied for the formation of covalent links between the fibrils of the
functionalized amylin (20-29) peptide.
Solid phase peptide synthesis was successfully used in the synthesis of amylin
(20-29) peptides with either an azide group or alkyne group coupled to the N-
terminus. Synthesis of the azide-form of the peptide required the initial synthesis
of 2-azidoacetic acid from bromoacetic acid and sodium azide, which comprises
the azide functional group and carboxy group for peptide bond formation. IR
spectroscopy, NMR and MS analysis of the product identified the successful
synthesis of the 2-azidoacetic acid, which was coupled to the N-terminal serine of
the amylin (20-29) peptide. In a one step synthesis the alkyne moiety in the form
of propiolic acid was coupled to the N-terminal serine of the amylin (20-29)
peptides. MS analysis clarified the presence and purity of the azide-form and
alkyne-form of the peptide.
Preliminary ex situ AFM investigations revealed that both azide and alkyne forms
of the amylin (20-29) peptide readily form fibrils in ultrapure water. The fibrils
were flattened ribbon-like structures that had a tendency to aggregate laterally or
into densely tangled clumps or as irregular twisted coils. Following Congo red
staining of samples aged 18 hours, a green gold birefringence was observed under
polarized light for both the azide-form and alkyne-form of the amylin (20-29)
peptide. Indicative therefore, that the fibrils formed by the azide- and alkyne-
amylin (20-29) peptides have retained the amyloidogenic structure necessary for
Congo red binding [27, 217].
Furthermore, the introduction of the copper catalyst in the cycloaddition reaction
solution at either concentration of 1 or 5 mM did not have any detrimental effects
on the formation of fibrils (figures 3.11, 3.13, 3.14, 3.16 and 3.17). Under both
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copper concentrations and in the absence of copper, the predominant fibril
morphologies and assemblies mirrored those observed in the preliminary ex situ
AFM study and can be similarly separated into two distinct morphological classes.
The first, displayed a tendency to associate together laterally in single or denser
layers. The second class showed a propensity to assemble into larger fibrillar
structures either by entwined or irregular associations.
Similar fibril morphologies were observed in the samples irrespective of copper
concentration or whether the copper catalyst had been present throughout
fibrillisation, or introduced to samples of pre-formed fibrils at 18 hours.
Furthermore, the range of morphologies observed within the samples containing
only one form of the amylin (20-29) peptide (figures 3.11, 3.13 & 3.14), with the
exception of the small population of fibril ‘balls’ observed in the azide-only
amylin samples (figure 3.13), can clearly be seen in the samples comprising a mix
of both forms of the peptide in the presence of the copper catalyst (figures 3.12,
3.15-17). Consequently, given that these observed morphologies and aggregation
patterns are also commonly observed in non-functionalised amylin (20-29) fibrils
(see Chapter 2), these findings suggest that the introduction of the copper (I)
catalyst either during fibrillisation, or to pre-formed fibrils results in no change in
morphology or aggregation patterns of the fibrils.
However, although no apparent changes in the morphology of the fibrils or
aggregation patterns were observed directly, variations in fibril dimensions were
noted. By comparison of the dimensions of non-functionalised amylin (20-29)
fibrils (mean width of 27.31 (±8.4) nm and height 1.66 (±1.0) nm), with the
functionalized amylin (20-29) fibrils formed in the absence of copper catalyst, we
see that the latter display significantly smaller widths, but similar heights.
Indicative therefore, that the azide and alkyne moieties are exerting some
influence on the packaging of fibrils. The model for amylin fibril ultrastructure
proposes formation occurs by the association of sub-fibrillar species into a
structural hierarchy, in which the peptides aggregate as a beta-sheet into
protofilaments. Several protofilaments then associate into protofilaments which
group together laterally or by coiling into the fibril [43, 44, 49]. It is therefore
conceivable that the additional bulk of the azide and alkyne moieties are
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influencing the aggregation of these sub-fibrillar species by limiting the number
of protofilament or protofilaments which associate into the observed species.
The frequency of fibrils (in all samples irrespective of the presence of copper)
displaying a periodicity along the axis was considerably greater than expected
based on a comparison with the fibrils formed by non-functionalised amylin (20-
29) presented in Chapter 2, in which periodicity was only observed in younger
fibrils and not the more mature species at 18 hours. Therefore, providing further
support that the functional groups may be influencing the assembly and packing
of the fibrils, either by promoting the coiling of fibrils into higher-order structures
or that the additional bulk of the functional moieties results in the looser packing
of sub-fibrillar structures into the fibrils and thus the periodicity of the packing is
resolvable by the AFM tip.
Furthermore, frequency distributions (see histograms in figure 3.18) of fibril
dimensions in samples containing both forms of the peptide in the presence of the
copper catalyst show a broadening and shift in population distribution, which was
dependent on the copper concentration. Two trends were noted, firstly when the
copper catalyst was present during fibrillisation (ie present from 0 hours, figures
3.18a and c) at both the 1 and 5 mM concentration a shift and increase in fibril
height was observed. Furthermore an additional population of fibrillar structures
with greater half-height widths and heights were observed in the samples in which
1 mM copper was present. Secondly, when the fibrils were allowed to pre-form
prior to the addition of the copper catalyst (ie copper added at 18 hours, figure
3.18b and d), when in the presence of both concentrations of the copper catalyst
there was a more pronounced increase and broadening in the distribution of the
fibrillar dimensions. However, the additional population noted in the 1mM sample
was no longer observed.
When considering these findings, it is apparent that the presence of the copper
catalyst both during fibrillisation and when added to the pre-formed fibril samples
is inducing a change in the fibril dimensions within the samples. However, the
increased fibrillar dimensions were not matched with the observation of any novel
morphologies or aggregation patterns within the samples. It is therefore probable
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that the observed increases in fibrillar dimensions are a consequence of the
formation of a few triazole linkers between fibrils but at a low efficiency of
formation.
Any future investigation into the success of this cross-linking reaction should be
verified by exploration of the sample using IR spectroscopy or by NMR
characterisation. Formation of the triazole cross-linker could be identifiable in an
IR spectrum by a loss of the azide (-N3) and carbon triple bond bands
characteristic of the two reactants and the appearance of bands corresponding to
the triazole ring vibration and C-N and N=N bonds of the triazole. The presence
of a 1,2,3 triazole ring would induce a chemical shift to ~8.5 p.p.m (corresponding
to the C-H of the ring structure) in an 1H-NMR spectrum [218].
A factor which may prove limiting to the success of the cycloaddition reaction to
link the azide and alkyne moieties on individual fibrils would be the presentation
of the functional groups in a sterically favourable manner for the reaction to
proceed and triazole ring formation. Unfavourable steric presentation of the
reacting moieties may provide a possible explanation for the apparent lack of any
novel aggregation patterns or wide-spread network formation in the samples of
functionalized amylin (20-29) fibrils. Several factors may influence whether the
triazole ring forms: the azide and alkyne moieties must be present on the outside
of the fibril, be in a sterically favourable orientation, and the azide and alkyne
pairing must be in close enough spacial proximity for the reaction to proceed.
Additionally, the 1,2,3 triazole ring is a planar 5-membered heterocycle which is
constrained by the bonds and electron densities between its constituent atoms
[219]. Thus the formation of triazole linkers between fibrils may be restricted
conformationally and sterically by the allowable bond angles within the ring and
in addition by the 1,4 bonds linking the peptide chain to the ring. Given that
similar morphologies were observed even in the samples where an excess of
copper catalyst was present (5 mM concentration), it seems unlikely that the
availability of the catalyst played any limiting factor in the progression of the
reaction. In the published literature the range of copper (I) catalyst concentrations
used for the cycloaddition reaction have employed concentrations 2.5 to 10 times
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less than this excess value and achieved successful catalysis [204, 211, 213, 214,
216].
Previous studies incorporating copper catalysed 1,3-dipolar cycloadditions of
azides and alkynes have fallen short of our ambition to link large biomolecular
structures; focusing on bioconjugation of proteins [211] and cells [210, 216]
expressing the azide or alkyne on specific amino acids with dyes or ligands
functionalized with the complementary group. In these instances only one triazole
ring was formed per linkage of a small ligand to the larger supramolecule and thus
no restraint was placed on the probability of other azide and alkynes being in
close enough proximity for further ligations to occur, as might be expected in our
experiment. Given the hydrophobic, aromatic and H-bonding interactions that
govern fibril assembly [61, 62, 95, 176, 190], any change in fibril aggregation
might be expected to require the formation of several triazole linkers to enforce
any noticeable change in aggregation pattern or morphology.
Consequently, one may surmise that the 1,3-dipolar cycloaddition click chemistry
may not be the effective choice for the synthesis of covalently linked fibrillar
networks of amylin (20-29) without better understanding and the ability to control
the presentation of the azide and alkyne functionalities on the fibrils. However,
more success may be found in the decoration of the functionalized fibrils with
function specific ligands, as previously demonstrated in the decoration of viral
coat proteins [211] and bacterial and yeast cells [210, 216]. Or alternatively, for
use in the immobilization of fibrils to an azide or alkyne functionalized support or
scaffold [214]. In each example the frequency of complementary functional
groups available on the surface would be greater and the probability of more
favourable positioning for the formation of the 1,2,3 triazole ring increased.
3.5 Conclusion
Amylin (20-29) peptides were successfully synthesized with an alkyne or azide
moiety coupled to the N-terminal amino acid residue. AFM images of samples of
the azide and alkyne forms of the amylin (20-29) reveal that both readily self-
assemble to form fibrillar structures, thus indicating that the introduction of an
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alkyne and azide moiety does not interfere with the fibrillisation of the peptide.
Furthermore, the fibrils formed by the azide and alkyne amylin (20-29) peptide
resembled the morphologies of non-functionalised amylin (20-29) peptides. Our
aim to form 1,2,3 triazole ring cross-linkers between these functionalised fibrils
by the 1,3 cycloaddition reaction of the azide and alkyne moieties proved to be of
some success but with an apparent low efficiency of formation. Despite the lack
of any observable novel fibril morphologies, networks or aggregation patterns, an
increase and shift in population distribution of the fibril dimensions was noted,
suggestive that some triazole linkers may have formed between fibrils producing
larger fibrillar structures. The findings presented in this chapter provide a good
foundation on which future studies can build for the possible application of the
1,3-dipolar cycloaddition of azide and alkyne for the functionalisation of amyloid-
forming peptides and synthesis of organized nanostructures.
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Chapter
4
AFM Study of Diphenylalanine Nanotubes
The studies in this chapter focus on the characterisation by AFM of the structures
formed by the second of the two peptide systems, the diphenylalanine peptide.
4.1 Introduction
In the quest to fully understand the formation of amyloid and the development of
potential therapeutics to combat the range of associated diseases, studies of short
peptide fragments have been investigated to identify the minimal amyloidogenic
fragment within the amyloid forming proteins [87, 174]. One such strand of
research led to the discovery that the core recognition motif of the ȕ-amyloid
polypeptide, a simple dipeptide of phenylalanine [86], is the smallest known unit
to self-assemble into discrete tubular structures. Furthermore, these nanotubes
retain many of the characteristics of the biofibrils formed from the full-length ȕ-
amyloid polypeptide; birefringence under polarised light upon Congo red staining
and ȕ-sheet like conformation as determined by FT-IR [86].
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Figure 4.1: The structure of diphenylalanine. The
structure of the dipeptide comprising the L-isomer of
phenylalanine.
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The diphenylalanine nanotubes are discrete, hollow water-filled structures with
uniform morphologies [86, 220], ranging in dimensions from 100 to 1500 nm in
diameter. The nanotubes are water soluble and have walls which display a degree
of porosity [221]. The nanotubes require only mild conditions to efficiently
assemble and thus are ideal materials for large scale, low cost manufacture. In
addition, the nanotubes have many inherent physical properties which make them
ideal building blocks for a range of bionanomaterials displaying high persistence
lengths, a high degree of strength with an average point stiffness of 160 N/m and
considerable rigidity by comparison to other bionanomaterials with Young’s
modulus of 19 GPa [220]. By comparison the Young’s modulus of microtubules,
hollow tube proteins which form part of the cytoskeleton of eukaryotic cells is
approximately 1 GPa [222].
The diphenylalanine nanotubes have proven successful as novel materials in a
wide range of applications from microelectronics to biosensors. For example, the
diphenylalanine nanotubes have been used as enzymatically digestible scaffolds
for the synthesis of silver nanowires for microelectronics [86], in the formation of
peptide nanotube platinum-nanoparticle composites [221] and as part of
electrochemical biosensor platforms [223, 224]. Furthermore, the potential ease
with which the peptide nanotubes can be biologically and chemically modified
will further broaden their application as novel specifically functionalised
materials. The generation of peptides of diphenylalanine with an N-terminally
attached Fmoc group have been shown to readily self-assemble into tubular
structures displaying a higher degree of flexibility, and which form as a rigid
hydrogel [225]. Hydrogels are of particular interest for use as tissue engineering
scaffolds due to the capacity to support cell growth and the ease of decoration
with growth promoting ligands [163, 226-228].
The exact structural organisation of the diphenylalanine molecules within the
nanotubes still remains to be elucidated. A model for the formation of the
diphenylalanine nanotubes is outlined in figure 4.2 [86, 229] and proposes that the
nanotubes form in a similar manner to fullerenes and carbon nanotubes by the
formation of a two-dimensional sheet stabilized by aromatic ring interactions. The
energetic contribution and ordered assembly of the diphenylalanine molecules
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Figure 4.2: Model for the formation of the diphenylalanine nanotubes. (Source
Reches and Gazit 2004 [229]) Ordered stacking of diphenylalanine into a two
dimensional sheet is driven by ʌ-ʌ stacking interactions, closure of the sheet into the
tubular structure is further stabilised by aromatic interactions and H-bonding.
into an extended ȕ-sheet is driven by the ʌ-ʌ interaction of the aromatic ring side
chains. The tubular structure is formed by the closure of the extended ȕ-sheet and
is further stabilised by aromatic interactions and H-bonding [229].
The importance of the aromatic ring in peptide nanotube formation may also
confer many ideal properties to the nanotubes. Aromatic clusters on the surface
and active sites of a range of thermophilic enzymes are key in conferring thermal
stability to the protein and comparisons with the mesophile homologues reveal
these aromatic clusters are preferentially mutated to non-aromatic residues [230].
The experiments within this chapter focus on the investigation of the physical and
chemical properties of the diphenylalanine nanotubes. The extent to which the
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diphenylalanine nanotubes can retain structural stability under harsh chemical and
thermal conditions may prove important in the scope of possible applications for
these novel materials; the ability to withstand extremes of heat, for example
during sterilisation would be a prerequisite for any material in consideration for
use as tissue engineering scaffolds or biosensors. To this end, the thermal stability
of the diphenylalanine nanotubes under wet and dry heating conditions was
studied by AFM. Further analysis of the resultant artefacts of heating was
investigated by time-of-flight secondary-ion mass spectrometry (TOF-SIMS).
As our understanding of the physical and chemical properties of the nanotubes
increases the focus turns to their potential uses and the means of how to
manipulate these structures to broaden the scope of possible applications. The use
of magnets has previously been demonstrated for the orientation and improved
growth of protein crystals for X-ray diffraction studies in the elucidation of
protein structures [231-234]. This method of orientation has also been used as a
tool to align biofibrils (collagen, tubulin and amyloid) in preparation for X-ray
fibre diffraction analysis [41, 235-241].
The behaviour of a substance within an externally applied magnetic field is
determined by the magnetic nature of the material. Diamagnetism is an intrinsic
form of magnetism; in diamagnetic materials, atoms have no permanent magnetic
moments in the absence of an applied magnetic field. However, in an externally
applied magnetic field a small magnetic moment is induced in the opposite
direction to the applied field. The magnetization of a diamagnetic material is
proportional to the applied magnetic field strength and the magnetic susceptibility
of the material (a constant). The diamagnetic susceptibility of a material is closely
related to its structure. The magnetic alignment of proteins occurs primarily due to
the intrinsic diamagnetic nature of the peptide bond due to the ordered
arrangement within the secondary structure conformations of the polypeptide
chain (Į-helix and ȕ-sheet) [242, 243]. However, in highly aromatic structures
where there are many conjugated rings, the net anisotropy of the structure is
derived predominantly by the aromatic ring. The aromatic ring has 10 fold greater
intrinsic diamagnetic anisotropy than the peptide bond due to the ordered and
close ʌ-ʌ stacking interactions [244]. Consequently, given the high aromatic
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content of the diphenylalanine nanotubes, the closing experiments within this
chapter have investigated the use of magnetic fields for the alignment of the
diphenylalanine nanoubes by AFM.
The work presented in this chapter was initiated in collaboration with Ehud
Gazit’s group from The University of Tel Aviv in Israel. The thermal stability
experiments have been published in the journals Langmuir [245] and Journal of
the American Chemical Society [246].
4.2 Experimental
4.2.1 Materials
Diphenylalanine peptide was purchased from Bachem, Switzerland. 1,1,1,3,3,3-
hexafluoro-2-propanol was purchased from Sigma Aldrich, UK. For solution
imaging isopropanol and acetone were purchased from Fischer. Amylin (20-29)
with azide or alkyne group coupled to the N-terminus were synthesised as
outlined in Chapter 3.
4.2.2 Method
4.2.2.1 Preparation of peptide samples
Stock solutions were prepared by diluting the lyophilised diphenylalanine
peptides in 1,1,1,3,3,3-hexafluoro-2-propanol (HFIP) to a concentration of 100
mg/ml. The peptide stock solutions were diluted in ultrapure water (pH 6,
resistivity 18.2 Mȍcm) to a final concentration of 2 mg/ml and vortex mixed for
20 seconds.
4.2.2.2 Atomic force microscopy
All AFM images were generated using a Multimode Nanoscope IIIa AFM
(Digital Instruments, Veeco Metrology Group, Santa Barbara, USA). Imaging was
performed using the J-type scanner using silicon TESP probes (supplied by Veeco
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Metrology Group) mounted on cantilevers with nominal spring constants of 42
N/m and resonant frequency of 320 kHz. Scan rates employed were 0.5-0.8 Hz.
Data analysis was performed using the Nanoscope analysis software package
v5.30r3.sr3 (Digital Instruments, Veeco Metrology Group, Santa Barbara, USA)
and SPIP program (Image Metrology A/S, Denmark). Images show topography
and phase data (where indicated), contrast scale bars are presented alongside
images where appropriate. The upper z range value is stated above each scale bar
with lighter colours indicating higher topographical features and greater phase
contrast respectively.
4.2.2.3 Air AFM imaging
A sample of the diluted (2 mg/ml) diphenylalanine peptide stock solution was
further diluted to 0.2 mg/ml in ultrapure water (pH 6, resistivity 18.2 Mȍcm), to
prevent molecular overcrowding of the scan area, immediately prior to imaging. A
10 µl aliquot sample was dropped onto freshly cleaved mica and dried under N2
and imaged in air using the AFM.
4.2.2.4 Solution AFM imaging
Imaging of biomolecules in solution by AFM requires the stable immobilisation
of the biomolecule to the substrate. For the imaging of the diphenylalanine
nanotubes in solution two strategies were investigated; altering the substrate and
changing the solution environment.
Mica, highly ordered pyrolytic graphite (HOPG), gold and silicon substrates were
all investigated for imaging the nanotubes in water. All substrates were cleaned
prior to use; mica and HOPG substrates were freshly cleaved, gold and silicon
substrates were UV cleaned (for 10 minutes). Aliquot (10 µl) samples of freshly
diluted (final concentration of 0.2 mg/ml) diphenylalanine nanotube solution were
dropped onto each substrate and immediately imaged by AFM using the liquid
cell.
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Using freshly cleaved mica as the substrate, different aqueous solvents were
investigated for nanotube solution imaging. The solvents investigated were 50 and
75 % v/v isopropanol or acetone in water. 100 mg/ml stock solutions of
diphenylalanine in HFIP were diluted to give a final peptide concentration of 2
mg/ml in 50 or 75 % v/v isopropanol or acetone and vortex mixed. Aliquot
samples were dropped onto freshly cleaved mica and imaged immediately using
the liquid cell. Solvent volume was maintained during imaging using a closed
liquid cell and syringe system.
4.2.2.5 AFM imaging of autoclaved samples
The autoclaved samples were prepared by our collaborators at the University of
Tel Aviv. A sample of the diluted (to 2 mg/ml) of diphenylalanine peptide stock
solution was autoclaved at 121 °C, 1.2 atmospheres. An aliquot sample of the
autoclaved nanotube solution was deposited onto freshly cleaved mica and air
dried at room temperature. Samples were imaged in air at room temperature by
tapping mode AFM in Nottingham.
4.2.2.6 In situ heat imaging
The thermal stability of the nanotube samples was investigated by heating of the
samples using the internal heater stage of the AFM J-scanner. The heat stage has
a built-in thermostat which monitors the temperature of the system, allowing the
sample to be heated bottom-up to a desired temperature, which is maintained by a
feedback coolant system.
Aliquot samples of the diluted (2 mg/ml) diphenylalanine nanotube solution were
dropped onto freshly cleaved mica and dried in an N2 stream. Samples were
mounted within the AFM and then heated successively to the desired
temperatures; 25, 50, 100, 150 and 200 °C. At each temperature, the system was
allowed to equilibrate for 5 minutes before imaging commenced, throughout
which the temperature was maintained. Immediately after each image was
captured, the temperature was increased to the next desired temperature. To allow
for comparisons to be drawn, the same nanotubes were imaged and the imaging
parameters were kept as constant as possible throughout the experiment.
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4.2.2.7 Ex situ heat imaging
The same AFM experimental set up was used as for the in situ imaging, with
exception that the samples were heated to the desired temperature and the system
was equilibrated for 5 minutes. Following this, the system was allowed to cool to
room temperature and equilibrated for a further 5 minutes prior to imaging.
Immediately after imaging the sample was heated to the next desired temperature.
The temperature increments were 25, 100, 125 and 150 °C. Several different
nanotube samples were studied, and in each sample the same nanotubes were
imaged with the imaging parameters kept as constant as possible.
4.2.2.8 Optical microscopy imaging of AFM cantilever following high-
temperature AFM imaging
Optical images of the AFM cantilevers used in the high-temperature in situ
imaging of the diphenylalanine nanotubes were generated using the Leica TCS
confocal microscope (Leica Microsystems (UK) Ltd) at x 2.5 and x 10
magnification.
4.2.2.9 Time-of-flight secondary-ion mass spectrometry analysis
The composition of the crystalline deposits observed on the AFM cantilevers
following high-temperature imaging of the peptide nanotubes was investigated
using time-of-flight secondary-ion mass spectrometry analysis (TOF SIMS) [247].
TOF SIMS spectra were obtained using a Ion-TOF SIMS IV instrument (GmbH,
Germany). The primary ion was a gallium beam with kinetic energy of 15 kV (20
µA), which delivers Ga+ cluster ions over a raster scan area of 300 x 300 cm2.
High-resolution mass spectra were generated of the AFM cantilever.
4.2.2.10 Magnetic anisotropy
4.2.2.10.1 Diphenylalanine nanotubes
An aliquot (10 µl) sample of the diluted stock solution (2 mg/ml) of
diphenylalanine nanotubes was dropped onto freshly cleaved mica and allowed to
evaporate completely for 1 to 2 hours inside a closed container at room
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temperature. The experiment was performed in four magnetic fields; 0.5, 3, 7 and
12 Tesla. A control experiment was also performed at 0 Tesla. In the 0.5 Tesla
experiment, the sample was placed horizontally in the gap of a C-shaped bench
magnet. For the 3 and 7 Tesla experiments, the samples were placed in the
homogenous field of a horizontal bore solenoid magnet of the magnetic resonance
imaging suite. In the 12 Tesla experiment, the aliquot sample was ‘hung’
vertically on the mica surface within the 5 cm-diameter vertical bore of a solenoid
magnet. In each case the mica surface was positioned parallel to the direction of
the magnetic field.
4.2.2.10.2 Amylin (20-29) fibrils
For comparative purposes to determine the effects of a high magnetic field on
fibrils formed by a peptide with low aromatic content, samples of functionalised
amylin (20-29) were investigated as a control. The sample comprised a 50:50 mix
of the modified amylin (20-29) with either an azide or alkyne group attached to
the N-terminus. A 50:50 mix of both forms of the lyophilised peptide were
dissolved in ultrapure water (pH 6, resistivity 18.2 Mȍcm) to a final peptide
concentration of 150 µg/ml and left to form fibrils in a sealed eppendorf tube
overnight at room temperature. A section of freshly cleaved mica was immersed
in the peptide solution and placed within the 5-cm vertical bore of the 12 Tesla
solenoid magnet. The solution was left to evaporate overnight at room
temperature.
4.2.2.10.3 AFM imaging and data analysis
Following exposure to the magnetic fields, the dried sample residues were imaged
using the AFM. Analysis of the AFM images was performed using the SPIP
program. Nanotube orientations relative to the direction of the magnetic field were
measured using the angle function within the SPIP program. Thus enabling the
nanotube anisotropy relative to the applied magnetic field to be determined by
calculating the average projected length of the nanotubes on the direction of the
magnetic field. This was then graphed as a polar plot using the statistical program
Origin (OriginLab Corp. USA).
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4.3 Results
4.3.1 AFM imaging of diphenylalanine nanotubes
Samples of the nanotubes formed by diphenylalanine peptide were imaged by
AFM using both tapping mode air and liquid imaging.
The AFM images presented in figure 4.3 are typical of the dried diphenylalanine
nanotube samples imaged in air. Figure 4.3a is a low resolution topography image
of a selection of nanotubes. The nanotubes are discrete, long and unbranched
structures displaying a range of diameters in agreement with the published values
measured from electron microscopy images [86, 220]. The nanotubes in the image
all display the typical uniformity in diameter along their axis and have half-height
widths of 256.2, 296.1 and 353.4 nm and respective heights of 105.74, 166.21,
and 133.65 nm.
Figure 4.3b is a topography image of a nanotube; the higher-resolution image
highlights the uniform and smooth surface topography of the tubular structures,
which do not have any discernable surface feature. A 3D representation of the
nanotube is presented in figure 4.3c demonstrating the tubular nature of the
structure. A profile of the nanotube cross-section (location is highlighted by the
line in figure 4.3b) is presented in figure 4.3d. The nanotube has a half-height
width of 247.02 (±4.14) nm and respective height of 117.35 (±2.71) nm.
Solution imaging by AFM allows biomolecules to be studied in their hydrated
state generating a better understanding of the native structure in a liquid
environment. However, obtaining a stable image of the nanotubes will require
sufficient immobilisation of the structures to the substrate during imaging. To this
end, several substrates including mica, gold, silicon wafer and HOPG were
investigated. However, none of the substrates assayed resulted in sufficient
immobilisation of the nanotubes in ultrapure water for stable imaging.
Investigations using organic solvents revealed that v/v aqueous concentrations of
isopropanol also proved ineffective but 50% and higher concentrations of acetone
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were sufficient and proved effective for the stable imaging of the nanotubes using
a mica substrate.
The AFM images presented in figure 4.4 are of a typical diphenylalanine
nanotube imaged in solutions of 50% v/v acetone. The low-resolution topography
image presented in figure 4.4a has been zoomed in to give the higher-resolution
image shown in figure 4.4b. The nanotube has a uniform surface topography with
no branching or surface features. Pockets of material can be observed on the
substrate surface and at the edges of the nanotubes. A further high-resolution
zoom in of a section of the nanotube where the surrounding material can be
observed is shown in figure 4.4c no further topographical information can be
discerned. A 3D representation of this image surface is presented in figure 4.4d
and a profile of the cross-section highlighted by the line is presented in figure
4.4e. The nanotube has a half-height width of 282.4 (±6.3) nm and height of 111.2
(±3.6) nm along its axis. Collectively, the images and profile illustrate the uniform
nature of the nanotube surface topography and demonstrate that the nanostructure
has a slightly flattened tubular morphology. These observations are in agreement
with our findings from the air images of the dried nanotube samples.
4.3.2 AFM imaging of autoclaved diphenylalanine nanotubes.
Samples of diphenylalanine nanotubes were autoclaved and imaged in air by
AFM to assess the thermal stability of the nanotubes following wet heat treatment.
The images presented in figure 4.5 are typical of the autoclaved nanotube
samples.
Figure 4.5a is a low-resolution topography image of a group of nanotubes
displaying a range of widths between 235 to 432 nm and heights of 46 to 231 nm.
The higher-resolution topography image presented in figure 4.5b, together with
the profile presented in figure 4.5c of the nanotube cross-section (highlighted by
line in figure 4.5b) demonstrate the uniform and smooth surface topography of the
nanotube. Collectively, these images show that the nanotubes do not lose any
observable structural integrity following autoclave treatment.
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Figure 4.3: Ex situ AFM images of diphenylalanine nanotubes. Figure 3a is a
topography image of diphenylalanine nanotubes dried onto freshly cleaved mica and
imaged by tapping mode AFM in air. Figure 3b is a higher-resolution topography image;
the line denotes the position of the cross-sectional profile presented in figure 3d. A 3D
representation of the nanotube is presented in figure 3c.
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Figure 4.4: AFM in situ images of diphenylalanine nanotubes in 50% v/v acetone.
Figure 4a is a topography image of the nanotubes imaged in situ 50% v/v acetone on mica.
Figure 4b and 4c are higher-resolution topography images, a 3D representation of the
nanotube surface topography is shown in figure 4d. Figure 4e is a profile of the nanotube
cross-section highlighted by the line in figure 4c.
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Figure 4.5: AFM images of diphenylalanine nanotubes after autoclave treatment.
Autoclave conditions were 121 °C at 1.2 atmospheres. Figure 5a is a topography image
of diphenylalanine nanotubes after autoclave treatment. Z range contrast bar is shown.
Figure 5b is a higher-resolution topography image of diphenylalanine nanotubes after
autoclave treatment; the line indicates the positioning of the cross-sectional profile,
which is shown in figure 5c.
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4.3.3 AFM in situ heat imaging
Samples of diphenylalanine nanotubes were dried onto freshly cleaved mica and
heated from the bottom-up using the heating stage of the AFM J-scanner to asses
the thermal stability of the nanotubes during dry heating. Samples were imaged at
room temperature and then heated to the desired temperature, following an
equilibrium period an AFM image was captured before the sample was heated to
the next temperature. The images presented in figure 4.6 are the series of typical
high-resolution AFM topography images captured (left), with cross-sectional
profiles (middle) and 3-D representations of the surface (right) of an exemplar
nanotube at each of the temperature increments of 24, 50, 100 and 150°C.
Figure 4.6a shows the nanotube at room temperature (24°C) it has a typically
smooth surface topography and uniform half-height width along it’s axis of 469
nm and height of 62.3 nm. When the nanotube was heated to 50°C no observable
change in the nanotube morphology (figure 4.6b) or dimensions was noted. The
topography image and 3D representation of the surface shown in figure 4.6c are of
the nanotube at 100°C. Loss of structural integrity can clearly be seen, with an
apparent breakdown in the nanotube wall and deformation of the tubular structure
with a prominent trough visible in the cross-sectional profile. Loss of outer wall
integrity also results in considerable variation in morphology along the nanotube
axis. The nanotube has a half-height width of 487 nm and height of 59 nm. Figure
4.6d is a topography image, profile and 3D representation of the nanotube at
150°C. The increased temperature results in loss of spatial volume, due to an
apparent collapse of the nanotube; with a narrower half-height width of 167 nm
and height of 12.3 nm. Occasionally along the nanotube axis pockets of higher
topography and width can be observed, however there is still a considerable
reduction in dimension sizes by comparison with the nanotube at lower
temperatures. Furthermore, in the 150°C (figure 4.6d) image granular material can
be observed on the mica surface which is not seen at lower temperatures.
Attempts to image the nanotubes at temperatures above 150°C were unsuccessful.
4.3.4 AFM ex situ heat imaging
Ex situ heat imaging of the nanotube samples was performed to investigate
whether the mechanical forces imposed by the AFM tip during high temperature
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imaging were responsible for the observed loss in nanotube structural integrity.
For the ex situ heat imaging experiment, the nanotube samples were heated and
then cooled before imaging at room temperature. The images presented in figure
4.7 are a series of typical high-resolution AFM topography images (left), with
cross-sectional profiles (middle) and 3-D representations of the surface (right) of
the same pair of nanotubes imaged at room temperature after heating to 24, 100,
125 and 150°C. The cross-sectional profiling positions are indicated by the line in
each topography image.
The images presented in figure 4.7a are of the nanotubes at 24°C. The nanotubes
are typical tubular structures with smooth surface topography and uniform half-
height width of 164 nm and height 96 nm. Figure 4.7b shows the nanotubes after
heat treatment to 100°C. The morphology of the nanotubes remains similar with a
slight loss in dimensions; half-height width 159 nm and height 81 nm. The jagged
appearance of the 3D representation and in the topography image along an edge of
the nanotube is most likely attributable to noise artefact during imaging rather
than a feature of the nanotubes. The images presented in figure 4.7c show the
nanotubes after heat treatment to 125°C. There is a slight change in surface
topography with a loss of the smooth outer wall appearance and depressions along
the surfaces of the nanotubes. However, a marginal increase in nanotube width to
168 nm and height to 88.2 nm is observed. A further increase in temperature to
150°C results in a considerable loss in the structural integrity of the nanotubes.
The images presented in figure 4.7d of the nanotubes after heat treatment to
150°C show this dramatic change in structure and topography. Pockets of narrow
and wide segments can be observed along the entire axis of the nanotubes. The
cross-sectional profiles highlight the difference in dimensions between the wider
(top) and narrower (bottom) sections. The wider sections have greater widths (256
nm) than those measured at lower temperatures but have considerably lower
heights around 24 nm, suggesting that in these regions the nanotubes have
collapsed and flattened. Whereas in the narrower segments, there is almost
complete loss of structure with the cross-sectional width measuring 203 nm and
height of 8 nm. In similarity to the in situ heat imaging background debris can be
observed deposited on the mica surface only in the 150 °C images. Furthermore,
attempts to image the nanotubes after heating to 200 °C were also unsuccessful.
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Figure 4.6: In situ heating of diphenylalanine nanotubes. AFM topography images (left) of
the same nanotube sample heated to a) 24 °C, b) 50 °C, c) 100 °C and d) 150 °C. Nanotube
samples were heated successively to each temperature. Cross-sectional line profiles (middle)
and 3D representation of the surface (right) are shown. Samples were heated to each
temperature and allowed to equilibrate for 5 minutes and then the temperature was
maintained throughout imaging. Immediately after each image was captured, the temperature
was increased. Scale bars represent 500 nm.
d
c
a
b
Mi
Chapter 4 Diphenylalanine nanotubes
- 165 -
Figure 4.7: Ex situ heating of diphenylalanine nanotubes. AFM topography images of
the same nanotube sample after heating to a) 24 °C, b) 100 °C, c) 125 °C and d) 150 °C.
Samples were heated to the desired temperature, allowed to equilibrate for 5 minutes,
then cooled to room temperature and equilibrated for a further 5 minutes before imaging.
Following imaging the samples were immediately heated to the next temperature. Cross-
sectional line profiles (middle) and 3D representation of the surface (right) are shown.
Scale bars represent 1 µm.
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For comparative purposes the average dimensions of the nanotube cross-sections
at each temperature for both the in situ and ex situ heat imaging experiments are
presented in graphical form in figure 4.8. Figure 4.8c shows the change in half-
height width and figure 4.8d the change in peak height with temperature for the in
situ imaging. The width of the nanotube remains reasonably constant up to 100°C,
after which there is a 66% loss in width. Similarly, the height measurements
follow the same trend, with a dramatic loss in height of 82 % occurring when the
temperature was raised to 150°C. The changing nanotube half-height width for the
ex situ imaging are presented in figure 4.8a and peak height in figure 4.8b. The
width of the nanotube remains moderately constant up to temperatures of 125°C
however, a further increase in temperature results in an increase in width. The
large error bars in these points are due to the variation in morphology of the
nanotubes with pockets of narrow and wide segments along the nanotube axis.
The height of the nanotube decreases marginally up to 125°C; however at 150°C
there is a dramatic loss of 81% in height.
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Figure 4.8: Graphical comparison of the change in widths and heights of the
diphenylalanine nanotubes with increasing temperature. Ex situ heating: the change
in nanotube 8a) half-height width and 8b) height with temperature. In situ heating: the
change in nanotube 8c) half-height width and 8d) height with temperature.
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4.3.5 Optical microscopy images of AFM cantilever following high-
temperature AFM imaging
Further investigation using optical microscopy of the AFM cantilevers used for
the ex situ and in situ temperature imaging revealed the presence of crystalline
deposits on the cantilevers and chips. The optical microscopy images of the AFM
cantilevers and chip used for the high-temperature in situ imaging are presented in
Figure 4.9. The image shown in figure 4.9a is of a cantilever at a magnification of
2.5 and a higher-resolution image at x 10 magnification is shown in figure 4.9b.
Extensive deposition of crystalline material along the edges of both the chip and
cantilever is observed with coverage particularly concentrated as larger crystals
around the tip region of the cantilever. The presence of this crystalline material
particularly around the tip region is most likely the cause of the unstable imaging
experienced in both the in situ and ex situ imaging experiments at 200 °C. The
presence of the deposited material would not only interfere with the reflection of
the laser but may also act as faux tips. Crystalline material was also observed on
the cantilevers used for ex situ imaging but to a lesser extent, which may be
attributable to the cantilever being a greater distance away from the sample
surface during heating.
4.3.6 TOF-SIMS analysis
TOF SIMS analysis was performed to determine the composition and origins of
the crystalline deposits which formed on the AFM cantilevers during high
temperature imaging.
Presented in figure 4.10 is the positive spectrum for the TOF SIMS analysis of the
silicon cantilevers. The spectrum reveals that despite extensive cleaning by a
process of plasma etching (20 Pa O2 at 100 W for 60 seconds) and UV cleaning
(10 minutes) prior to imaging, a residual contamination of poly(dimethylsiloxane)
(PDMS) was found to be present on the cantilevers. The presence of PDMS is
most likely attributed to the packaging conditions used for the storage of new
AFM cantilevers. However, by subtracting the peaks corresponding to the PDMS
contaminant (the spectrum reference for PDMS rubber from The Static SIMS
Library (SurfaceSpectra Ltd) can be found in appendix B) three peaks of interest
are observed at m/u 77, 91 and 120 (highlighted by arrows in figure 4.10). The
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Figure 4.9: AFM cantilever tips with crystalline deposits formed during high
temperature (200 °C) imaging of diphenylalanine nanotubes. Optical microscopy
images of the AFM cantilevers at a) x 2.5, and b) x 10 magnifications.
a
b
Chapter 4 Diphenylalanine nanotubes
- 169 -
Figure 4.10: TOF SIMS spectrum of AFM cantilevers with crystalline deposits
following heat treatment of the diphenylalanine nanotubes. The positive TOF
SIMS spectrum, with peaks of interest highlighted by the arrows at m/u of 77, 91 and
120. The suggested chemical structures of the molecules for these peaks and the
structure of phenylalanine (far right) are presented below.
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proposed chemical structures for these molecular weights are shown below the
spectrum in figure 4.10 and correspond to hydrocarbon compounds of C6H6 (m/u
77), C7H7 (m/u 91) and C8H10 (m/u 120). All three structures are fragments
comprising an aromatic ring, suggesting that the compounds can be attributed to
the varying degrees of fragmentation of phenylalanine, specifically containing the
aromatic side chain. The spectrum analysis therefore demonstrates that the
crystalline deposits observed on the AFM cantilever comprise aromatic fragments
of phenylalanine.
4.3.7 Magnetic Anisotropy
In the following experiments the influence of varying magnetic field strengths on
the orientation and alignment of the diphenylalanine nanotubes has been
investigated. Solutions of diphenylalanine nanotubes were evaporated under
different magnetic field strengths and the residues were imaged by AFM.
Presented in figure 4.11 are the AFM topography images and respective polar
plots of nanotube samples that have been evaporated in different magnetic fields
of 0, 0.5, 3, 7 and 12 Tesla. The polar plots show the distribution of nanotube
orientation relative to the magnetic field direction for each image and therefore
give an indication of nanotube anisotropy with the magnetic field. In the simplest
interpretation of the polar plot, the ellipticity of the plot is an indication of the
materials anisotropy: a circular plot would denote no alignment of the nanotubes,
whereas a figure of eight shape indicates perfect alignment; intermediate of these
extremes would give a plot with an hour glass shape with the smaller the neck
indicating more alignment.
The morphology and range of half-height widths (0.5 to 2.0 µm) displayed by the
nanotubes in all the samples exposed to the magnetic fields are in agreement with
that observed in the control samples not exposed to an applied magnetic field
(figure 4.11a). Furthermore, the dimensions and morphology displayed are
concurrent with published data from early EM studies of diphenylalanine
nanotubes [86, 220].
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The topography image and polar plot shown in figure 4.11a are of the control
sample at 0 Tesla magnetic field. Both the circular polar plot and the lack of
visible orientation of the nanotubes in the topography image indicate there is no
alignment in the sample. Similarly in the 0.5 Tesla sample (figure 4.11b), there is
no evidence in the topography image that there is alignment of the nanotubes by
the magnetic field. However, the shape of the polar plot suggests there is slight
alignment of the nanotubes within the sample but very weakly associated with the
direction of the magnetic field. In the topography image presented in figure 4.11c
of the 3 Tesla sample some of the nanotubes appear orientated with the direction
of the magnetic field. The polar plot for the sample provides further support for
this indicating a slight preference for alignment in a direction close to that of the
magnetic field. The topography images presented in figures 4.11d and e of the 7
and 12 Tesla samples, respectively, clearly display alignment of the nanotubes
with their long axis parallel to the direction of the magnetic field. The polar plots
provide further support for this, with the 12 Tesla sample displaying a stronger
anisotropy with the direction of the field strength.
An observation worth noting is the small, yet significant, number of nanotubes
that remain misaligned in the highest field strengths (12 Tesla, see figure 4.11e).
Although the majority are aligned, it may be supposed that the nanotubes which
are not, have been restrained either due to substrate interactions or have been
pinned in place by neighbouring under and over lying nanotubes and are thus
unable to orientate in the field.
A quantitative comparison of the alignment of the nanotubes with increasing
magnetic field strength may be drawn by plotting the ratio of the maximum to
minimum average projection values of the nanotubes in each image versus the
relative magnetic field strength. The plotted graph is presented in figure 4.12 and
a linear relationship between the ratio of projected value to magnetic field strength
can be seen. Concluding therefore that as the magnetic field strength increases, the
degree of diphenylalanine nanotube anisotropy to the magnetic field increases.
Figure 4.11: AFM images of diphenylalanine nanotubes with the relative anisotropy polar plots under differing field strengths. Topography
images of the diphenylalanine nanotubes after exposure to magnetic field strengths of a) 0 Tesla, b) 0.5 Tesla, c) 3 Tesla, d) 7 Tesla and e) 12 Tesla, the
direction of the applied magnetic field (B) relative to the sample is also shown. Scale bar represents 25 µm. Beneath each AFM image are the polar plots
calculated to determine the anisotropy of the nanotubes relative to the magnetic field.
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To establish whether the observed alignment of the diphenylalanine nanotubes is
an inherent characteristic of peptide-based fibrillar structures, a control
experiment was performed using samples of amylin (20-29) fibrils. Samples of
azide and alkyne functionalised amylin (20-29) peptides were allowed to pre-form
before placing in a 12 Tesla magnetic field to evaporate overnight. The AFM
topography image and relative polar plot of the sample are presented in figure
4.13. The morphology and dimensions of the amylin fibrils concur with those
previously observed in Chapter 3. The samples of amylin (20-29) biofibrils do not
display any preferred orientation in the AFM topography image and together with
the circular appearance of the corresponding polar plot indicate no alignment
under the 12 Tesla magnetic field.
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Figure 4.12: Ratio of maximum to minimum alignment versus applied
magnetic field. The line graph is the change in the ratio of the maximum
alignment value to the minimum value versus the increase in magnetic field
strength. The maximum and minimum alignment values are obtained from the
maximum and minimum average projection values for the sample.
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Figure 4.13: Ex situ AFM image of amylin (20-29) following exposure to 12 T
magnetic field. Figure 13a is a topography image of amylin (20-29) fibrils after
overnight exposure to a 12 T magnetic field. The direction of the applied magnetic
field (B) relative to the sample is shown. Figure 13b is the polar plot calculated to
determine the anisotropy of the peptide fibrils relative to the magnetic field.
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4.4 Discussion
The focus of the experiments presented in this chapter are the nanotubes which
self-assemble from the core recognition motif of the ȕ-amyloid polypeptide; a
simple dipeptide of phenylalanine. The dipeptide readily self-assembles under
mild conditions to form discrete tubular structures. The mechanical properties of
the diphenylalanine nanotubes reveal these structures to have a high degree of
rigidity and stiffness by comparison with other bionanomaterials [220]. Here we
have investigated the physical properties of the nanotubes by AFM, building on
and corroborating current knowledge of the thermal and chemical stability from
EM, CD spectroscopy and thermo gravimetric experiments [245]. One advantage
AFM possesses over EM which is of particular relevance to the study of the
thermal and chemical stability, is the ability to directly visualise specimens
without drying and coating; a preparative process which could directly influence
or alter the properties of the nanotubes.
In this chapter diphenylalanine nanotubes have been successfully imaged by AFM
in both dry conditions and in solution. AFM imaging of the nanotubes in solution
required an aqueous organic solvent environment with stable images generated in
solutions of 50% acetone using mica as the substrate. The diphenylalanine
nanotubes observed display the same characteristics irrespective of imaging in a
dried or hydrated form: the nanotubes were discrete, long tubular structures with
uniform morphologies displaying diameters in the range of 0.1 to 2 µm (figures
4.3 and 4.4) and were in agreement with published EM data [86, 220, 221, 229].
In addition, imaging of the nanotubes in aqueous acetone further demonstrates the
chemical stability of these structures in an organic solvent.
The thermal stability of the diphenylalanine nanotubes was investigated under wet
heating and dry heating conditions using the AFM. AFM images of samples
following autoclaving (121°C, 1.2 atmospheres) demonstrate that the nanotubes
retain structural integrity following wet heating conditions. The ability to
withstand autoclave treatment is a highly desirable property when considering the
potential applications for these nanostructures. The ability to undergo autoclaving
as a sterilisation technique may be a prerequisite for use of the nanotubes in any
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application that required aseptic conditions, for example as tissue engineering
scaffolds or biosensors.
The AFM in situ and ex situ dry heat imaging of the diphenylalanine nanotubes
demonstrates the thermal stability up to 100°C with no deterioration in
morphology or structure (figures 4.6a & b and 4.7a & b). However, as the
temperature is progressively increased above this, structural changes begin to
occur in the nanotubes (figures 4.6c & d and 4.7c & d); there is loss in structural
integrity and the nanotubes appear to collapse. Furthermore, significant deposition
of granular material on the mica substrate can be seen at temperatures of 150°C
(figures 4.6d and 4.7d), and crystalline deposits (figure 4.10) form on the AFM
cantilever at temperatures of 200°C (figure 4.9), preventing the generation of
stable images.
The AFM images clearly demonstrate the changes in diphenylalanine nanotube
structure as the samples are heated above 100°C. However, to establish whether
the deterioration in nanotube structure observed in the in situ heating experiment
was due solely to the temperature or was a result of the mechanical deformation
caused by the oscillating AFM probe during high-temperature imaging, the
samples were heated and then imaged at room temperature (ex situ heating).
Ideally for a direct comparison of the in situ and ex situ AFM heating, the same
sample of nanotubes would be heated. However the nature of the experiment
prevents this as the same nanotube cannot be reheated, and as such the example
nanotubes were chosen on the basis of their similarity in dimension. Imaging
parameters were kept as constant as possible and the AFM tapping tips that were
used have a nominal spring constant of 42 N/m and were raster scanned across the
sample surface at a rate of 0.5-0.8 Hz with an oscillating downward tapping
frequency of 320 kHz. The results clearly indicate the collapse of the nanotubes as
they are progressively heated by both in situ and ex situ AFM heating.
Furthermore, a dramatic loss of ~80% in height upon heating the nanotubes to
150°C was observed in both in situ and ex situ heating conditions (figure 4.8). The
data strongly suggests that at higher temperatures the nanotubes lose structural
integrity and that the degradation and deformation is not solely attributable to the
mechanical forces of the oscillating AFM tapping tip; temperature alone is the
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controlling factor. However, once the nanotubes are heated to 150°C, the samples
will be deformed no matter at what temperature the sample is imaged.
In a recent study, thermo-gravimetric analysis (TGA) was used to assay the
thermal degradation of diphenylalanine nanotubes. In TGA studies the change in
weight of a sample as a function of increasing temperature is measured [245]. The
thermogram (figure 4.14) from this experiment shows a 15% loss in nanotube
mass at around 50°C followed by a steady decrease in weight as the temperature
increases, which is attributed to loss of water from the nanotubes. At around
150°C there is an acute 10 % drop in mass, followed by a plateau at 175°C until a
dramatic loss in weight at temperatures above 300°C. Considering this data
together with our AFM and TOF SIMS findings we can suggest that at
temperatures up to 100°C, the limited changes observed in nanotube integrity are
due to loss of water from the diphenylalanine nanotubes. As the temperature was
raised to 150°C, in both the in situ and ex situ AFM heating images there was
considerable degradation of the nanotubes and loss of structural integrity together
with the appearance of granular deposits on the mica substrate. This is concurrent
with a dramatic loss of 10 % mass noted in the TGA data between 150 and 175°C.
Figure 4.14: TGA data of diphenylalanine nanotubes and alanine dipeptides
(Source Adler-Abramovich et al 2006 [245]) The black line indicates the
diphenylalanine nanotube experiment. A sample of alanine dipeptides, which do not self-
assemble to form nanotubes, was also studied as the control (red line). The colour of the
dotted line in figure 14a corresponds to the feature highlighted by the same colour arrow
in figure 14b.
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Consideration of these findings together with our TOF SIMS analysis of the
phenylalanine crystal deposits on the cantilevers, suggests that the observed
deterioration and loss in mass at temperatures at and above 150°C is due to the
loss of free phenylalanine from the nanotubes. Phenylalanine will at temperatures
of 130°C, sublime under vacuum and decomposes at 283°C, whereas
diphenylalanine does not [248]. Therefore we suggest that as the temperature is
raised, sublimation of phenylalanine molecules and their fragments from the
nanotubes occurs, collecting as crystal deposits on the cantilever within the AFM.
The evidence suggests therefore that heat-induced degradation of the nanotube’s
structural integrity occurs initially by the loss of water from the hollow water-
filled nanotubes; as the temperature is increased, the nanotubes appear to deform
suggesting that the walls are collapsing with loss of nanotube structural integrity.
Thermal degradation of the diphenylalanine building blocks occurs as the
temperature is further increased with loss of free phenylalanine from the tubes due
to sublimation, resulting in the observed flat ribbon-like structure.
The thermal stability study of diphenylalanine nanotubes suggests that the
nanotubes will withstand autoclaving as a potential sterilisation technique.
Furthermore, the dry heating experiments demonstrate that it may be possible to
use heat and localised mechanical forces to selectively deform the diphenylalanine
nanotube. One key factor in developing novel applications for these nanotubes is
the ability to control and manipulate their use as innovative materials.
In the final section of this chapter the application of magnetic fields to directly
manipulate the orientation of diphenylalanine nanotubes has been investigated.
The AFM images of diphenylalanine nanotube samples evaporated in different
magnetic field strengths (figure 4.11) provide direct evidence for the alignment of
the nanotubes in high magnetic fields (12 Tesla). Furthermore, a linear correlation
is observed when the degree of sample anisotropy under each magnetic field is
plotted against field strength (figure 4.12). By comparison when the control
sample of amylin (20-29) fibrils was positioned within the highest strength (12
Tesla) magnetic field, no anisotropy was observed (figure 4.13).
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The alignment of the nanotubes within a magnetic field arises due to the net
diamagnetic susceptibility of the structure. When a substance is placed in a
magnetic field it will experience a force tending to turn it into the position of
minimum potential energy, thus leading to the alignment of like-substances in a
sample. The diamagnetic anisotropy of most proteins is attributed to the
anisotropy of the peptide bond, resulting from the resonance of its planar partial
double-bond [244]. The cumulative contribution of the individual peptide bond
anisotropies to the net anisotropy of the protein arises due to the regular structural
organisation of the polypeptide chain in secondary structures (Į helix and ȕ-
sheets).
However, the aromatic ring has anisotropy 10 times greater than that of the
peptide bond [242]. In most proteins the aromatic content is very low, but within
the diphenylalanine nanotubes there is 1 aromatic ring per peptide bond.
Therefore the dominant contributor to the net diamagnetic anisotropy of the
nanotubes is most likely the aromatic rings. The large diamagnetic anisotropy of
the aromatic rings arises due to ʌ-ʌ interactions that govern the regular packing of
the phenylalanine side chains within the nanotubes.
In diamagnetic material, the orbital motion of electrons creates atomic current
loops (magnetic moments), which produce magnetic fields. When placed inside an
applied magnetic field the moving charges will generate fields opposing the
applied field. In terms of the aromatic side chains of the phenylalanine, the
delocalised ring of ʌ-electrons of each aromatic ring act as a magnetic dipole and
will align opposing the applied magnetic field. The resultant torque imposed as
the aromatic rings try to align in the magnetic field causes the rotation of the
nanotubes and alignment in the sample. From the AFM images we can observe
that the nanotubes are aligning with their long axis parallel to the magnetic field.
Consequently, our experimental observations may provide empirical evidence to
support or rule out future models for the arrangement of the diphenylalanine
residues within the nanotubes. Currently, within the collaborative group, work is
underway to generate a model of the nanotube structure based around a constraint
on the average ring orientation of the dipeptides within the nanotubes. The
constraint was derived from the magnetic alignment direction of the nanotubes
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within the AFM images and may provide an insight into the possible ultrastructure
of the nanotubes.
4.5 Conclusion
Diphenylalanine peptide nanotubes were for the first time successfully imaged in
solution using the AFM. The thermal stability of the nanotubes under wet and dry
heating was probed using the AFM, revealing their structural stability following
autoclave treatment and under dry heating up to 100°C. As the temperature is
progressively increased the nanotubes loose structural integrity due to the thermal
degradation of the diphenylalanine building blocks, as free phenylalanine
sublimes from the nanotube resulting in loss of mass and spatial volume.
Furthermore, we show that high magnetic fields can be used to directly align the
diphenylalanine nanotubes. The findings presented in this chapter display the
ability to directly manipulate the diphenylalanine nanotubes demonstrating their
potential to produce well-ordered functional and exploitable nanomaterials with
considerable thermal stability.
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Chapter
5
General Conclusions
The work presented in this thesis has focussed on the investigation of self-
assembling peptides utilising both in situ and ex situ AFM. Short peptide
sequences are well established as model systems for the study of amyloid. This is
due to the comparative ease with which the shorter fragments can be synthesised
and prepared. However, pivotal to this work is the identification that key
fragments within the full-length amyloidogenic polypeptides are crucial to the
self-assembly mechanism and readily assemble in isolation to form amyloid-like
nanostructures.
The ability of short peptide fragments to self-assemble into fibrillar structures
demonstrates that the capacity for well-ordered fibril formation is retained within
these shortened sequences. However, the structures which assemble from these
fragments are often morphologically distinct. Consequently, amyloid formation by
the full-length polypeptide chain is more complex than might be revealed from
fibrillisation studies of these key fragments and the influence of the remaining
polypeptide chain must be considered if a true representation of the mechanism is
to be determined. However, the ability of the self-assembling peptide to form a
variety of distinct amyloid and amyloid-like structures with unique properties and
exploitable characteristics makes their use as potential nanomaterials highly
versatile.
Within this thesis two peptide systems have been studied; the peptide fragment
corresponding to amino acid residues 20 to 29 of the human amylin polypeptide
and an aromatic dipeptide corresponding to residues 19 and 20 of the ȕ-amyloid
polypeptide. The former peptide contains the minimal core amyloidogenic
fragment (NFGAIL) of the amylin polypeptide, and the latter is the smallest
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fragment of the ȕ-amyloid polypeptide known to self-assemble. Both peptides
readily self-assemble into fibrillar structures under simple conditions.
In the introductory chapter of this work, an overview of the current understanding
of amyloid assembly, characterisation and properties has been presented,
highlighting the important role the AFM has contributed to the many
advancements made in understanding this complex world of peptide self-
assembly. Within this final chapter, the findings and general conclusions of the
experimental studies presented in this thesis will be discussed in light of the
current understanding of amyloid formation and the implications for the
development of strategies for the generation of novel controllable and specialised
fibrillar materials. Nanofibrillar material have already been utilised in applications
ranging from microelectronics to tissue engineering scaffolds for regenerative
growth.
The first experimental study presented within this thesis addressed the self-
assembly of the amylin (20-29) peptide fragment. This fragment has long been
recognised to play a key role in the interactions governing amylin assembly into
amyloid fibrils and has been studied by several research groups as a model for
amyloid formation. However, these studies have predominantly concentrated on
the mature fibrils, with no direct visual observation of the early stages in
fibrillisation. To this end, a preliminary AFM study which focussed on younger
solutions of amylin (20-29) was undertaken. The formation of fibrils was
observed by ex situ imaging after an initial lag period of only 4 hours, with visible
fibril polymorphisms noted in samples aged 18 hours. In samples of fibrils aged
up to 6 hours, periodicity was noted in the fibrils, reminiscent of the pre-fibrillar
globular protofilaments noted in other amyloid samples [56]. However, over the
time-course studied these younger fibril morphologies were replaced by mature
fibrils (aged >18 hours) which were straight flat ribbon-like structures displaying
a range of morphologies, in agreement with those previously observed by EM and
AFM [43, 44, 49].
One of the major contributions that the AFM has facilitated in the study of
amyloid formation is the capacity to directly visualise dynamic events in an
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aqueous environment, providing vital insights into the fibril assembly
mechanisms. Within Chapter 2, the influence of a range of solution conditions on
amylin (20-29) fibril formation was directly visualised by in situ AFM. AFM
images revealed that a range of morphologies including truncated ribbons, long
unbranched fibrils, shorter fibrils and globular aggregates were formed dependent
on the pH, electrolyte composition and ionic strength of the solution. Fibril
dimensions were also influenced by electrolyte composition. Successful in situ
imaging of the amylin (20-29) fibrils facilitated kinetic studies to be made for the
first time on the growth of fibrils. Growth rates varied between individual fibrils,
ranging from 2 to 11 nm min-1 on the mica surface. By comparison the published
rate of full-length amylin fibrillisation is much slower at 1.1 nm min-1 [44].
The findings within Chapter 2 demonstrate that different amyloid assembly
pathways may be triggered by variations in environmental conditions. Similar
findings have been reported for other amyloid fibrils [128] and provide further
support that these well-ordered supramolecular structures may assemble via
various pathways which may also include off-pathway events. Understanding the
mechanisms that underpin amyloid fibril assembly are vital to the development of
a full knowledge of amyloid, not only from a medical perspective for the
development of therapeutics, but also for the recognition that these highly-ordered
structures may be exploited as novel peptide-based nanofibrillar material.
The studies presented in Chapter 3 address the potential use of the amylin (20-29)
peptide fibrils as specifically functionalised structures. This work investigates
whether fibrils can be assembled from naturally occurring peptides which have
been chemically modified to produce nanofibrillar structures that display a
specific function. Azide and alkyne functional moieties were successfully coupled
to the N-terminal of the amylin (20-29) peptide sequence. AFM investigations
revealed the modified peptides readily self-assemble to form fibrillar structures
displaying similar morphologies to non-functionalised amylin (20-29) fibrils.
Furthermore, Congo red binding indicated that the modified fibrils have retained
the core ȕ-sheet ultrastructure and thus are amyloidogenic in nature. However, the
fibrils that formed displayed smaller widths and heights suggesting that the
moieties may influence the packing and assembly of the fibrils. These findings
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demonstrate that the additional steric bulk of the functional moieties do not
impose any detrimental affects on the fibril forming potential of the peptide
fragments, but may influence the higher-order fibrillar packaging.
These observations have two implications, in the first instance, they provide
further information regarding the interactions and packaging of the peptide fibrils
within the amyloid core. This suggests that fibril formation will proceed providing
the ordered ȕ-sheet core can still form; any additional steric bulk outside of the
core amyloidogenic region may influence the structural hierarchy but not the
capacity to form amyloid. Secondly, this result demonstrates that fibrillar
structures displaying all the intrinsic characteristics of amyloid may be self-
assembled from chemically tailored individual building blocks, generating
functionalised supramolecular structures. During attempts to form covalently
linked fibrillar networks of the azide and alkyne functionalised fibrils using the
1,3-dipolar cycloaddition reaction of alkyne and azides an increase in the fibril
population dimensions was observed that was dependent on the catalyst
concentration present and the stage during fibril formation that the ions were
added. Despite no significant change in morphology or aggregation into novel
fibrillar network, this increase in dimensions suggests that the reaction may have
been successful but with low efficieny. This can most likely be attributed to
unfavourable conformational and steric presentation of the functional moieties for
the formation of triazole ring linkers between fibrils. However, this does not rule
out the potential of this chemistry for other applications including the generation
of decorated fibrils with function specific ligands or the immobilisation of fibrils
to a functionalised support or scaffold.
The focus of Chapter 4 is the second of the two peptide systems, the
diphenylalanine peptide. The structures that readily self-assemble under mild
conditions from the dipeptide are large, water-filled nanotubes which display a
range of dimensions from 100s of nanometres in diameter and microns in length.
The scope of possible applications for these diphenylalanine nanotubes is already
being explored with proven success in microelectronics and biosensors. As with
all material engineering, understanding the fundamental properties and principles
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of the building blocks will enable their full potential to be realised and novel
applications for the materials to be developed.
In the opening experiments of Chapter 4, the AFM is used to study the physical
properties of the diphenylalanine nanotubes. In situ imaging of the nanotubes in
an organic solvent demonstrates their chemical stability even with prolonged
exposure and repeated imaging. Furthermore, the nanotubes exhibited
considerable thermal stability under both dry and wet heating conditions;
indicating that the nanotubes retain structural integrity at high temperatures. The
ability to withstand wet heating conditions suggests that the nanotubes may be
used in applications requiring sterilisation, such as biosensors and tissue
engineering. During in situ and ex situ dry heating of the nanotubes a loss of wall
integrity was observed at 125ºC with loss of structural integrity at temperatures
above 150ºC. TOF SIMS analysis identified the decomposition of structure to be
the result of sublimation of free phenylalanine from the nanotubes. Suggestive
that the nanotubes may be degraded at higher temperatures, indicative of their
potential use as thermally degradable devices.
In the final experiment of this thesis the potential to directly control and orientate
the diphenylalanine nanotubes using magnetic fields is examined. X-ray
crystallographers have previously probed the use of magnetic fields to produce
highly-orientated crystals for the elucidation of biomolecular structures, including
some amyloid fibrils. Following evaporation of phenylalanine nanotubes samples
within different magnetic fields, AFM imaging revealed the nanotubes became
increasingly orientated with the direction of the magnetic field with intensifying
field strengths. Under magnetic field strength of 12 T there was almost complete
alignment of the nanotubes. Consequently, strong magnetic fields may be a useful
tool for future manipulation of the diphenylalanine nanotubes, demonstrating the
potential to produce well-ordered functional and exploitable nanomaterials with
considerable thermal stability.
Throughout this thesis the results generated are testament to the effectiveness and
versatility of the AFM in the study of peptides which self-assemble into amyloid
and amyloid-like structures. The high-resolution images generated provide
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detailed information on both static and dynamic events during fibrillisation, as
well as providing insights into the physical properties of these fibrillar structures.
The application of AFM in the study of amyloid and their resultant fibrillar
nanostructures can only strengthen with the continuing developments in the
technology. From achieving higher-resolution images by improved tip geometries
through the utilization of carbon nanotubes, to the development of high-speed
scanning to enable real-time images of amyloid fibrillisation events.
In conclusion, the results presented throughout this thesis have revealed the
potential of self-assembling peptides for the production of fibrillar nanostructures.
By direct modification and manipulation, the ideal intrinsic or engineered
properties of the fibrillar structures can be utilized to generate novel architectures
and functionalised well-ordered nanomaterials.
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Appendix A
Animations
The animations on the enclosed CD contain time-lapse sequence of images of amylin
(20-29) fibrillisation in 100 mM sodium acetate (pH5.5). The images presented are
also displayed in figure 2.19.
To view animation in full, copy and paste file to Desktop and open.
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Appendix B
TOF SIMS spectra for poly(dimethylsiloxane)
The positive spectra for poly(dimethylsiloxane) (PDMS) rubber. Spectra from The
Static SIMS Library (SurfaceSpectra Ltd).
